L	R	pw.id	pw.name	pval	qval	LR.corr	rank	len	rank.corr
ADAM15	ITGB1	R-HSA-1500931	Cell-Cell communication	0.114614825923543	0.127904794065651	0.350597388163379	6	12	-0.144763961347661
ADAM15	ITGB1	R-HSA-1566948	Elastic fibre formation	0.0503569167267422	0.0673617710691683	0.350597388163379	2	4	-0.0242848608645396
ADAM15	ITGB1	R-HSA-216083	Integrin cell surface interactions	0.0329143488859686	0.0510261365432204	0.350597388163379	10	19	0.0734092803556544
ADAM15	ITGB1	R-HSA-3000157	Laminin interactions	0.0464746056030278	0.0638358088455382	0.350597388163379	4	9	-0.0320088913587108
ADAM15	ITGB1	R-HSA-3000170	Syndecan interactions	0.0562000330609627	0.0735317950815881	0.350597388163379	3	6	-0.0242848608645396
ADAM15	ITGB1	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0846949866424052	0.0989169158574072	0.350597388163379	6	11	-0.0320088913587108
ADAM15	ITGB1	R-HSA-3000178	ECM proteoglycans	0.0654290718507703	0.0819434838724931	0.350597388163379	6	12	-0.0242848608645396
ADAM15	ITGB1	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.120144016101701	0.132899944745234	0.350597388163379	36	66	-0.0221172547929981
ADAM15	ITGB1	R-HSA-6806834	Signaling by MET	0.121340690699924	0.133642511876875	0.350597388163379	17	32	-0.0679633231453182
ADAM15	ITGB1	R-HSA-8874081	MET activates PTK2 signaling	0.0612720426727818	0.0781014303935725	0.350597388163379	3	6	-0.0403445401500417
ADAM15	ITGB1	R-HSA-8875878	MET promotes cell motility	0.0857411055961189	0.0999615816462069	0.350597388163379	7	13	-0.0320088913587108
ADAM9	ITGAV	R-HSA-3000157	Laminin interactions	0.0380877512314935	0.0556756730539874	0.57882745207002	3	6	-0.40577938316199
ADAM9	ITGB5	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0354744705399764	0.0533792138030705	0.457038123071486	2	4	-0.067569287884304
APOC1	VLDLR	R-HSA-174824	Plasma lipoprotein assembly, remodeling, and clearance	0.162525848524009	0.166949904572657	0.284735381513006	6	12	-0.165320750676901
APOC1	VLDLR	R-HSA-8964043	Plasma lipoprotein clearance	0.0874789249033601	0.10182206031771	0.284735381513006	5	10	-0.0288974790415201
APP	GPC1	R-HSA-1630316	Glycosaminoglycan metabolism	0.114127830853954	0.127559867065136	0.287079744373437	28	52	0.00861350375104196
APP	GPC1	R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.131085513918629	0.141976304349935	0.287079744373437	9	18	-0.0767991108641289
APP	GPC1	R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.143368756467392	0.153197315032966	0.287079744373437	6	12	-0.123867741039178
APP	GPC1	R-HSA-196854	Metabolism of vitamins and cofactors	0.120345948438838	0.132899944745234	0.287079744373437	3	7	-0.181545309957933
APP	GPC1	R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.169802812744997	0.173554692427887	0.287079744373437	4	9	-0.278949565010362
APP	GPC1	R-HSA-2022928	HS-GAG biosynthesis	0.139649001711862	0.149445274966276	0.287079744373437	3	6	-0.181545309957933
APP	GPC1	R-HSA-2187338	Visual phototransduction	0.160038491878321	0.164867239478098	0.287079744373437	5	10	-0.181545309957933
APP	GPC1	R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.13672734486444	0.147197456858563	0.287079744373437	6	11	-0.0767991108641289
APP	GPC1	R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.139649001711862	0.149445274966276	0.287079744373437	3	6	-0.181545309957933
APP	GPC1	R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.139649001711862	0.149445274966276	0.287079744373437	3	6	-0.181545309957933
APP	GPC1	R-HSA-3656237	Defective EXT2 causes exostoses 2	0.139649001711862	0.149445274966276	0.287079744373437	3	6	-0.181545309957933
APP	GPC1	R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.139649001711862	0.149445274966276	0.287079744373437	3	6	-0.181545309957933
APP	GPC1	R-HSA-3781865	Diseases of glycosylation	0.154850194469846	0.160762315792561	0.287079744373437	33	61	-0.0227285357043623
APP	GPC1	R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.139649001711862	0.149445274966276	0.287079744373437	3	6	-0.181545309957933
APP	GPC1	R-HSA-5668914	Diseases of metabolism	0.148929120956583	0.157728478177061	0.287079744373437	46	84	-0.00211169769380383
APP	GPC1	R-HSA-6806667	Metabolism of fat-soluble vitamins	0.120345948438838	0.132899944745234	0.287079744373437	3	7	-0.181545309957933
APP	GPC1	R-HSA-71387	Metabolism of carbohydrates	0.147883415021265	0.156852675399774	0.287079744373437	75	137	0.00861350375104196
APP	GPC1	R-HSA-975634	Retinoid metabolism and transport	0.120345948438838	0.132899944745234	0.287079744373437	3	7	-0.181545309957933
ARPC5	ADRB2	R-HSA-5688426	Deubiquitination	0.125750028178312	0.137129688522966	0.377493748263407	40	73	-0.108030008335649
ARPC5	ADRB2	R-HSA-5689880	Ub-specific processing proteases	0.12595624798135	0.137250197268431	0.377493748263407	26	48	-0.164267852181161
ARPC5	ADRB2	R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.115818495865092	0.128846953507015	0.377493748263407	28	51	-0.0543484301194776
ARPC5	ADRB2	R-HSA-8856828	Clathrin-mediated endocytosis	0.110761603155301	0.124402749038219	0.377493748263407	53	98	-0.0229508196721312
ARPC5	ADRB2	R-HSA-9660821	ADORA2B mediated anti-inflammatory cytokines production	0.0839775699396891	0.0982249880044977	0.377493748263407	9	18	-0.0715198666296194
ARPC5	ADRB2	R-HSA-9662851	Anti-inflammatory response favouring Leishmania parasite infection	0.12074179328983	0.133085112665347	0.377493748263407	31	57	-0.0726312864684635
ARPC5	ADRB2	R-HSA-9664433	Leishmania parasite growth and survival	0.12074179328983	0.133085112665347	0.377493748263407	31	57	-0.0726312864684635
B2M	HLA-F	R-HSA-909733	Interferon alpha/beta signaling	0.0360102541870492	0.0539589388758919	0.546540705751598	6	12	-0.121367046401778
BMP6	BMPR2	R-HSA-201451	Signaling by BMP	0.0831217805738438	0.0975422531447562	0.402334645889626	4	8	-0.159488746874132
BMP6	BMPR2	R-HSA-9006936	Signaling by TGF-beta family members	0.0968949908232197	0.11080336271172	0.402334645889626	15	29	-0.0958599611003057
BMP8B	BMPR2	R-HSA-201451	Signaling by BMP	0.0324236811608351	0.0504422005629123	0.56398999722145	4	8	-0.159488746874132
BMP8B	BMPR2	R-HSA-9006936	Signaling by TGF-beta family members	0.0377962582952984	0.0554757772727308	0.56398999722145	15	29	-0.0958599611003057
CALM1	PTPRA	R-HSA-375165	NCAM signaling for neurite out-growth	0.0666611699260843	0.0826206721469359	0.3939427618783	11	21	-0.0202834120589053
CALM1	PTPRA	R-HSA-5673001	RAF/MAP kinase cascade	0.0742814496681967	0.0898899568136659	0.3939427618783	44	80	0.0191164212281189
CALM1	PTPRA	R-HSA-5683057	MAPK family signaling cascades	0.102093307122299	0.116099764007436	0.3939427618783	58	106	-0.0151153098082801
CALM1	PTPRA	R-HSA-5684996	MAPK1/MAPK3 signaling	0.0732940319749491	0.0889954630415555	0.3939427618783	45	83	0.0137267978426935
CALM1	PTPRA	R-HSA-9607240	FLT3 Signaling	0.0648029779095436	0.0813013738602673	0.3939427618783	48	88	0.0265073631564323
CALM2	SCN4A	R-HSA-373760	L1CAM interactions	0.166513802462564	0.170588913326939	0.311308696860239	17	31	-0.119507078464971
CALM2	SCN4A	R-HSA-397014	Muscle contraction	0.0771241839946677	0.0919335659587311	0.311308696860239	46	85	0.0358988607946652
CALM2	SCN4A	R-HSA-445095	Interaction between L1 and Ankyrins	0.170825179479864	0.174475290152511	0.311308696860239	5	10	-0.37732703528758
CALM3	ABCA1	R-HSA-174824	Plasma lipoprotein assembly, remodeling, and clearance	0.114980960932226	0.128213606513851	0.388607946651848	4	9	-0.368197972543393
CALM3	ABCA1	R-HSA-9024446	NR1H2 and NR1H3-mediated signaling	0.102579807057128	0.116468284497166	0.388607946651848	6	12	-0.176493470408447
CALM3	ABCA1	R-HSA-9029569	NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux	0.108055891720641	0.122009565927086	0.388607946651848	6	11	-0.176493470408447
CALM3	KCNQ1	R-HSA-5576891	Cardiac conduction	0.0568251694509377	0.0740523601477475	0.426618505140317	25	46	0.0135593220338983
CALM3	SCN4A	R-HSA-373760	L1CAM interactions	0.129553108122618	0.140848489043089	0.365045846068352	17	31	-0.119507078464971
CALM3	SCN4A	R-HSA-397014	Muscle contraction	0.0600051022807927	0.077190363842086	0.365045846068352	46	85	0.0358988607946652
CALM3	SCN4A	R-HSA-445095	Interaction between L1 and Ankyrins	0.132907498477167	0.143516078927905	0.365045846068352	5	10	-0.37732703528758
CALR	HLA-F	R-HSA-909733	Interferon alpha/beta signaling	0.060510114212322	0.0775480553222079	0.459849958321756	6	12	-0.121367046401778
CALR	HLA-F	R-HSA-913531	Interferon Signaling	0.0369192460294014	0.054748912932949	0.459849958321756	26	49	0.0236732425673798
CD14	ITGA4	R-HSA-8878159	Transcriptional regulation by RUNX3	0.122516602825514	0.134421429572905	0.377610136326193	15	29	-0.160130037943183
CD14	ITGA4	R-HSA-8949275	RUNX3 Regulates Immune Response and Cell Migration	0.108618221572601	0.122451674320055	0.377610136326193	2	4	-0.341849706197289
CD14	TLR4	R-HSA-1236974	ER-Phagosome pathway	0.0485449685557879	0.0657397676983639	0.366323978883023	8	15	0.037454848569047
CD14	TLR4	R-HSA-1236975	Antigen processing-Cross presentation	0.0368543746396756	0.0547092890613817	0.366323978883023	12	22	0.0742428452347875
CD14	TLR4	R-HSA-140534	Caspase activation via Death Receptors in the presence of ligand	0.100181624918933	0.114197496131756	0.366323978883023	5	10	-0.140427896637955
CD14	TLR4	R-HSA-5260271	Diseases of Immune System	0.0963368546944483	0.110253032427645	0.366323978883023	8	15	-0.0696860238955265
CD14	TLR4	R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	0.100181624918933	0.114197496131756	0.366323978883023	5	10	-0.140427896637955
CD14	TLR4	R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.0963368546944483	0.110253032427645	0.366323978883023	8	15	-0.0696860238955265
CD14	TLR4	R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.0496967134786669	0.0666028851667368	0.366323978883023	3	6	-0.0159488746874132
CD14	TLR4	R-HSA-5686938	Regulation of TLR by endogenous ligand	0.0447569456301832	0.0618318497434322	0.366323978883023	2	4	-0.0159488746874132
CD14	TLR4	R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.0811749283172032	0.0956490116736807	0.366323978883023	4	9	-0.140427896637955
CD14	TLR4	R-HSA-937072	TRAF6-mediated induction of TAK1 complex within TLR4 complex	0.0375999292016467	0.0553575959703915	0.366323978883023	6	11	0.0742428452347875
CD14	TLR4	R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.0375999292016467	0.0553575959703915	0.366323978883023	6	11	0.0742428452347875
CD40LG	TRAF3	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.159713747411628	0.164658363144128	0.328146707418727	46	85	-0.152986940816894
CD40LG	TRAF3	R-HSA-166166	MyD88-independent TLR4 cascade	0.159714954823449	0.164658363144128	0.328146707418727	40	74	-0.168546818560711
CD40LG	TRAF3	R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.159308928267001	0.164658363144128	0.328146707418727	36	66	-0.122145040288969
CD40LG	TRAF3	R-HSA-168898	Toll-like Receptor Cascades	0.159720908740225	0.164658363144128	0.328146707418727	49	90	-0.152986940816894
CD40LG	TRAF3	R-HSA-168928	DDX58/IFIH1-mediated induction of interferon-alpha/beta	0.0793132262455256	0.09407375222174	0.328146707418727	18	34	0.0115587663239789
CD40LG	TRAF3	R-HSA-5260271	Diseases of Immune System	0.12343303074517	0.135219989372478	0.328146707418727	7	14	-0.122145040288969
CD40LG	TRAF3	R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.12343303074517	0.135219989372478	0.328146707418727	7	14	-0.122145040288969
CD40LG	TRAF3	R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.0592888499711965	0.0764888673405245	0.328146707418727	16	30	0.0393998332870242
CD40LG	TRAF3	R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.0404147067156812	0.0577684720170358	0.328146707418727	6	12	0.0459016393442623
CD40LG	TRAF3	R-HSA-5688426	Deubiquitination	0.0673395757555875	0.0831023680150709	0.328146707418727	40	74	0.0383995554320645
CD40LG	TRAF3	R-HSA-5689896	Ovarian tumor domain proteases	0.156310016464108	0.161957054631164	0.328146707418727	11	21	-0.198888580161156
CD40LG	TRAF3	R-HSA-936440	Negative regulators of DDX58/IFIH1 signaling	0.146852262458852	0.155989736567403	0.328146707418727	9	17	-0.152875798833009
CD40LG	TRAF3	R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.143798785163607	0.153542410963971	0.328146707418727	5	10	-0.225006946373993
CD40LG	TRAF3	R-HSA-937061	TRIF(TICAM1)-mediated TLR4 signaling	0.159714954823449	0.164658363144128	0.328146707418727	40	74	-0.168546818560711
CD55	CR1	R-HSA-8878171	Transcriptional regulation by RUNX1	0.0736525156527128	0.0893550824416161	0.266110882101935	23	43	0.0445463391822683
CD80	CTLA4	R-HSA-389513	CTLA4 inhibitory signaling	0.0383173400302631	0.0558713244339909	0.299015448327532	9	17	0.0843011947763268
CD80	CTLA4	R-HSA-8877330	RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)	0.101679204004217	0.115720617890514	0.299015448327532	3	6	-0.0994720755765491
CD80	CTLA4	R-HSA-8878171	Transcriptional regulation by RUNX1	0.0552822953205359	0.0727291848528885	0.299015448327532	23	43	0.053626007224229
CGN	TGFBR2	R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.0343890564536697	0.0522992238670653	0.573252226691326	19	35	-0.0524590163934426
CGN	TGFBR2	R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.0358190539263868	0.0537848411837054	0.573252226691326	6	12	-0.187051958877466
CGN	TGFBR2	R-HSA-5689603	UCH proteinases	0.0399542509391819	0.0573545569109051	0.573252226691326	6	12	-0.298082800777994
CNTF	IL6ST	R-HSA-1059683	Interleukin-6 signaling	0.0627538137663656	0.0793553517997956	0.394220616838011	4	9	-0.114754098360656
CNTF	IL6ST	R-HSA-447115	Interleukin-12 family signaling	0.0582747580985222	0.0754205804271488	0.394220616838011	24	44	0.0278410669630453
CNTF	IL6ST	R-HSA-6783589	Interleukin-6 family signaling	0.0651712981391912	0.0816919943458044	0.394220616838011	7	14	-0.052014448457905
CNTF	IL6ST	R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	0.0397552686139014	0.0572380072212195	0.394220616838011	4	8	0.00630739521310124
CNTF	IL6ST	R-HSA-8984722	Interleukin-35 Signalling	0.0600728354586946	0.077190363842086	0.394220616838011	5	10	-0.052014448457905
CNTF	IL6ST	R-HSA-9020956	Interleukin-27 signaling	0.0339846056013167	0.0520105917100193	0.394220616838011	4	8	0.0278410669630453
COL4A3	ITGA2	R-HSA-373760	L1CAM interactions	0.0609726405065716	0.0778582070226391	0.486857460405668	12	23	-0.107752153375938
COL4A3	ITGA2	R-HSA-6806834	Signaling by MET	0.0567712680771323	0.0740523601477475	0.486857460405668	15	29	-0.0755765490414004
COL4A3	ITGA2	R-HSA-8875878	MET promotes cell motility	0.0592209543625272	0.0764888673405245	0.486857460405668	5	10	-0.188774659627674
COL4A4	ITGA2	R-HSA-373760	L1CAM interactions	0.0792119098347184	0.09407375222174	0.440566824117811	12	23	-0.107752153375938
COL4A4	ITGA2	R-HSA-6806834	Signaling by MET	0.0737537448069638	0.0893653550932291	0.440566824117811	15	29	-0.0755765490414004
COL4A4	ITGA2	R-HSA-8874081	MET activates PTK2 signaling	0.0331700273868135	0.0513115634009607	0.440566824117811	2	4	-0.0328980272297861
COL4A4	ITGA2	R-HSA-8875878	MET promotes cell motility	0.076936226778384	0.0919114932351056	0.440566824117811	5	10	-0.188774659627674
COL4A4	ITGB1	R-HSA-1500931	Cell-Cell communication	0.112204817120209	0.12590117977338	0.355043067518755	6	12	-0.144763961347661
COL4A4	ITGB1	R-HSA-1566948	Elastic fibre formation	0.0492980605827634	0.0663787970663687	0.355043067518755	2	4	-0.0242848608645396
COL4A4	ITGB1	R-HSA-216083	Integrin cell surface interactions	0.0322222580510175	0.0503341155176025	0.355043067518755	10	19	0.0734092803556544
COL4A4	ITGB1	R-HSA-3000157	Laminin interactions	0.0454973829118771	0.0627942705444001	0.355043067518755	4	9	-0.0320088913587108
COL4A4	ITGB1	R-HSA-3000170	Syndecan interactions	0.0550183135640894	0.0724935231654417	0.355043067518755	3	6	-0.0242848608645396
COL4A4	ITGB1	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0829141030458745	0.0974507741955212	0.355043067518755	6	11	-0.0320088913587108
COL4A4	ITGB1	R-HSA-3000178	ECM proteoglycans	0.0640532931250797	0.0805723002994424	0.355043067518755	6	12	-0.0242848608645396
COL4A4	ITGB1	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.117617744878585	0.130544772566479	0.355043067518755	36	66	-0.0221172547929981
COL4A4	ITGB1	R-HSA-6806834	Signaling by MET	0.118789256970186	0.131743073855566	0.355043067518755	17	32	-0.0679633231453182
COL4A4	ITGB1	R-HSA-8874081	MET activates PTK2 signaling	0.0599836739032984	0.077190363842086	0.355043067518755	3	6	-0.0403445401500417
COL4A4	ITGB1	R-HSA-8875878	MET promotes cell motility	0.0839382252302569	0.0982249880044977	0.355043067518755	7	13	-0.0320088913587108
COL5A2	ITGB1	R-HSA-1500931	Cell-Cell communication	0.144764799468798	0.154458870861798	0.299527646568491	6	12	-0.144763961347661
COL5A2	ITGB1	R-HSA-1566948	Elastic fibre formation	0.063603542500485	0.0802882746000841	0.299527646568491	2	4	-0.0242848608645396
COL5A2	ITGB1	R-HSA-216083	Integrin cell surface interactions	0.0415726244639745	0.0589082445467781	0.299527646568491	10	19	0.0734092803556544
COL5A2	ITGB1	R-HSA-3000157	Laminin interactions	0.0586999710229616	0.0759023971568322	0.299527646568491	4	9	-0.0320088913587108
COL5A2	ITGB1	R-HSA-3000170	Syndecan interactions	0.0709837182986889	0.0870005572994187	0.299527646568491	3	6	-0.0242848608645396
COL5A2	ITGB1	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.106974404563326	0.120978940176506	0.299527646568491	6	11	-0.0320088913587108
COL5A2	ITGB1	R-HSA-3000178	ECM proteoglycans	0.0826404995129053	0.0972161413466006	0.299527646568491	6	12	-0.0242848608645396
COL5A2	ITGB1	R-HSA-445144	Signal transduction by L1	0.0340449995347834	0.052047472636332	0.299527646568491	5	10	0.077354820783551
COL5A2	ITGB1	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.151748469346722	0.158259858213236	0.299527646568491	36	66	-0.0221172547929981
COL5A2	ITGB1	R-HSA-6806834	Signaling by MET	0.153259934873501	0.159488205086068	0.299527646568491	17	32	-0.0679633231453182
COL5A2	ITGB1	R-HSA-8874081	MET activates PTK2 signaling	0.0773899440940201	0.0921737374010173	0.299527646568491	3	6	-0.0403445401500417
COL5A2	ITGB1	R-HSA-8875878	MET promotes cell motility	0.108295710069264	0.122184144956195	0.299527646568491	7	13	-0.0320088913587108
COL9A2	ITGB1	R-HSA-1500931	Cell-Cell communication	0.0756107239366162	0.0908636728514498	0.432509030286191	6	12	-0.144763961347661
COL9A2	ITGB1	R-HSA-1566948	Elastic fibre formation	0.0332201606401669	0.0513337396099131	0.432509030286191	2	4	-0.0242848608645396
COL9A2	ITGB1	R-HSA-3000170	Syndecan interactions	0.0370748299860942	0.0548661570692044	0.432509030286191	3	6	-0.0242848608645396
COL9A2	ITGB1	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0558727826198169	0.0732372671634529	0.432509030286191	6	11	-0.0320088913587108
COL9A2	ITGB1	R-HSA-3000178	ECM proteoglycans	0.0431631723843277	0.0605043882689403	0.432509030286191	6	12	-0.0242848608645396
COL9A2	ITGB1	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.0792582980509159	0.09407375222174	0.432509030286191	36	66	-0.0221172547929981
COL9A2	ITGB1	R-HSA-6806834	Signaling by MET	0.0800477372177879	0.0946318674116306	0.432509030286191	17	32	-0.0679633231453182
COL9A2	ITGB1	R-HSA-8874081	MET activates PTK2 signaling	0.0404208047801312	0.0577684720170358	0.432509030286191	3	6	-0.0403445401500417
COL9A2	ITGB1	R-HSA-8875878	MET promotes cell motility	0.0565629011169376	0.0738717670325032	0.432509030286191	7	13	-0.0320088913587108
DLL1	NOTCH1	R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.0323764553522368	0.0504422005629123	0.590415260720363	2	5	-0.424284523478744
DLL1	NOTCH1	R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.0323764553522368	0.0504422005629123	0.590415260720363	2	5	-0.424284523478744
DLL1	NOTCH1	R-HSA-5668914	Diseases of metabolism	0.0354241765145388	0.0533595263884965	0.590415260720363	48	88	-0.0587385384829119
DLL1	NOTCH2	R-HSA-1980145	Signaling by NOTCH2	0.0556601327566853	0.0730720074135022	0.52029230018541	6	12	-0.285357043623229
DLL1	NOTCH2	R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	0.0376780794845446	0.0554157599803456	0.52029230018541	3	6	-0.145929424840233
DLL1	NOTCH2	R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.0532580350768118	0.0706494193340871	0.52029230018541	3	6	-0.338816337871631
EFNB1	EPHB6	R-HSA-2682334	EPH-Ephrin signaling	0.0389091799229377	0.0563593575853462	0.572770213948319	26	48	-0.0803556543484301
EFNB1	EPHB6	R-HSA-3928664	Ephrin signaling	0.0409239115374298	0.0580732431054246	0.572770213948319	4	9	-0.568213392609058
EFNB1	EPHB6	R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.0405658912603822	0.0577684720170358	0.572770213948319	8	16	-0.290191719922201
EFNB2	PECAM1	R-HSA-202733	Cell surface interactions at the vascular wall	0.11689036180003	0.129837938668662	0.389797808305282	24	45	-0.127873961045595
EFNB2	PECAM1	R-HSA-210990	PECAM1 interactions	0.0330553552936953	0.0511893946988759	0.389797808305282	4	8	0.0343428730202834
F8	LDLR	R-HSA-174824	Plasma lipoprotein assembly, remodeling, and clearance	0.107230849528724	0.121173394975721	0.359588674255318	6	12	-0.136605571820866
F8	LDLR	R-HSA-196854	Metabolism of vitamins and cofactors	0.0572324549270729	0.0742727062130521	0.359588674255318	3	7	-0.091217346491417
F8	LDLR	R-HSA-2187338	Visual phototransduction	0.0865025578034612	0.100767398773488	0.359588674255318	5	10	-0.091217346491417
F8	LDLR	R-HSA-6806667	Metabolism of fat-soluble vitamins	0.0572324549270729	0.0742727062130521	0.359588674255318	3	7	-0.091217346491417
F8	LDLR	R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.0931910767874363	0.107338155914204	0.359588674255318	27	50	-0.00439132868544908
F8	LDLR	R-HSA-8856828	Clathrin-mediated endocytosis	0.0737856209416898	0.0893653550932291	0.359588674255318	55	100	0.0341856600196353
F8	LDLR	R-HSA-8964038	LDL clearance	0.0961283355303804	0.1102021330608	0.359588674255318	4	8	-0.136605571820866
F8	LDLR	R-HSA-8964043	Plasma lipoprotein clearance	0.0971037209271578	0.110953574350234	0.359588674255318	4	9	-0.179377438834737
F8	LDLR	R-HSA-975634	Retinoid metabolism and transport	0.0572324549270729	0.0742727062130521	0.359588674255318	3	7	-0.091217346491417
FARP2	PLXNA1	R-HSA-373755	Semaphorin interactions	0.179251714411068	0.182432191955623	0.29597110308419	17	31	-0.126146151708808
FARP2	PLXNA1	R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.184107413777215	0.186579527460443	0.29597110308419	4	9	-0.534870797443734
FARP2	PLXNA1	R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.174661257470015	0.178139575541964	0.29597110308419	3	7	-0.401889413726035
FARP2	PLXNA1	R-HSA-399956	CRMPs in Sema3A signaling	0.062599220635161	0.0793553517997956	0.29597110308419	4	8	0.00775792113397781
FARP2	PLXNA3	R-HSA-373755	Semaphorin interactions	0.0878800579028118	0.102206004081616	0.370436232286746	17	31	-0.00933592664629064
FARP2	PLXNA3	R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.128775275839606	0.140215448408501	0.370436232286746	4	9	-0.428674631842178
FARP2	PLXNA3	R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.122303391676321	0.134393152232831	0.370436232286746	3	7	-0.386107252014449
FARP2	PLXNA3	R-HSA-399956	CRMPs in Sema3A signaling	0.110782643320646	0.124402749038219	0.370436232286746	4	8	-0.216004445679355
FBN1	ITGB1	R-HSA-1500931	Cell-Cell communication	0.0628303547806255	0.0793821398726141	0.465962767435399	6	12	-0.144763961347661
FBN1	ITGB1	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0464286885750054	0.0638358088455382	0.465962767435399	6	11	-0.0320088913587108
FBN1	ITGB1	R-HSA-3000178	ECM proteoglycans	0.035867365013434	0.053801047520151	0.465962767435399	6	12	-0.0242848608645396
FBN1	ITGB1	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.0658613848218429	0.0821977596471042	0.465962767435399	36	66	-0.0221172547929981
FBN1	ITGB1	R-HSA-6806834	Signaling by MET	0.0665173862506067	0.0826050113943602	0.465962767435399	17	32	-0.0679633231453182
FBN1	ITGB1	R-HSA-8874081	MET activates PTK2 signaling	0.0335885357609195	0.0517357253288492	0.465962767435399	3	6	-0.0403445401500417
FBN1	ITGB1	R-HSA-8875878	MET promotes cell motility	0.0470021573603475	0.0643140206629182	0.465962767435399	7	13	-0.0320088913587108
FGF11	FGFR1	R-HSA-1226099	Signaling by FGFR in disease	0.0556957490257726	0.0730720074135022	0.379549874965268	13	24	0.0286190608502362
FGF11	FGFR1	R-HSA-1839124	FGFR1 mutant receptor activation	0.037343837561373	0.0550936862788157	0.379549874965268	8	16	0.0286190608502362
FGF2	SDC3	R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.0949853631669103	0.109054452186829	0.424951375382051	6	12	-0.265127249889018
FGF2	SDC3	R-HSA-196854	Metabolism of vitamins and cofactors	0.0486400931157351	0.0657397676983639	0.424951375382051	3	7	-0.123619389000385
FGF2	SDC3	R-HSA-6806667	Metabolism of fat-soluble vitamins	0.0486400931157351	0.0657397676983639	0.424951375382051	3	7	-0.123619389000385
FGF2	SDC3	R-HSA-975634	Retinoid metabolism and transport	0.0486400931157351	0.0657397676983639	0.424951375382051	3	7	-0.123619389000385
FGF2	SDC4	R-HSA-1630316	Glycosaminoglycan metabolism	0.123624341728543	0.135222964179047	0.251438101635162	28	52	0.0148673059653859
FGF2	SDC4	R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.113671934246483	0.127149417870091	0.251438101635162	9	18	-0.0296512438599378
FGF2	SDC4	R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.10491266247261	0.118834721947648	0.251438101635162	6	12	-0.0296512438599378
FGF2	SDC4	R-HSA-196854	Metabolism of vitamins and cofactors	0.0419687836873496	0.0592385273104689	0.251438101635162	3	7	0.0196316785330497
FGF2	SDC4	R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.0705958748215358	0.0866733600120568	0.251438101635162	4	9	-0.0296512438599378
FGF2	SDC4	R-HSA-2022928	HS-GAG biosynthesis	0.0665909296875037	0.0826050113943602	0.251438101635162	3	6	0.0196316785330497
FGF2	SDC4	R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.0665909296875037	0.0826050113943602	0.251438101635162	3	6	0.0196316785330497
FGF2	SDC4	R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.0665909296875037	0.0826050113943602	0.251438101635162	3	6	0.0196316785330497
FGF2	SDC4	R-HSA-3656237	Defective EXT2 causes exostoses 2	0.0665909296875037	0.0826050113943602	0.251438101635162	3	6	0.0196316785330497
FGF2	SDC4	R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.0665909296875037	0.0826050113943602	0.251438101635162	3	6	0.0196316785330497
FGF2	SDC4	R-HSA-3781865	Diseases of glycosylation	0.0483925000212271	0.0656526443050517	0.251438101635162	33	60	0.0803668202839177
FGF2	SDC4	R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.0665909296875037	0.0826050113943602	0.251438101635162	3	6	0.0196316785330497
FGF2	SDC4	R-HSA-5668914	Diseases of metabolism	0.116364166218242	0.129353654540278	0.251438101635162	45	83	0.0273447272335322
FGF2	SDC4	R-HSA-6806667	Metabolism of fat-soluble vitamins	0.0419687836873496	0.0592385273104689	0.251438101635162	3	7	0.0196316785330497
FGF2	SDC4	R-HSA-975634	Retinoid metabolism and transport	0.0419687836873496	0.0592385273104689	0.251438101635162	3	7	0.0196316785330497
FN1	ITGA2	R-HSA-3000157	Laminin interactions	0.0523238545452154	0.0697327206485492	0.301532391421034	2	4	0.0111141983884412
FN1	ITGA2	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.051527827288774	0.0687997247040055	0.301532391421034	3	7	-0.0328980272297861
FN1	ITGA2	R-HSA-3000178	ECM proteoglycans	0.0446832129675673	0.0617895153283429	0.301532391421034	4	8	0.0487357599333148
FN1	ITGA2	R-HSA-373760	L1CAM interactions	0.157056282592831	0.162495461210765	0.301532391421034	12	23	-0.107752153375938
FN1	ITGA2	R-HSA-6806834	Signaling by MET	0.146234183860128	0.155679153419023	0.301532391421034	15	29	-0.0755765490414004
FN1	ITGA2	R-HSA-8874081	MET activates PTK2 signaling	0.0657673979297491	0.0821977596471042	0.301532391421034	2	4	-0.0328980272297861
FN1	ITGA2	R-HSA-8875878	MET promotes cell motility	0.152544204523597	0.158974120121249	0.301532391421034	5	10	-0.188774659627674
FN1	ITGA4	R-HSA-8878159	Transcriptional regulation by RUNX3	0.1510329650009	0.157918351279543	0.334046514212676	15	29	-0.160130037943183
FN1	ITGA4	R-HSA-8949275	RUNX3 Regulates Immune Response and Cell Migration	0.133899664852757	0.144478645145864	0.334046514212676	2	4	-0.341849706197289
GDF11	ACVR1B	R-HSA-1181150	Signaling by NODAL	0.150185550774099	0.157918351279543	0.306085023617672	2	5	-0.386718532925813
GDF11	ACVR1B	R-HSA-1502540	Signaling by Activin	0.150185550774099	0.157918351279543	0.306085023617672	2	5	-0.386718532925813
GDF11	ACVR1B	R-HSA-9006936	Signaling by TGF-beta family members	0.0857356666127653	0.0999615816462069	0.306085023617672	14	27	0.000833564879133093
GDF7	BMPR2	R-HSA-201451	Signaling by BMP	0.112615812806575	0.126263546180319	0.340650180605724	4	8	-0.159488746874132
GDF7	BMPR2	R-HSA-9006936	Signaling by TGF-beta family members	0.131276159787609	0.142075481611646	0.340650180605724	15	29	-0.0958599611003057
GDF9	TGFBR1	R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.132801455379294	0.14350963603158	0.365768268963601	19	36	-0.175104195609892
GDF9	TGFBR1	R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.105140008982953	0.118998242211172	0.365768268963601	10	19	-0.0831342039455404
GDF9	TGFBR1	R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.115278449547395	0.128445451943252	0.365768268963601	12	23	-0.103473186996388
GDF9	TGFBR1	R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.121488148802673	0.133702229764416	0.365768268963601	7	14	-0.191831064184496
GDF9	TGFBR1	R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	0.120388443670892	0.132899944745234	0.365768268963601	2	5	-0.437176993609336
GDF9	TGFBR1	R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.130782451892203	0.141755129261844	0.365768268963601	3	6	-0.437176993609336
GDF9	TGFBR1	R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.125069249311931	0.136595052180738	0.365768268963601	2	4	-0.437176993609336
GDF9	TGFBR1	R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.125069249311931	0.136595052180738	0.365768268963601	2	4	-0.437176993609336
GDF9	TGFBR1	R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.13253272009244	0.143327240280965	0.365768268963601	2	5	-0.667574326201723
GDF9	TGFBR1	R-HSA-5663202	Diseases of signal transduction by growth factor receptors and second messengers	0.0672359140221329	0.0831023680150709	0.365768268963601	94	171	0.039622117254793
GDF9	TGFBR1	R-HSA-5689603	UCH proteinases	0.0713837414493776	0.0874161274452669	0.365768268963601	6	12	-0.0495693248124479
GDF9	TGFBR1	R-HSA-9006936	Signaling by TGF-beta family members	0.129887058278488	0.141104576947994	0.365768268963601	22	40	-0.103473186996388
HLA-B	CANX	R-HSA-8984722	Interleukin-35 Signalling	0.0570382928419188	0.0742222431354915	0.428674631842178	6	11	-0.0320088913587108
HLA-B	CANX	R-HSA-9020956	Interleukin-27 signaling	0.0423953608622083	0.059778709416329	0.428674631842178	4	8	-0.0320088913587108
HSPG2	ITGB1	R-HSA-1500931	Cell-Cell communication	0.0717155533473769	0.087735151072667	0.442233953876077	6	12	-0.144763961347661
HSPG2	ITGB1	R-HSA-3000170	Syndecan interactions	0.0351648788595325	0.0531363922914327	0.442233953876077	3	6	-0.0242848608645396
HSPG2	ITGB1	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0529944340434679	0.0703648318688268	0.442233953876077	6	11	-0.0320088913587108
HSPG2	ITGB1	R-HSA-3000178	ECM proteoglycans	0.040939573523528	0.0580732431054246	0.442233953876077	6	12	-0.0242848608645396
HSPG2	ITGB1	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.075175218621867	0.0905132355195275	0.442233953876077	36	66	-0.0221172547929981
HSPG2	ITGB1	R-HSA-6806834	Signaling by MET	0.0759239889515067	0.0909565581925319	0.442233953876077	17	32	-0.0679633231453182
HSPG2	ITGB1	R-HSA-8874081	MET activates PTK2 signaling	0.0383384820383871	0.0558713244339909	0.442233953876077	3	6	-0.0403445401500417
HSPG2	ITGB1	R-HSA-8875878	MET promotes cell motility	0.0536490003181905	0.0710366264600972	0.442233953876077	7	13	-0.0320088913587108
ICAM1	IL2RA	R-HSA-451927	Interleukin-2 family signaling	0.0563026263204621	0.0735988752447974	0.453181439288691	14	26	-0.0222839677688247
ICAM1	IL2RA	R-HSA-512988	Interleukin-3, Interleukin-5 and GM-CSF signaling	0.0626953033736203	0.0793553517997956	0.453181439288691	18	34	-0.0383995554320645
ICAM1	IL2RA	R-HSA-5673001	RAF/MAP kinase cascade	0.0764765170511355	0.0915420078892557	0.453181439288691	45	82	-0.0282300639066407
ICAM1	IL2RA	R-HSA-5683057	MAPK family signaling cascades	0.0743634069100426	0.089913259282463	0.453181439288691	59	108	-0.0151153098082801
ICAM1	IL2RA	R-HSA-5684996	MAPK1/MAPK3 signaling	0.0747144989642721	0.0902616609222966	0.453181439288691	46	85	-0.0282300639066407
ICAM1	IL2RA	R-HSA-8877330	RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)	0.079383079906504	0.0940787905668816	0.453181439288691	3	6	-0.347818838566268
ICAM1	IL2RA	R-HSA-8878171	Transcriptional regulation by RUNX1	0.0833178498289982	0.0976923930129054	0.453181439288691	23	43	-0.127090858571826
ICAM1	IL2RA	R-HSA-9020558	Interleukin-2 signaling	0.047993859243432	0.0652352551233	0.453181439288691	4	9	-0.124312308974715
ICAM1	IL2RA	R-HSA-912526	Interleukin receptor SHC signaling	0.0469825764199559	0.0643140206629182	0.453181439288691	9	18	-0.0411225340372326
ICAM1	IL2RA	R-HSA-9607240	FLT3 Signaling	0.0769774779465564	0.0919114932351056	0.453181439288691	51	94	-0.0305084745762712
ICAM1	IL2RG	R-HSA-1266695	Interleukin-7 signaling	0.0477710302598432	0.0651175450500144	0.254959711030842	8	16	0.0565156988052237
ICAM1	IL2RG	R-HSA-451927	Interleukin-2 family signaling	0.0646837478434784	0.0812228497439124	0.254959711030842	16	30	0.0565156988052237
ICAM1	IL2RG	R-HSA-512988	Interleukin-3, Interleukin-5 and GM-CSF signaling	0.0487815933188245	0.0658069659634942	0.254959711030842	18	34	0.0694081689358155
ICAM1	IL2RG	R-HSA-5673001	RAF/MAP kinase cascade	0.0550526127804505	0.0724935231654417	0.254959711030842	45	82	0.0694081689358155
ICAM1	IL2RG	R-HSA-5684996	MAPK1/MAPK3 signaling	0.0527205072390676	0.0701961071316833	0.254959711030842	46	85	0.0637963850629095
ICAM1	IL2RG	R-HSA-8983432	Interleukin-15 signaling	0.0612111091886539	0.0780931766695104	0.254959711030842	7	13	0.0694081689358155
ICAM1	IL2RG	R-HSA-8985947	Interleukin-9 signaling	0.0356075384638478	0.0535232810871675	0.254959711030842	3	6	0.100305640455682
ICAM1	IL2RG	R-HSA-9020958	Interleukin-21 signaling	0.0339756639986551	0.0520105917100193	0.254959711030842	4	8	0.100305640455682
ICAM1	IL2RG	R-HSA-912526	Interleukin receptor SHC signaling	0.125282736269156	0.136724082047161	0.254959711030842	9	18	-0.0455682133926091
ICAM1	IL2RG	R-HSA-9607240	FLT3 Signaling	0.056856100782894	0.0740523601477475	0.254959711030842	51	94	0.0611280911364268
ICAM1	ITGAM	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.0622434320847329	0.0790585310978804	0.501472631286469	47	87	-0.0622950819672131
ICAM1	ITGAM	R-HSA-168898	Toll-like Receptor Cascades	0.0618084141197896	0.0785755902905836	0.501472631286469	50	92	-0.0522367324256738
ICAM2	ITGAL	R-HSA-8878159	Transcriptional regulation by RUNX3	0.0325059881262239	0.0505022610758451	0.579438732981384	15	29	-0.0810225062517366
ICAM4	ITGAM	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.195993629781571	0.197647584463271	0.274914185510891	47	87	-0.0622950819672131
ICAM4	ITGAM	R-HSA-168898	Toll-like Receptor Cascades	0.194623834654378	0.196404348271906	0.274914185510891	50	92	-0.0522367324256738
ICAM4	ITGAV	R-HSA-210990	PECAM1 interactions	0.0366857827708192	0.0545154533609894	0.549716662697722	3	7	-0.251958877465963
ICAM4	ITGAV	R-HSA-3000157	Laminin interactions	0.0460591285876903	0.06344744514385	0.549716662697722	3	6	-0.40577938316199
ICAM4	ITGAV	R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.0338563790742898	0.0520105917100193	0.549716662697722	31	57	-0.00388996943595443
IL15	IL2RB	R-HSA-5673001	RAF/MAP kinase cascade	0.0467084145688682	0.0640955660208201	0.354542928591275	45	82	0.0577938316198944
IL15	IL2RB	R-HSA-5683057	MAPK family signaling cascades	0.0479080436154922	0.0651803933060871	0.354542928591275	59	108	0.0531258682967491
IL15	IL2RB	R-HSA-5684996	MAPK1/MAPK3 signaling	0.038011191321618	0.0556295299925069	0.354542928591275	46	85	0.0594053903862184
IL15	IL2RB	R-HSA-9607240	FLT3 Signaling	0.0399562080571786	0.0573545569109051	0.354542928591275	51	94	0.0577938316198944
IL16	CD4	R-HSA-162587	HIV Life Cycle	0.0901995080634367	0.104479882522591	0.279326664311248	35	65	0.0316134557088915
IL16	CD4	R-HSA-162906	HIV Infection	0.0489396452477958	0.0659581309072737	0.279326664311248	47	86	0.0674718277320512
IL16	CD4	R-HSA-162909	Host Interactions of HIV factors	0.0578026473915903	0.0748771421495397	0.279326664311248	18	33	0.0674718277320512
IL16	CD4	R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.0541870022761314	0.0714849689640961	0.279326664311248	4	8	0.0367520386156372
IL16	CD4	R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.033536764427779	0.0517357253288492	0.279326664311248	6	11	0.124722343812641
IL16	CD4	R-HSA-167590	Nef Mediated CD4 Down-regulation	0.0541870022761314	0.0714849689640961	0.279326664311248	4	8	0.0367520386156372
IL16	CD4	R-HSA-180534	Vpu mediated degradation of CD4	0.0627444689151208	0.0793553517997956	0.279326664311248	3	6	0.0110032699198792
IL16	CD4	R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.065766607132189	0.0821977596471042	0.279326664311248	29	54	0.0491516625862625
IL16	CD4	R-HSA-8856828	Clathrin-mediated endocytosis	0.0800393270190801	0.0946318674116306	0.279326664311248	55	100	0.0491516625862625
IL16	KCND1	R-HSA-5576891	Cardiac conduction	0.0444180135004261	0.061619772620183	0.505473742706307	25	47	-0.0192275632120033
IL18	IL18BP	R-HSA-446652	Interleukin-1 family signaling	0.0388193210914523	0.0563423275165155	0.361494627501747	26	48	0.0625729369269242
IL24	IL10RB	R-HSA-6783783	Interleukin-10 signaling	0.161046248426679	0.165740190905655	0.262239510975271	14	26	-0.0459016393442623
IL24	IL10RB	R-HSA-8854691	Interleukin-20 family signaling	0.208036263279446	0.208472398003302	0.262239510975271	6	12	-0.295859961100306
INHBC	ACVR2A	R-HSA-1181150	Signaling by NODAL	0.16733299342281	0.171152291418195	0.294594972970198	2	4	-0.386718532925813
INHBC	ACVR2A	R-HSA-1502540	Signaling by Activin	0.16733299342281	0.171152291418195	0.294594972970198	2	4	-0.386718532925813
INHBC	ACVR2A	R-HSA-201451	Signaling by BMP	0.047534847199592	0.0649049179046231	0.294594972970198	4	8	0.0449013614893026
INHBC	ACVR2A	R-HSA-9006936	Signaling by TGF-beta family members	0.0672942880928815	0.0831023680150709	0.294594972970198	15	29	0.0268963601000278
INSL3	VIPR1	R-HSA-373080	Class B/2 (Secretin family receptors)	0.216987416968383	0.216987416968383	0.250972546791919	6	12	-0.287468741317033
INSL3	VIPR1	R-HSA-420092	Glucagon-type ligand receptors	0.185209891147009	0.187431887018215	0.250972546791919	5	10	-0.179549874965268
INSL3	VIPR1	R-HSA-9660821	ADORA2B mediated anti-inflammatory cytokines production	0.207074757683683	0.207944819690757	0.250972546791919	10	19	-0.152097804945818
LAMB1	ITGA2	R-HSA-373760	L1CAM interactions	0.0644927632019885	0.0810540073897033	0.477188107807724	12	23	-0.107752153375938
LAMB1	ITGA2	R-HSA-6806834	Signaling by MET	0.0600488336794349	0.077190363842086	0.477188107807724	15	29	-0.0755765490414004
LAMB1	ITGA2	R-HSA-8875878	MET promotes cell motility	0.0626399472708843	0.0793553517997956	0.477188107807724	5	10	-0.188774659627674
LAMC1	ITGB1	R-HSA-1500931	Cell-Cell communication	0.0529910971826734	0.0703648318688268	0.495359822172826	6	12	-0.144763961347661
LAMC1	ITGB1	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0391579381802385	0.0566053259581271	0.495359822172826	6	11	-0.0320088913587108
LAMC1	ITGB1	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.0555474667597441	0.0730110608006169	0.495359822172826	36	66	-0.0221172547929981
LAMC1	ITGB1	R-HSA-6806834	Signaling by MET	0.0561007381137731	0.0734689118311878	0.495359822172826	17	32	-0.0679633231453182
LAMC1	ITGB1	R-HSA-8875878	MET promotes cell motility	0.0396416015343831	0.0571891917508103	0.495359822172826	7	13	-0.0320088913587108
LIN7C	ABCA1	R-HSA-174824	Plasma lipoprotein assembly, remodeling, and clearance	0.166530998755042	0.170588913326939	0.310752986940817	4	9	-0.368197972543393
LIN7C	ABCA1	R-HSA-9024446	NR1H2 and NR1H3-mediated signaling	0.148569968304511	0.157464400996799	0.310752986940817	6	12	-0.176493470408447
LIN7C	ABCA1	R-HSA-9029569	NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux	0.156501175705183	0.162038040405222	0.310752986940817	6	11	-0.176493470408447
LTA	TNFRSF1B	R-HSA-6783783	Interleukin-10 signaling	0.0390859455089604	0.0565582702924815	0.539372047791053	13	24	-0.0505848241349717
LTB	LTBR	R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.0345158416986183	0.0524319035972654	0.565823839955543	13	25	-0.0787440955821062
MDK	SDC1	R-HSA-1630316	Glycosaminoglycan metabolism	0.0694540463147664	0.085344560767245	0.340857379650429	28	52	0.0296372749009388
MDK	SDC1	R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.0494968249412323	0.0664947013612187	0.340857379650429	9	18	0.0196316785330497
MDK	SDC1	R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.04869134953923	0.0657470764964744	0.340857379650429	6	12	0.0196316785330497
MDK	SDC1	R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.0528968469152854	0.0703648318688268	0.340857379650429	4	9	-0.0433071807661005
MDK	SDC1	R-HSA-2187338	Visual phototransduction	0.0338808107247005	0.0520105917100193	0.340857379650429	5	10	0.0590735217744488
MDK	SDC1	R-HSA-3000170	Syndecan interactions	0.0606480554143514	0.0775819013953433	0.340857379650429	4	8	-0.0181786773374944
MDK	SDC1	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0606480554143514	0.0775819013953433	0.340857379650429	4	8	-0.0181786773374944
MDK	SDC1	R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.114244356086825	0.127590659367996	0.340857379650429	6	11	-0.0952872850012742
MDK	SDC1	R-HSA-3781865	Diseases of glycosylation	0.0409428513107283	0.0580732431054246	0.340857379650429	33	61	0.0620223408142612
MDK	SDC1	R-HSA-5668914	Diseases of metabolism	0.0343415952713091	0.0522992238670653	0.340857379650429	46	84	0.0717382875024662
MDK	SDC1	R-HSA-71387	Metabolism of carbohydrates	0.0728717884495972	0.0885577496921376	0.340857379650429	75	137	0.0387122544248697
MMP9	CD44	R-HSA-1474228	Degradation of the extracellular matrix	0.189027008003122	0.191159893848009	0.272085593845034	8	16	-0.189941650458461
MMP9	CD44	R-HSA-71387	Metabolism of carbohydrates	0.071766619392077	0.087735151072667	0.272085593845034	77	141	0.0505140316754654
NAMPT	INSR	R-HSA-1257604	PIP3 activates AKT signaling	0.207579180907311	0.208305490147715	0.265772964305632	55	101	-0.0700734872394691
NAMPT	INSR	R-HSA-199418	Negative regulation of the PI3K/AKT network	0.208650647668354	0.208796251749072	0.265772964305632	30	55	-0.124485452717993
NAMPT	INSR	R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	0.207947424716561	0.208472398003302	0.265772964305632	28	52	-0.124485452717993
NAMPT	INSR	R-HSA-74749	Signal attenuation	0.175087682580145	0.178320835809608	0.265772964305632	2	4	-0.317013680262402
NAMPT	INSR	R-HSA-74751	Insulin receptor signalling cascade	0.182335554768257	0.184914558371769	0.265772964305632	9	18	-0.144486579087655
NAMPT	INSR	R-HSA-74752	Signaling by Insulin receptor	0.182335554768257	0.184914558371769	0.265772964305632	9	18	-0.144486579087655
NAMPT	INSR	R-HSA-9006925	Intracellular signaling by second messengers	0.191838807467499	0.193730175991826	0.265772964305632	67	123	-0.021169481456624
NTN1	ADORA2B	R-HSA-9660821	ADORA2B mediated anti-inflammatory cytokines production	0.102208856224422	0.11613906483821	0.418325966630898	10	19	-0.312164021034933
PLAT	ITGAM	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.180835055327978	0.183782756442466	0.293748263406502	47	87	-0.0622950819672131
PLAT	ITGAM	R-HSA-168898	Toll-like Receptor Cascades	0.179571203141098	0.182627734258394	0.293748263406502	50	92	-0.0522367324256738
PLAU	ITGB5	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0541738193997456	0.0714849689640961	0.376809605457797	2	4	-0.067569287884304
PLTP	ABCA1	R-HSA-174824	Plasma lipoprotein assembly, remodeling, and clearance	0.0538939320391978	0.0712951093581269	0.523978883023062	4	9	-0.368197972543393
PLTP	ABCA1	R-HSA-9024446	NR1H2 and NR1H3-mediated signaling	0.0480812571516908	0.0652921617003074	0.523978883023062	6	12	-0.176493470408447
PLTP	ABCA1	R-HSA-9029569	NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux	0.0506480102237082	0.067688021119103	0.523978883023062	6	11	-0.176493470408447
PSEN1	NOTCH4	R-HSA-157118	Signaling by NOTCH	0.0382308709307104	0.0558279724181657	0.434176160044457	30	55	0.0446235065295916
PSEN1	NOTCH4	R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.0424988250858595	0.0598657319971735	0.434176160044457	13	24	0.027229786051681
PSEN1	NOTCH4	R-HSA-1912422	Pre-NOTCH Expression and Processing	0.0343809290216509	0.0522992238670653	0.434176160044457	14	27	0.027229786051681
PSEN1	NOTCH4	R-HSA-350054	Notch-HLH transcription pathway	0.0467636561745236	0.0641100219448057	0.434176160044457	5	10	-0.0448457904973604
PSEN1	NOTCH4	R-HSA-3781865	Diseases of glycosylation	0.0385293674880547	0.0560356115394223	0.434176160044457	33	61	0.0402445818767739
PSEN1	NOTCH4	R-HSA-3906995	Diseases associated with O-glycosylation of proteins	0.0493996072040195	0.066453130141242	0.434176160044457	11	21	-0.00839121978327313
PSEN1	NOTCH4	R-HSA-5668914	Diseases of metabolism	0.0431435784369243	0.0605043882689403	0.434176160044457	46	84	0.0402445818767739
PSEN1	NOTCH4	R-HSA-9013694	Signaling by NOTCH4	0.0478960613195963	0.0651803933060871	0.434176160044457	11	20	0.0175604334537372
PSEN1	NOTCH4	R-HSA-9013695	NOTCH4 Intracellular Domain Regulates Transcription	0.0727467854671555	0.0884808230363877	0.434176160044457	5	10	-0.150486246179494
RGMB	NEO1	R-HSA-373752	Netrin-1 signaling	0.122426970762262	0.134421429572905	0.382272853570436	7	13	-0.309085857182551
RPS27A	ADRB2	R-HSA-5688426	Deubiquitination	0.0919707976437142	0.106188505492018	0.437621561544874	40	73	-0.108030008335649
RPS27A	ADRB2	R-HSA-5689880	Ub-specific processing proteases	0.0921216222602173	0.106277076686365	0.437621561544874	26	48	-0.164267852181161
RPS27A	ADRB2	R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.0847070939141534	0.0989169158574072	0.437621561544874	28	51	-0.0543484301194776
RPS27A	ADRB2	R-HSA-8856828	Clathrin-mediated endocytosis	0.0810085940978457	0.0955438885990275	0.437621561544874	53	98	-0.0229508196721312
RPS27A	ADRB2	R-HSA-9660821	ADORA2B mediated anti-inflammatory cytokines production	0.0614193428297461	0.0782196604066216	0.437621561544874	9	18	-0.0715198666296194
RPS27A	ADRB2	R-HSA-9662851	Anti-inflammatory response favouring Leishmania parasite infection	0.0883078850849377	0.10248110629836	0.437621561544874	31	57	-0.0726312864684635
RPS27A	ADRB2	R-HSA-9664433	Leishmania parasite growth and survival	0.0883078850849377	0.10248110629836	0.437621561544874	31	57	-0.0726312864684635
RPS27A	SMAD3	R-HSA-1181150	Signaling by NODAL	0.151242632047489	0.157918351279543	0.339816615726591	2	4	-0.822228396776883
RPS27A	SMAD3	R-HSA-157118	Signaling by NOTCH	0.0495232503861796	0.0664947013612187	0.339816615726591	22	40	0.0629654330193188
RPS27A	SMAD3	R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.151253367775335	0.157918351279543	0.339816615726591	23	42	-0.202389552653515
RPS27A	SMAD3	R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.15011310020193	0.157918351279543	0.339816615726591	7	13	-0.298193942761878
RPS27A	SMAD3	R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.14637343091401	0.155711795200809	0.339816615726591	8	16	-0.234843011947763
RPS27A	SMAD3	R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.151304123521111	0.157918351279543	0.339816615726591	17	32	-0.297582661850514
RPS27A	SMAD3	R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.151207659803765	0.157918351279543	0.339816615726591	11	20	-0.298193942761878
RPS27A	SMAD3	R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.146989642863963	0.156020094646131	0.339816615726591	11	21	-0.186885245901639
RPS27A	SMAD3	R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	0.150597860950652	0.157918351279543	0.339816615726591	2	5	-0.709863851069742
RPS27A	SMAD3	R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.150597860950652	0.157918351279543	0.339816615726591	2	5	-0.709863851069742
RPS27A	SMAD3	R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.15087669155788	0.157918351279543	0.339816615726591	2	4	-0.709863851069742
RPS27A	SMAD3	R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.15087669155788	0.157918351279543	0.339816615726591	2	4	-0.709863851069742
RPS27A	SMAD3	R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.15087669155788	0.157918351279543	0.339816615726591	2	4	-0.709863851069742
RPS27A	SMAD3	R-HSA-446652	Interleukin-1 family signaling	0.115806228671228	0.128846953507015	0.339816615726591	26	48	-0.0210058349541539
RPS27A	SMAD3	R-HSA-5688426	Deubiquitination	0.151310564098857	0.157918351279543	0.339816615726591	41	75	-0.202389552653515
RPS27A	SMAD3	R-HSA-5689880	Ub-specific processing proteases	0.15131088888291	0.157918351279543	0.339816615726591	26	48	-0.294274608364145
RPS27A	SMAD3	R-HSA-8878159	Transcriptional regulation by RUNX3	0.0914264348337372	0.105645050404173	0.339816615726591	17	31	0.00533481522645179
RPS27A	SMAD3	R-HSA-8941855	RUNX3 regulates CDKN1A transcription	0.0835893254293199	0.0979306312627817	0.339816615726591	2	5	-0.202389552653515
RPS27A	SMAD3	R-HSA-8952158	RUNX3 regulates BCL2L11 (BIM) transcription	0.14606161916497	0.155610967223304	0.339816615726591	2	4	-0.502639622117255
RPS27A	SMAD3	R-HSA-9006936	Signaling by TGF-beta family members	0.151305531572601	0.157918351279543	0.339816615726591	25	46	-0.234843011947763
RPS27A	SMAD3	R-HSA-9008059	Interleukin-37 signaling	0.15019039915936	0.157918351279543	0.339816615726591	6	12	-0.351708808002223
RPS27A	SMAD3	R-HSA-9013694	Signaling by NOTCH4	0.145904653671669	0.155559311052173	0.339816615726591	5	10	-0.298193942761878
RPS27A	SMAD3	R-HSA-9614085	FOXO-mediated transcription	0.150683840170479	0.157918351279543	0.339816615726591	16	30	-0.202389552653515
RPS27A	SMAD3	R-HSA-9615017	FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes	0.146558680861016	0.155793290107262	0.339816615726591	6	12	-0.27707696582384
RPS27A	SMAD3	R-HSA-9617828	FOXO-mediated transcription of cell cycle genes	0.149410720174344	0.157918351279543	0.339816615726591	7	13	-0.276854681856071
RPS27A	TLR4	R-HSA-1236974	ER-Phagosome pathway	0.0363972585874905	0.0544250978252986	0.422784106696305	8	15	0.037454848569047
RPS27A	TLR4	R-HSA-140534	Caspase activation via Death Receptors in the presence of ligand	0.0751125526778125	0.0905132355195275	0.422784106696305	5	10	-0.140427896637955
RPS27A	TLR4	R-HSA-5260271	Diseases of Immune System	0.0722298832635926	0.0880014040781578	0.422784106696305	8	15	-0.0696860238955265
RPS27A	TLR4	R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	0.0751125526778125	0.0905132355195275	0.422784106696305	5	10	-0.140427896637955
RPS27A	TLR4	R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.0722298832635926	0.0880014040781578	0.422784106696305	8	15	-0.0696860238955265
RPS27A	TLR4	R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.0372607952017265	0.0550277861166589	0.422784106696305	3	6	-0.0159488746874132
RPS27A	TLR4	R-HSA-5686938	Regulation of TLR by endogenous ligand	0.0335571362419557	0.0517357253288492	0.422784106696305	2	4	-0.0159488746874132
RPS27A	TLR4	R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.0608620201985894	0.0777862183286784	0.422784106696305	4	9	-0.140427896637955
S100A9	TLR4	R-HSA-109581	Apoptosis	0.0445791404881648	0.0617051037258961	0.260284248248712	40	73	0.0774659627674354
S100A9	TLR4	R-HSA-1236974	ER-Phagosome pathway	0.0781284203557351	0.0929760620664931	0.260284248248712	8	15	0.037454848569047
S100A9	TLR4	R-HSA-1236975	Antigen processing-Cross presentation	0.0593135428749395	0.0764888673405245	0.260284248248712	12	22	0.0742428452347875
S100A9	TLR4	R-HSA-140534	Caspase activation via Death Receptors in the presence of ligand	0.161232612491903	0.165740190905655	0.260284248248712	5	10	-0.140427896637955
S100A9	TLR4	R-HSA-166058	MyD88:MAL(TIRAP) cascade initiated on plasma membrane	0.0349848978748249	0.0529201936207795	0.260284248248712	34	63	0.0817449291469853
S100A9	TLR4	R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.0366567669696956	0.0545154533609894	0.260284248248712	36	66	0.0843011947763268
S100A9	TLR4	R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.0349848978748249	0.0529201936207795	0.260284248248712	34	63	0.0817449291469853
S100A9	TLR4	R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.0349848978748249	0.0529201936207795	0.260284248248712	34	63	0.0817449291469853
S100A9	TLR4	R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.0349848978748249	0.0529201936207795	0.260284248248712	34	63	0.0817449291469853
S100A9	TLR4	R-HSA-2562578	TRIF-mediated programmed cell death	0.0434884147030138	0.0609007682462127	0.260284248248712	3	7	0.0112809113642679
S100A9	TLR4	R-HSA-5260271	Diseases of Immune System	0.155044827573997	0.160762315792561	0.260284248248712	8	15	-0.0696860238955265
S100A9	TLR4	R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	0.161232612491903	0.165740190905655	0.260284248248712	5	10	-0.140427896637955
S100A9	TLR4	R-HSA-5357801	Programmed Cell Death	0.0459699480960882	0.0633854861247986	0.260284248248712	41	75	0.0747429841622673
S100A9	TLR4	R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.155044827573997	0.160762315792561	0.260284248248712	8	15	-0.0696860238955265
S100A9	TLR4	R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.0444479387152533	0.061619772620183	0.260284248248712	2	5	-0.0159488746874132
S100A9	TLR4	R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.0799820421450636	0.0946318674116306	0.260284248248712	3	6	-0.0159488746874132
S100A9	TLR4	R-HSA-5686938	Regulation of TLR by endogenous ligand	0.0720319647136081	0.08790964885048	0.260284248248712	2	4	-0.0159488746874132
S100A9	TLR4	R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.130643177049848	0.141711282821091	0.260284248248712	4	9	-0.140427896637955
S100A9	TLR4	R-HSA-937041	IKK complex recruitment mediated by RIP1	0.0387249187895889	0.0562629519192204	0.260284248248712	7	14	0.0742428452347875
S100A9	TLR4	R-HSA-937072	TRAF6-mediated induction of TAK1 complex within TLR4 complex	0.0605134406593798	0.0775480553222079	0.260284248248712	6	11	0.0742428452347875
S100A9	TLR4	R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.0326513264874694	0.050673162535748	0.260284248248712	34	63	0.0843011947763268
S100A9	TLR4	R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.0605134406593798	0.0775480553222079	0.260284248248712	6	11	0.0742428452347875
SELPLG	ITGAM	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.0499581409719177	0.0668907321696825	0.537371492081134	47	87	-0.0622950819672131
SELPLG	ITGAM	R-HSA-168898	Toll-like Receptor Cascades	0.0496089846338102	0.0665475060475994	0.537371492081134	50	92	-0.0522367324256738
SEMA4D	CD72	R-HSA-373755	Semaphorin interactions	0.0440186175722183	0.0612247309394384	0.31486524034454	16	30	0.0651847735482079
SORBS1	INSR	R-HSA-1257604	PIP3 activates AKT signaling	0.153213341007006	0.159488205086068	0.334928458262488	55	101	-0.0700734872394691
SORBS1	INSR	R-HSA-199418	Negative regulation of the PI3K/AKT network	0.15400418622337	0.160030436988633	0.334928458262488	30	55	-0.124485452717993
SORBS1	INSR	R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	0.153485140250426	0.15960673757731	0.334928458262488	28	52	-0.124485452717993
SORBS1	INSR	R-HSA-74749	Signal attenuation	0.129231499517557	0.14060544029452	0.334928458262488	2	4	-0.317013680262402
SORBS1	INSR	R-HSA-74751	Insulin receptor signalling cascade	0.134581124216329	0.144995741642536	0.334928458262488	9	18	-0.144486579087655
SORBS1	INSR	R-HSA-74752	Signaling by Insulin receptor	0.134581124216329	0.144995741642536	0.334928458262488	9	18	-0.144486579087655
SORBS1	INSR	R-HSA-9006925	Intracellular signaling by second messengers	0.14159543600868	0.151415253718454	0.334928458262488	67	123	-0.021169481456624
TF	ADRB2	R-HSA-5688426	Deubiquitination	0.113479419043183	0.127132411646816	0.397838258419311	40	73	-0.108030008335649
TF	ADRB2	R-HSA-5689880	Ub-specific processing proteases	0.113665516046761	0.127149417870091	0.397838258419311	26	48	-0.164267852181161
TF	ADRB2	R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.104516999444241	0.118480140081455	0.397838258419311	28	51	-0.0543484301194776
TF	ADRB2	R-HSA-8856828	Clathrin-mediated endocytosis	0.0999535551636789	0.114118947535602	0.397838258419311	53	98	-0.0229508196721312
TF	ADRB2	R-HSA-9660821	ADORA2B mediated anti-inflammatory cytokines production	0.0757830911648075	0.0908636728514498	0.397838258419311	9	18	-0.0715198666296194
TF	ADRB2	R-HSA-9662851	Anti-inflammatory response favouring Leishmania parasite infection	0.108959884584145	0.12264401451622	0.397838258419311	31	57	-0.0726312864684635
TF	ADRB2	R-HSA-9664433	Leishmania parasite growth and survival	0.108959884584145	0.12264401451622	0.397838258419311	31	57	-0.0726312864684635
TGFB1	ITGAV	R-HSA-194138	Signaling by VEGF	0.102718580731737	0.116533579722556	0.334926368435677	31	58	-0.00388996943595443
TGFB1	ITGAV	R-HSA-202733	Cell surface interactions at the vascular wall	0.0444745220794208	0.061619772620183	0.334926368435677	25	46	0.0640186721188778
TGFB1	ITGAV	R-HSA-210990	PECAM1 interactions	0.119343422364069	0.132255384598204	0.334926368435677	3	7	-0.251958877465963
TGFB1	ITGAV	R-HSA-216083	Integrin cell surface interactions	0.0913264046845811	0.105614567998137	0.334926368435677	6	11	-0.032342317310364
TGFB1	ITGAV	R-HSA-3000157	Laminin interactions	0.149836084215546	0.157918351279543	0.334926368435677	3	6	-0.40577938316199
TGFB1	ITGAV	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.100509962449425	0.114480767396724	0.334926368435677	4	9	-0.156256213891481
TGFB1	ITGAV	R-HSA-3000178	ECM proteoglycans	0.0679001192482244	0.083650146908895	0.334926368435677	4	8	-0.032342317310364
TGFB1	ITGAV	R-HSA-373760	L1CAM interactions	0.0430403099183884	0.0604630313135574	0.334926368435677	12	23	0.0524034454015004
TGFB1	ITGAV	R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.110139019598485	0.123874003219001	0.334926368435677	31	57	-0.00388996943595443
TGFB1	ITGB1	R-HSA-1500931	Cell-Cell communication	0.165231012682018	0.169607209868299	0.268574604056682	6	12	-0.144763961347661
TGFB1	ITGB1	R-HSA-1566948	Elastic fibre formation	0.0725955327267528	0.0883718114857075	0.268574604056682	2	4	-0.0242848608645396
TGFB1	ITGB1	R-HSA-216083	Integrin cell surface interactions	0.0474499800036838	0.0648648916351597	0.268574604056682	10	19	0.0734092803556544
TGFB1	ITGB1	R-HSA-3000157	Laminin interactions	0.0669987157936109	0.0829673216304301	0.268574604056682	4	9	-0.0320088913587108
TGFB1	ITGB1	R-HSA-3000170	Syndecan interactions	0.0810190854507793	0.0955438885990275	0.268574604056682	3	6	-0.0242848608645396
TGFB1	ITGB1	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.122097977283932	0.13427032164506	0.268574604056682	6	11	-0.0320088913587108
TGFB1	ITGB1	R-HSA-3000178	ECM proteoglycans	0.094323851331057	0.108468646999788	0.268574604056682	6	12	-0.0242848608645396
TGFB1	ITGB1	R-HSA-445144	Signal transduction by L1	0.0388581324364253	0.0563423275165155	0.268574604056682	5	10	0.077354820783551
TGFB1	ITGB1	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.173202003215632	0.17677699118236	0.268574604056682	36	66	-0.0221172547929981
TGFB1	ITGB1	R-HSA-6806834	Signaling by MET	0.174927153117681	0.178283964158319	0.268574604056682	17	32	-0.0679633231453182
TGFB1	ITGB1	R-HSA-8874081	MET activates PTK2 signaling	0.0883309953868711	0.10248110629836	0.268574604056682	3	6	-0.0403445401500417
TGFB1	ITGB1	R-HSA-8875878	MET promotes cell motility	0.12360608317438	0.135222964179047	0.268574604056682	7	13	-0.0320088913587108
TGFB2	TGFBR2	R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.0338031323256344	0.0520103988787122	0.575846666255575	19	35	-0.0524590163934426
TGFB2	TGFBR2	R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.0352087653606874	0.0531467047655007	0.575846666255575	6	12	-0.187051958877466
TGFB2	TGFBR2	R-HSA-5689603	UCH proteinases	0.0392735064798397	0.0567152147956597	0.575846666255575	6	12	-0.298082800777994
TGM2	SDC4	R-HSA-1630316	Glycosaminoglycan metabolism	0.0753860824652391	0.0906909750462692	0.362782931554272	28	52	0.0148673059653859
TGM2	SDC4	R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.0693171076931215	0.0852493417083501	0.362782931554272	9	18	-0.0296512438599378
TGM2	SDC4	R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.0639757066789859	0.0805723002994424	0.362782931554272	6	12	-0.0296512438599378
TGM2	SDC4	R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.04304934098406	0.0604630313135574	0.362782931554272	4	9	-0.0296512438599378
TGM2	SDC4	R-HSA-2022928	HS-GAG biosynthesis	0.0406071267734812	0.0577684720170358	0.362782931554272	3	6	0.0196316785330497
TGM2	SDC4	R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.0406071267734812	0.0577684720170358	0.362782931554272	3	6	0.0196316785330497
TGM2	SDC4	R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.0406071267734812	0.0577684720170358	0.362782931554272	3	6	0.0196316785330497
TGM2	SDC4	R-HSA-3656237	Defective EXT2 causes exostoses 2	0.0406071267734812	0.0577684720170358	0.362782931554272	3	6	0.0196316785330497
TGM2	SDC4	R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.0406071267734812	0.0577684720170358	0.362782931554272	3	6	0.0196316785330497
TGM2	SDC4	R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.0406071267734812	0.0577684720170358	0.362782931554272	3	6	0.0196316785330497
TGM2	SDC4	R-HSA-5668914	Diseases of metabolism	0.07095882985399	0.0870005572994187	0.362782931554272	45	83	0.0273447272335322
THBS1	CD47	R-HSA-202733	Cell surface interactions at the vascular wall	0.0887670860955792	0.102903800696088	0.426895185287993	25	46	-0.0606279522089469
THBS1	ITGA4	R-HSA-8878159	Transcriptional regulation by RUNX3	0.208265844520626	0.208556718605152	0.260500889537243	15	29	-0.160130037943183
THBS1	ITGA4	R-HSA-8949275	RUNX3 Regulates Immune Response and Cell Migration	0.184640000819835	0.186987119474325	0.260500889537243	2	4	-0.341849706197289
THBS1	ITGA6	R-HSA-210991	Basigin interactions	0.0575158146319696	0.07457294591523	0.411643568764958	3	7	-0.144763961347661
THBS1	ITGA6	R-HSA-216083	Integrin cell surface interactions	0.0372006446748598	0.054995592230669	0.411643568764958	2	5	-0.100550611646781
THBS1	ITGA6	R-HSA-3000157	Laminin interactions	0.0425983695482478	0.0599470676468963	0.411643568764958	2	5	-0.126967392914602
THBS1	ITGA6	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0419709510093699	0.0592385273104689	0.411643568764958	4	8	-0.0154607688262196
THBS1	ITGA6	R-HSA-446728	Cell junction organization	0.0324321540578836	0.0504422005629123	0.411643568764958	2	4	0.00172404256695255
THBS1	SDC4	R-HSA-1630316	Glycosaminoglycan metabolism	0.0813360851504519	0.0957602184776256	0.346942251915077	28	52	0.0148673059653859
THBS1	SDC4	R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.0747881039754317	0.0902745295461019	0.346942251915077	9	18	-0.0296512438599378
THBS1	SDC4	R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.0690251218240676	0.0849631113267922	0.346942251915077	6	12	-0.0296512438599378
THBS1	SDC4	R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.0464470993775925	0.0638358088455382	0.346942251915077	4	9	-0.0296512438599378
THBS1	SDC4	R-HSA-2022928	HS-GAG biosynthesis	0.0438121283525512	0.0609966913180179	0.346942251915077	3	6	0.0196316785330497
THBS1	SDC4	R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.0438121283525512	0.0609966913180179	0.346942251915077	3	6	0.0196316785330497
THBS1	SDC4	R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.0438121283525512	0.0609966913180179	0.346942251915077	3	6	0.0196316785330497
THBS1	SDC4	R-HSA-3656237	Defective EXT2 causes exostoses 2	0.0438121283525512	0.0609966913180179	0.346942251915077	3	6	0.0196316785330497
THBS1	SDC4	R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.0438121283525512	0.0609966913180179	0.346942251915077	3	6	0.0196316785330497
THBS1	SDC4	R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.0438121283525512	0.0609966913180179	0.346942251915077	3	6	0.0196316785330497
THBS1	SDC4	R-HSA-5668914	Diseases of metabolism	0.0765594024578984	0.0915647899287959	0.346942251915077	45	83	0.0273447272335322
TNFSF13B	TNFRSF13C	R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.0945759479295958	0.108671401707564	0.432342317310364	14	26	-0.217338149485968
TNFSF13B	TNFRSF13C	R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.0907108154423616	0.104987336032564	0.432342317310364	2	5	-0.523312031119756
TNFSF13	TNFRSF1A	R-HSA-5357786	TNFR1-induced proapoptotic signaling	0.0352707652253453	0.0531843084470507	0.589997221450403	4	8	-0.341594887468741
TNFSF13	TNFRSF1A	R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.03439202796837	0.0522992238670653	0.589997221450403	11	21	-0.154820783550986
TNFSF13	TNFRSF1A	R-HSA-5626978	TNFR1-mediated ceramide production	0.0343264437965624	0.0522992238670653	0.589997221450403	2	5	-0.49369269241456
TNFSF4	TRAF2	R-HSA-109581	Apoptosis	0.0640208637121986	0.0805723002994424	0.447735482078355	41	75	0.00138927479855515
TNFSF4	TRAF2	R-HSA-168928	DDX58/IFIH1-mediated induction of interferon-alpha/beta	0.0370034999628882	0.0548171683334522	0.447735482078355	20	37	0.0360100027785496
TNFSF4	TRAF2	R-HSA-5213460	RIPK1-mediated regulated necrosis	0.0757330846720373	0.0908636728514498	0.447735482078355	5	10	-0.201389274798555
TNFSF4	TRAF2	R-HSA-5218859	Regulated Necrosis	0.0757330846720373	0.0908636728514498	0.447735482078355	5	10	-0.201389274798555
TNFSF4	TRAF2	R-HSA-5357786	TNFR1-induced proapoptotic signaling	0.0673101858695164	0.0831023680150709	0.447735482078355	4	8	-0.171436510141706
TNFSF4	TRAF2	R-HSA-5357801	Programmed Cell Death	0.0783732461700563	0.0931900787793207	0.447735482078355	42	77	-0.0321200333425952
TNFSF4	TRAF2	R-HSA-5357905	Regulation of TNFR1 signaling	0.0770511788724654	0.0919229538295469	0.447735482078355	11	21	-0.117477076965824
TNFSF4	TRAF2	R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.0829758684049731	0.0974507741955212	0.447735482078355	11	20	-0.143873298138372
TNFSF4	TRAF2	R-HSA-5675482	Regulation of necroptotic cell death	0.0658075688685567	0.0821977596471042	0.447735482078355	4	9	-0.201389274798555
TNFSF4	TRAF2	R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.0637530164000539	0.0804061789953186	0.447735482078355	7	13	-0.0772992497916088
TNFSF4	TRAF2	R-HSA-5688426	Deubiquitination	0.037772343499928	0.0554757772727308	0.447735482078355	41	76	0.0360100027785496
TNFSF4	TRAF2	R-HSA-5689880	Ub-specific processing proteases	0.0805519084355807	0.0951494536216003	0.447735482078355	28	51	-0.0563489858293971
TNFSF4	TRAF2	R-HSA-73887	Death Receptor Signalling	0.0615338974779566	0.0782960150695561	0.447735482078355	29	54	-0.0101694915254237
TNFSF4	TRAF2	R-HSA-75893	TNF signaling	0.0533743738704604	0.0707383106564143	0.447735482078355	15	28	-0.0101694915254237
TNFSF4	TRAF2	R-HSA-933541	TRAF6 mediated IRF7 activation	0.0444104161982374	0.061619772620183	0.447735482078355	5	10	-0.048791330925257
TNFSF4	TRAF2	R-HSA-933542	TRAF6 mediated NF-kB activation	0.0719388048337851	0.0878707377611992	0.447735482078355	7	14	-0.143873298138372
UBA52	ADRB2	R-HSA-5688426	Deubiquitination	0.206581876581284	0.207740821190436	0.268630175048625	40	73	-0.108030008335649
UBA52	ADRB2	R-HSA-5689880	Ub-specific processing proteases	0.206920654031411	0.207935681766674	0.268630175048625	26	48	-0.164267852181161
UBA52	ADRB2	R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.190266376598386	0.192277649078284	0.268630175048625	28	51	-0.0543484301194776
UBA52	ADRB2	R-HSA-8856828	Clathrin-mediated endocytosis	0.18195892410082	0.184793978159048	0.268630175048625	53	98	-0.0229508196721312
UBA52	ADRB2	R-HSA-9660821	ADORA2B mediated anti-inflammatory cytokines production	0.137958171780903	0.148411116529493	0.268630175048625	9	18	-0.0715198666296194
UBA52	ADRB2	R-HSA-9662851	Anti-inflammatory response favouring Leishmania parasite infection	0.198354359048202	0.199747296962866	0.268630175048625	31	57	-0.0726312864684635
UBA52	ADRB2	R-HSA-9664433	Leishmania parasite growth and survival	0.198354359048202	0.199747296962866	0.268630175048625	31	57	-0.0726312864684635
UBA52	TLR4	R-HSA-140534	Caspase activation via Death Receptors in the presence of ligand	0.0380173914872084	0.0556295299925069	0.540094470686302	5	10	-0.140427896637955
UBA52	TLR4	R-HSA-5260271	Diseases of Immune System	0.0365583601037499	0.0545154533609894	0.540094470686302	8	15	-0.0696860238955265
UBA52	TLR4	R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	0.0380173914872084	0.0556295299925069	0.540094470686302	5	10	-0.140427896637955
UBA52	TLR4	R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.0365583601037499	0.0545154533609894	0.540094470686302	8	15	-0.0696860238955265
WNT11	FZD7	R-HSA-3858494	Beta-catenin independent WNT signaling	0.0398378451685355	0.0572993680759077	0.519548569692604	29	54	-0.0081133648235621
WNT11	FZD7	R-HSA-9664420	Killing mechanisms	0.0366458276460646	0.0545154533609894	0.519548569692604	3	6	-0.135871075298694
WNT11	FZD7	R-HSA-9673324	WNT5:FZD7-mediated leishmania damping	0.0366458276460646	0.0545154533609894	0.519548569692604	3	6	-0.135871075298694
WNT7B	LRP5	R-HSA-201681	TCF dependent signaling in response to WNT	0.0934727364352987	0.107576166972888	0.322189804416232	28	52	0.0127257571547652
WNT7B	LRP5	R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.0676420010041041	0.0834038086327475	0.322189804416232	11	21	0.0193387051958878
WNT7B	LRP5	R-HSA-4641263	Regulation of FZD by ubiquitination	0.0522005566614998	0.0696331146535728	0.322189804416232	2	4	-0.00550152820227841
B2M	CD247	GO:0050690	regulation of defense response to virus by virus	0.0922292978955461	0.106315766223644	0.371637961371049	3	7	-0.22004805879709
CALM2	KCNQ5	GO:0071805	potassium ion transmembrane transport	0.138711977514609	0.149110176728598	0.304640177827174	21	39	-0.0348430119477633
CALM3	KCNQ5	GO:0071805	potassium ion transmembrane transport	0.0475697829273075	0.0649049179046231	0.510030564045568	21	39	-0.0348430119477633
CCL28	CCR10	GO:0007204	positive regulation of cytosolic calcium ion concentration	0.0961386809337944	0.1102021330608	0.403223117532648	3	6	-0.272964712420117
CCL5	CXCR3	GO:0007204	positive regulation of cytosolic calcium ion concentration	0.0397510077821807	0.0572380072212195	0.33198110586274	3	6	0.0439566546262851
CD40LG	CD40	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	0.0384499414168143	0.0559768690271185	0.40655737704918	24	44	0.0536815782161712
COL5A2	DDR1	GO:0046777	protein autophosphorylation	0.0339373017061513	0.0520105917100193	0.557877188107808	15	29	-0.0584606835232009
GNAI2	S1PR4	GO:0007204	positive regulation of cytosolic calcium ion concentration	0.130557262148016	0.141711282821091	0.312531258682968	3	6	-0.199944429008058
IL16	KCNA3	GO:0006813	potassium ion transport	0.166544266846384	0.170588913326939	0.265129202556266	9	18	-0.111919977771603
IL16	KCNA3	GO:0071805	potassium ion transmembrane transport	0.20050971405411	0.201776091195505	0.265129202556266	21	39	-0.0994720755765491
LTB	CD40	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	0.0361904768104476	0.0541723838686658	0.418116143373159	24	44	0.0536815782161712
A2M	LRP1	R-HSA-196854	Metabolism of vitamins and cofactors	0.000565411040813735	0.00488433393088492	0.813939392623713	3	7	0.0882712652214322
A2M	LRP1	R-HSA-2187338	Visual phototransduction	0.00018815133619581	0.00228651708563383	0.813939392623713	5	10	0.210558488469019
A2M	LRP1	R-HSA-6806667	Metabolism of fat-soluble vitamins	0.000565411040813735	0.00488433393088492	0.813939392623713	3	7	0.0882712652214322
A2M	LRP1	R-HSA-975634	Retinoid metabolism and transport	0.000565411040813735	0.00488433393088492	0.813939392623713	3	7	0.0882712652214322
ADAM15	ITGA5	R-HSA-202733	Cell surface interactions at the vascular wall	0.00310878734361238	0.0145211760610428	0.721589330369547	24	44	0.0785773826062795
ADAM15	ITGA5	R-HSA-216083	Integrin cell surface interactions	0.00141920443376737	0.0087039645197091	0.721589330369547	3	7	0.0813119504569147
ADAM15	ITGA5	R-HSA-373760	L1CAM interactions	9.23545164751189e-05	0.00146424382202876	0.721589330369547	12	22	0.253125868296749
ADAM15	ITGA5	R-HSA-445144	Signal transduction by L1	0.000649896580110126	0.00535604422918345	0.721589330369547	4	9	0.144206724090025
ADAM15	ITGA5	R-HSA-8878166	Transcriptional regulation by RUNX2	0.00242988120470257	0.0123562044239131	0.721589330369547	16	30	0.0877465962767436
ADAM15	ITGAV	R-HSA-194138	Signaling by VEGF	0.0196880905181827	0.0376436290707653	0.619949986107252	31	58	-0.00388996943595443
ADAM15	ITGAV	R-HSA-202733	Cell surface interactions at the vascular wall	0.00852444037110814	0.024063085614506	0.619949986107252	25	46	0.0640186721188778
ADAM15	ITGAV	R-HSA-210990	PECAM1 interactions	0.0228745771749895	0.0404964736653517	0.619949986107252	3	7	-0.251958877465963
ADAM15	ITGAV	R-HSA-216083	Integrin cell surface interactions	0.0175045499005291	0.0359448823047005	0.619949986107252	6	11	-0.032342317310364
ADAM15	ITGAV	R-HSA-3000157	Laminin interactions	0.0287191116535186	0.046852339148061	0.619949986107252	3	6	-0.40577938316199
ADAM15	ITGAV	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0192647642187682	0.0370814387781391	0.619949986107252	4	9	-0.156256213891481
ADAM15	ITGAV	R-HSA-3000178	ECM proteoglycans	0.0130144291756301	0.0305508653956215	0.619949986107252	4	8	-0.032342317310364
ADAM15	ITGAV	R-HSA-373760	L1CAM interactions	0.00824954464486726	0.0234719186919437	0.619949986107252	12	23	0.0524034454015004
ADAM15	ITGAV	R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.0211103674913693	0.0389139834016191	0.619949986107252	31	57	-0.00388996943595443
ADAM15	ITGAV	R-HSA-445144	Signal transduction by L1	0.00425280842652176	0.0167082939277595	0.619949986107252	4	9	0.0566824117810503
ADAM15	ITGB1	R-HSA-195258	RHO GTPase Effectors	0.0025909265728837	0.0128116851914318	0.350597388163379	98	179	0.108641289247013
ADAM15	ITGB1	R-HSA-202733	Cell surface interactions at the vascular wall	0.00232455276496122	0.0119477013080802	0.350597388163379	28	51	0.167657682689636
ADAM15	ITGB1	R-HSA-210991	Basigin interactions	0.0202414335234726	0.038277530712006	0.350597388163379	4	9	0.0583495415393165
ADAM15	ITGB1	R-HSA-373760	L1CAM interactions	0.000925946298977395	0.00677452547313053	0.350597388163379	14	26	0.233009169213671
ADAM15	ITGB1	R-HSA-445144	Signal transduction by L1	0.0269544924564853	0.0451617352514063	0.350597388163379	5	10	0.077354820783551
ADAM9	ITGAV	R-HSA-194138	Signaling by VEGF	0.0261106646656251	0.0443780801473554	0.57882745207002	31	58	-0.00388996943595443
ADAM9	ITGAV	R-HSA-202733	Cell surface interactions at the vascular wall	0.011305250947854	0.0280781679654802	0.57882745207002	25	46	0.0640186721188778
ADAM9	ITGAV	R-HSA-210990	PECAM1 interactions	0.0303366349028368	0.0484216656349601	0.57882745207002	3	7	-0.251958877465963
ADAM9	ITGAV	R-HSA-216083	Integrin cell surface interactions	0.0232148177170004	0.0409471692572922	0.57882745207002	6	11	-0.032342317310364
ADAM9	ITGAV	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0255492424678785	0.0438991832259878	0.57882745207002	4	9	-0.156256213891481
ADAM9	ITGAV	R-HSA-3000178	ECM proteoglycans	0.0172599468549565	0.0357153878643688	0.57882745207002	4	8	-0.032342317310364
ADAM9	ITGAV	R-HSA-373760	L1CAM interactions	0.0109406797813785	0.0275244470289418	0.57882745207002	12	23	0.0524034454015004
ADAM9	ITGAV	R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.0279969114336506	0.0460793893625722	0.57882745207002	31	57	-0.00388996943595443
ADAM9	ITGAV	R-HSA-445144	Signal transduction by L1	0.00564014344659282	0.0194350080188209	0.57882745207002	4	9	0.0566824117810503
ADAM9	ITGB5	R-HSA-216083	Integrin cell surface interactions	0.00524804081931542	0.0191833579172205	0.457038123071486	3	6	0.195517832222394
ADAM9	ITGB5	R-HSA-397014	Muscle contraction	0.00160251689062997	0.00945682807063119	0.457038123071486	46	85	0.130359863772154
ADAM9	ITGB5	R-HSA-445355	Smooth Muscle Contraction	0.00132435963027566	0.00832952504304956	0.457038123071486	12	23	0.19704138111977
ADM	VIPR1	R-HSA-373080	Class B/2 (Secretin family receptors)	0.0280203818160132	0.0460793893625722	0.624284523478744	6	12	-0.287468741317033
ADM	VIPR1	R-HSA-420092	Glucagon-type ligand receptors	0.0239168332364526	0.0417743469684203	0.624284523478744	5	10	-0.179549874965268
ADM	VIPR1	R-HSA-9660821	ADORA2B mediated anti-inflammatory cytokines production	0.0267403237285444	0.0449197965233441	0.624284523478744	10	19	-0.152097804945818
ADM	VIPR1	R-HSA-9662851	Anti-inflammatory response favouring Leishmania parasite infection	0.00183229498106634	0.0101456895313269	0.624284523478744	31	58	0.110760717188192
ADM	VIPR1	R-HSA-9664433	Leishmania parasite growth and survival	0.00183229498106634	0.0101456895313269	0.624284523478744	31	58	0.110760717188192
APOC1	VLDLR	R-HSA-8866427	VLDLR internalisation and degradation	0.00124167844172813	0.00816773800659695	0.284735381513006	3	7	0.281437242282319
APOE	LDLR	R-HSA-174824	Plasma lipoprotein assembly, remodeling, and clearance	0.0253071078634285	0.043881974215425	0.606928966806155	6	12	-0.136605571820866
APOE	LDLR	R-HSA-196854	Metabolism of vitamins and cofactors	0.0135071942122427	0.0310654752932157	0.606928966806155	3	7	-0.091217346491417
APOE	LDLR	R-HSA-2187338	Visual phototransduction	0.0204151097414205	0.0383686335113985	0.606928966806155	5	10	-0.091217346491417
APOE	LDLR	R-HSA-6806667	Metabolism of fat-soluble vitamins	0.0135071942122427	0.0310654752932157	0.606928966806155	3	7	-0.091217346491417
APOE	LDLR	R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.0219936393541017	0.039325285328905	0.606928966806155	27	50	-0.00439132868544908
APOE	LDLR	R-HSA-8856828	Clathrin-mediated endocytosis	0.0174138382391645	0.0358363226239516	0.606928966806155	55	100	0.0341856600196353
APOE	LDLR	R-HSA-8964038	LDL clearance	0.022686849602432	0.0402635424874846	0.606928966806155	4	8	-0.136605571820866
APOE	LDLR	R-HSA-8964043	Plasma lipoprotein clearance	0.0229170462627508	0.0405216329726075	0.606928966806155	4	9	-0.179377438834737
APOE	LDLR	R-HSA-975634	Retinoid metabolism and transport	0.0135071942122427	0.0310654752932157	0.606928966806155	3	7	-0.091217346491417
APOE	LRP1	R-HSA-196854	Metabolism of vitamins and cofactors	0.00729391552077087	0.0215859647324	0.473665930386506	3	7	0.0882712652214322
APOE	LRP1	R-HSA-2187338	Visual phototransduction	0.00242718987120822	0.0123562044239131	0.473665930386506	5	10	0.210558488469019
APOE	LRP1	R-HSA-6806667	Metabolism of fat-soluble vitamins	0.00729391552077087	0.0215859647324	0.473665930386506	3	7	0.0882712652214322
APOE	LRP1	R-HSA-975634	Retinoid metabolism and transport	0.00729391552077087	0.0215859647324	0.473665930386506	3	7	0.0882712652214322
APOE	SORL1	R-HSA-977225	Amyloid fiber formation	0.024270644232339	0.0422379900839491	0.528461271733801	3	6	-0.0493497833372949
APP	CAV1	R-HSA-163560	Triglyceride catabolism	0.00383855694404993	0.0157587229041109	0.852514587385385	2	5	-0.765091747171154
APP	CAV1	R-HSA-194138	Signaling by VEGF	5.31801953676783e-07	2.8391741313959e-05	0.852514587385385	33	60	0.247013059183106
APP	CAV1	R-HSA-201681	TCF dependent signaling in response to WNT	0.00105412052845781	0.00733790697965294	0.852514587385385	29	53	0.0685746040566824
APP	CAV1	R-HSA-202131	Metabolism of nitric oxide: eNOS activation and regulation	0.00373327051487333	0.0157534654560702	0.852514587385385	3	6	-0.412781328146707
APP	CAV1	R-HSA-202733	Cell surface interactions at the vascular wall	5.83857179830237e-08	1.0465639948457e-05	0.852514587385385	24	45	0.29747151986663
APP	CAV1	R-HSA-203615	eNOS activation	0.0035411615948179	0.0153414674530782	0.852514587385385	2	4	-0.412781328146707
APP	CAV1	R-HSA-210991	Basigin interactions	1.28758292745891e-06	5.27541119421735e-05	0.852514587385385	3	6	0.521978327313143
APP	CAV1	R-HSA-4420097	VEGFA-VEGFR2 Pathway	7.2277806037141e-06	0.000215929945535959	0.852514587385385	32	59	0.197943873298138
APP	CAV1	R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.000689264245690514	0.00559610671023231	0.852514587385385	12	22	0.105140316754654
APP	CAV1	R-HSA-5218920	VEGFR2 mediated vascular permeability	0.00384627128064075	0.0157587229041109	0.852514587385385	10	19	-0.412781328146707
APP	CAV1	R-HSA-8939211	ESR-mediated signaling	0.00327694125891943	0.0148706764724382	0.852514587385385	39	72	-0.0262850791886635
APP	CAV1	R-HSA-8979227	Triglyceride metabolism	0.00208709272547876	0.011167503613196	0.852514587385385	5	10	-0.0606279522089469
APP	CAV1	R-HSA-9006931	Signaling by Nuclear Receptors	0.00087550215817404	0.00650900844959561	0.852514587385385	49	90	0.0680744651292026
APP	CAV1	R-HSA-9009391	Extra-nuclear estrogen signaling	0.00351876125982992	0.0153370931507481	0.852514587385385	17	32	-0.0964156710197277
APP	CAV1	R-HSA-9614085	FOXO-mediated transcription	0.00381519889121781	0.0157587229041109	0.852514587385385	15	29	-0.20150041678244
APP	CAV1	R-HSA-9617828	FOXO-mediated transcription of cell cycle genes	0.00381783783300189	0.0157587229041109	0.852514587385385	6	12	-0.351602550777899
APP	CD74	R-HSA-2132295	MHC class II antigen presentation	0.00023573006146075	0.00262044114833113	0.290469574881912	25	46	0.227507641011392
APP	NCSTN	R-HSA-1236394	Signaling by ERBB4	0.00010538496604848	0.0015266905631359	0.666185051403168	2	4	0.434787440955821
APP	NCSTN	R-HSA-1251985	Nuclear signaling by ERBB4	0.00010538496604848	0.0015266905631359	0.666185051403168	2	4	0.434787440955821
APP	NCSTN	R-HSA-157118	Signaling by NOTCH	0.00874076638628197	0.0244809746053288	0.666185051403168	23	43	0.0335093081411503
APP	NCSTN	R-HSA-193692	Regulated proteolysis of p75NTR	0.00602659612192436	0.0195788570310922	0.666185051403168	3	7	-0.0322867463184218
APP	NCSTN	R-HSA-193704	p75 NTR receptor-mediated signalling	0.00999217861747423	0.0259728597088795	0.666185051403168	14	27	0.00372325646012781
APP	NCSTN	R-HSA-1980143	Signaling by NOTCH1	0.000502419884675849	0.00452103415845861	0.666185051403168	11	20	0.217560433453737
APP	NCSTN	R-HSA-1980145	Signaling by NOTCH2	5.57049531978781e-05	0.00096242051669587	0.666185051403168	6	12	0.315809947207558
APP	NCSTN	R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.00942424298732716	0.0252133664996775	0.666185051403168	11	20	0.0335093081411503
APP	NCSTN	R-HSA-205043	NRIF signals cell death from the nucleus	0.000702197332205484	0.00565702794597002	0.666185051403168	6	11	0.24156710197277
APP	NCSTN	R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.000352121032094544	0.00350063233426965	0.666185051403168	7	14	0.217560433453737
APP	NCSTN	R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.00600389717514494	0.0195788570310922	0.666185051403168	8	16	0.0335093081411503
APP	NCSTN	R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.00600389717514494	0.0195788570310922	0.666185051403168	8	16	0.0335093081411503
APP	NCSTN	R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.00600389717514494	0.0195788570310922	0.666185051403168	8	16	0.0335093081411503
APP	NCSTN	R-HSA-2682334	EPH-Ephrin signaling	1.26620523602689e-07	1.45329154683725e-05	0.666185051403168	26	49	0.297582661850514
APP	NCSTN	R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.00600389717514494	0.0195788570310922	0.666185051403168	8	16	0.0335093081411503
APP	NCSTN	R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.00600389717514494	0.0195788570310922	0.666185051403168	8	16	0.0335093081411503
APP	NCSTN	R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.000177263492050934	0.00217261408206017	0.666185051403168	6	11	0.315809947207558
APP	NCSTN	R-HSA-3928665	EPH-ephrin mediated repulsion of cells	3.77356621118132e-07	2.16451757873361e-05	0.666185051403168	11	20	0.434787440955821
APP	NCSTN	R-HSA-5663202	Diseases of signal transduction by growth factor receptors and second messengers	0.00462624681707643	0.0175969176012934	0.666185051403168	96	175	0.0653514865240345
APP	NCSTN	R-HSA-73887	Death Receptor Signalling	0.0141757827165817	0.0318921916874461	0.666185051403168	30	55	0.00372325646012781
APP	NCSTN	R-HSA-9012852	Signaling by NOTCH3	0.0004646905719473	0.00427157871905402	0.666185051403168	7	14	0.204125819935609
APP	NCSTN	R-HSA-9013507	NOTCH3 Activation and Transmission of Signal to the Nucleus	0.00010538496604848	0.0015266905631359	0.666185051403168	2	4	0.434787440955821
APP	NCSTN	R-HSA-9013694	Signaling by NOTCH4	0.00797837782154069	0.0230665197501802	0.666185051403168	8	15	0.0335093081411503
APP	NCSTN	R-HSA-9013700	NOTCH4 Activation and Transmission of Signal to the Nucleus	2.11737019702198e-05	0.000497755551234346	0.666185051403168	2	5	0.414337315921089
APP	NCSTN	R-HSA-9017802	Noncanonical activation of NOTCH3	0.00010538496604848	0.0015266905631359	0.666185051403168	2	4	0.434787440955821
APP	NCSTN	R-HSA-977225	Amyloid fiber formation	0.000560213311967385	0.00488433393088492	0.666185051403168	4	8	0.24156710197277
APP	TNFRSF21	R-HSA-1989781	PPARA activates gene expression	0.00392300549176316	0.0158467320427842	0.794219041236665	20	38	0.000166759317168953
APP	TNFRSF21	R-HSA-400206	Regulation of lipid metabolism by PPARalpha	0.00392300549176316	0.0158467320427842	0.794219041236665	20	38	0.000166759317168953
B2M	HLA-F	R-HSA-1236974	ER-Phagosome pathway	1.82867970900217e-05	0.000460057316264755	0.546540705751598	9	17	0.361489302584051
B2M	HLA-F	R-HSA-1236975	Antigen processing-Cross presentation	9.39413916035924e-08	1.34711955559551e-05	0.546540705751598	12	22	0.460516810225063
B2M	HLA-F	R-HSA-1236977	Endosomal/Vacuolar pathway	0.015853483167751	0.0336642420227306	0.546540705751598	2	5	-0.0874131703250903
B2M	HLA-F	R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.00898519682130851	0.0245424233176312	0.546540705751598	18	33	0.0945818282856349
B2M	HLA-F	R-HSA-877300	Interferon gamma signaling	0.0115496830013075	0.0285064465126936	0.546540705751598	9	17	0.0744651292025563
B2M	HLA-F	R-HSA-913531	Interferon Signaling	0.0219710613873247	0.039325285328905	0.546540705751598	26	49	0.0236732425673798
B2M	HLA-F	R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.00216226866364336	0.0113996075870021	0.546540705751598	11	20	0.189385940539039
BTLA	CD79A	R-HSA-5690714	CD22 mediated BCR regulation	0.00595400255309912	0.0195788570310922	0.665851625451514	14	27	0.0475687691025285
BTLA	CD79A	R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.00821467146640915	0.0234719186919437	0.665851625451514	24	44	0.0475687691025285
BTLA	CD79A	R-HSA-983705	Signaling by the B Cell Receptor (BCR)	2.97803165591998e-05	0.00064704505978625	0.665851625451514	39	72	0.187496526813004
CALM1	KCNQ1	R-HSA-397014	Muscle contraction	0.00117365893557404	0.00790153480569567	0.637065851625452	46	84	0.118588496804668
CALM1	KCNQ1	R-HSA-5576891	Cardiac conduction	0.0152326181323838	0.0329963359544387	0.637065851625452	25	46	0.0135593220338983
CALM2	KCNQ1	R-HSA-397014	Muscle contraction	0.00170610355291583	0.00966589506281853	0.583439844401223	46	84	0.118588496804668
CALM2	KCNQ1	R-HSA-5576891	Cardiac conduction	0.0221430801812616	0.0394940012188173	0.583439844401223	25	46	0.0135593220338983
CALM2	SCN4A	R-HSA-5576891	Cardiac conduction	0.0235695681692208	0.0412683281497713	0.311308696860239	25	47	0.0883578771881078
CALM2	SCN4A	R-HSA-5576892	Phase 0 - rapid depolarisation	0.026751399045283	0.0449197965233441	0.311308696860239	8	16	0.0825229230341762
CALM3	ABCA1	R-HSA-1989781	PPARA activates gene expression	0.00400507071910667	0.0159979705047325	0.388607946651848	24	45	0.139983328702417
CALM3	ABCA1	R-HSA-400206	Regulation of lipid metabolism by PPARalpha	0.00400507071910667	0.0159979705047325	0.388607946651848	24	45	0.139983328702417
CALM3	ABCA1	R-HSA-9006931	Signaling by Nuclear Receptors	0.00134138479527357	0.00836324259314045	0.388607946651848	52	96	0.135370936371214
CALM3	KCNQ1	R-HSA-397014	Muscle contraction	0.00437832599176205	0.0170611942178989	0.426618505140317	46	84	0.118588496804668
CALM3	SCN4A	R-HSA-5576891	Cardiac conduction	0.0183378841169457	0.0362091553977585	0.365045846068352	25	47	0.0883578771881078
CALM3	SCN4A	R-HSA-5576892	Phase 0 - rapid depolarisation	0.0208134511475349	0.0387616739552793	0.365045846068352	8	16	0.0825229230341762
CALR	HLA-F	R-HSA-1236974	ER-Phagosome pathway	3.07283635029914e-05	0.000657678705422235	0.459849958321756	9	17	0.361489302584051
CALR	HLA-F	R-HSA-1236975	Antigen processing-Cross presentation	1.5785515719137e-07	1.45329154683725e-05	0.459849958321756	12	22	0.460516810225063
CALR	HLA-F	R-HSA-1236977	Endosomal/Vacuolar pathway	0.0266395252907918	0.0448680749491244	0.459849958321756	2	5	-0.0874131703250903
CALR	HLA-F	R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.0150983462391972	0.0329042986428705	0.459849958321756	18	33	0.0945818282856349
CALR	HLA-F	R-HSA-877300	Interferon gamma signaling	0.0194076007876827	0.0372563581386038	0.459849958321756	9	17	0.0744651292025563
CALR	HLA-F	R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.00363338517732096	0.0155530577441142	0.459849958321756	11	20	0.189385940539039
CCL2	CCR1	R-HSA-6783783	Interleukin-10 signaling	0.000201151119630486	0.00236435004549276	0.840297422559876	12	23	0.154678415069475
CCL2	CCR2	R-HSA-6783783	Interleukin-10 signaling	0.00362246894172183	0.0155527558755362	0.660417891973264	13	24	0.105280706882998
CCL5	CCR1	R-HSA-6783783	Interleukin-10 signaling	0.000329560140245782	0.00337563743651751	0.792423337077356	12	23	0.154678415069475
CCL5	SDC4	R-HSA-1630316	Glycosaminoglycan metabolism	0.010124474986186	0.0260655244707195	0.685591225181374	28	52	0.0148673059653859
CCL5	SDC4	R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.00930940168269622	0.0250841129920326	0.685591225181374	9	18	-0.0296512438599378
CCL5	SDC4	R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.00859204273273699	0.0242062657735655	0.685591225181374	6	12	-0.0296512438599378
CCL5	SDC4	R-HSA-196854	Metabolism of vitamins and cofactors	0.00343712164369907	0.015272861539873	0.685591225181374	3	7	0.0196316785330497
CCL5	SDC4	R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.0057815973680007	0.0194350080188209	0.685591225181374	4	9	-0.0296512438599378
CCL5	SDC4	R-HSA-2022928	HS-GAG biosynthesis	0.00545360397880562	0.019287730632717	0.685591225181374	3	6	0.0196316785330497
CCL5	SDC4	R-HSA-202733	Cell surface interactions at the vascular wall	0.00247021748409788	0.0124290942884083	0.685591225181374	24	45	0.0910935120645512
CCL5	SDC4	R-HSA-2187338	Visual phototransduction	0.00230918301383115	0.0119113972727837	0.685591225181374	5	10	0.112574684982763
CCL5	SDC4	R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.00238135556506361	0.0121959424296472	0.685591225181374	6	11	0.146727804667734
CCL5	SDC4	R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.00545360397880562	0.019287730632717	0.685591225181374	3	6	0.0196316785330497
CCL5	SDC4	R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.00545360397880562	0.019287730632717	0.685591225181374	3	6	0.0196316785330497
CCL5	SDC4	R-HSA-3656237	Defective EXT2 causes exostoses 2	0.00545360397880562	0.019287730632717	0.685591225181374	3	6	0.0196316785330497
CCL5	SDC4	R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.00545360397880562	0.019287730632717	0.685591225181374	3	6	0.0196316785330497
CCL5	SDC4	R-HSA-3781865	Diseases of glycosylation	0.00396320537794865	0.0159194300055416	0.685591225181374	33	60	0.0803668202839177
CCL5	SDC4	R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.00545360397880562	0.019287730632717	0.685591225181374	3	6	0.0196316785330497
CCL5	SDC4	R-HSA-5668914	Diseases of metabolism	0.00952988767173332	0.0253148704193155	0.685591225181374	45	83	0.0273447272335322
CCL5	SDC4	R-HSA-6806667	Metabolism of fat-soluble vitamins	0.00343712164369907	0.015272861539873	0.685591225181374	3	7	0.0196316785330497
CCL5	SDC4	R-HSA-71387	Metabolism of carbohydrates	0.000373201240985404	0.00363954807596127	0.685591225181374	75	137	0.115853829102231
CCL5	SDC4	R-HSA-975634	Retinoid metabolism and transport	0.00343712164369907	0.015272861539873	0.685591225181374	3	7	0.0196316785330497
CD14	ITGA4	R-HSA-202733	Cell surface interactions at the vascular wall	0.00557197314359999	0.0194350080188209	0.377610136326193	23	43	0.135011600618762
CD14	ITGA4	R-HSA-216083	Integrin cell surface interactions	0.00794476292556284	0.0230665197501802	0.377610136326193	2	5	0.121315888619013
CD14	ITGB2	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.00210449741008068	0.0112187705801327	0.48991386496249	47	86	0.125145873853848
CD14	ITGB2	R-HSA-168898	Toll-like Receptor Cascades	0.000999471820817246	0.00716454875246052	0.48991386496249	50	91	0.140316754654071
CD14	ITGB2	R-HSA-202733	Cell surface interactions at the vascular wall	1.03489180032354e-06	4.5275681159492e-05	0.48991386496249	25	47	0.290691858849681
CD14	ITGB2	R-HSA-216083	Integrin cell surface interactions	0.000438843673953385	0.0041130838460729	0.48991386496249	2	5	0.302639622117255
CD14	ITGB2	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	8.17334748585287e-05	0.00133413322377151	0.48991386496249	35	65	0.194943039733259
CD14	TLR4	R-HSA-109581	Apoptosis	0.0276991773721834	0.0457084238799897	0.366323978883023	40	73	0.0774659627674354
CD14	TLR4	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.0158086403369062	0.0336344068889074	0.366323978883023	46	84	0.0931925534870798
CD14	TLR4	R-HSA-166058	MyD88:MAL(TIRAP) cascade initiated on plasma membrane	0.0217378101275813	0.0390137918935565	0.366323978883023	34	63	0.0817449291469853
CD14	TLR4	R-HSA-166166	MyD88-independent TLR4 cascade	0.0133830756550925	0.0310037649263371	0.366323978883023	40	73	0.101972770213948
CD14	TLR4	R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.022776623305556	0.0403729021262885	0.366323978883023	36	66	0.0843011947763268
CD14	TLR4	R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.0217378101275813	0.0390137918935565	0.366323978883023	34	63	0.0817449291469853
CD14	TLR4	R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.0145353726394503	0.0322499393648061	0.366323978883023	35	64	0.101972770213948
CD14	TLR4	R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.0217378101275813	0.0390137918935565	0.366323978883023	34	63	0.0817449291469853
CD14	TLR4	R-HSA-168898	Toll-like Receptor Cascades	0.0184106108137856	0.0362091553977585	0.366323978883023	49	90	0.0843011947763268
CD14	TLR4	R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.0217378101275813	0.0390137918935565	0.366323978883023	34	63	0.0817449291469853
CD14	TLR4	R-HSA-2562578	TRIF-mediated programmed cell death	0.0270214566566992	0.0451617352514063	0.366323978883023	3	7	0.0112809113642679
CD14	TLR4	R-HSA-5357801	Programmed Cell Death	0.0285633534464772	0.0466513084763648	0.366323978883023	41	75	0.0747429841622673
CD14	TLR4	R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.0276176553612244	0.0456502250101265	0.366323978883023	2	5	-0.0159488746874132
CD14	TLR4	R-HSA-937041	IKK complex recruitment mediated by RIP1	0.0240616661185066	0.0419251873802412	0.366323978883023	7	14	0.0742428452347875
CD14	TLR4	R-HSA-937061	TRIF(TICAM1)-mediated TLR4 signaling	0.0133830756550925	0.0310037649263371	0.366323978883023	40	73	0.101972770213948
CD14	TLR4	R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.0202878492925093	0.038277530712006	0.366323978883023	34	63	0.0843011947763268
CD14	TLR4	R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.0145353726394503	0.0322499393648061	0.366323978883023	35	64	0.101972770213948
CD274	PDCD1	R-HSA-388841	Costimulation by the CD28 family	0.000415354330210382	0.00394847943266988	0.252014448457905	25	47	0.206668519033065
CD274	PDCD1	R-HSA-389948	PD-1 signaling	0.00320119210171185	0.0147131713905602	0.252014448457905	8	16	0.212058905251459
CD40LG	TRAF3	R-HSA-9013973	TICAM1-dependent activation of IRF3/IRF7	0.00541145846147939	0.019287730632717	0.328146707418727	3	6	0.24784662406224
CD40LG	TRAF3	R-HSA-918233	TRAF3-dependent IRF activation pathway	0.00783402089511773	0.0228798084798347	0.328146707418727	4	9	0.142261739372048
CD55	CR1	R-HSA-166658	Complement cascade	1.77740322270118e-06	6.37199055338372e-05	0.266110882101935	17	31	0.374781065074756
CD55	CR1	R-HSA-8877330	RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)	0.0182895150453302	0.0362091553977585	0.266110882101935	3	6	0.165707935460927
CD55	CR1	R-HSA-977606	Regulation of Complement cascade	1.77740322270118e-06	6.37199055338372e-05	0.266110882101935	17	31	0.374781065074756
CD80	CTLA4	R-HSA-388841	Costimulation by the CD28 family	0.00879479864696275	0.0245091622980174	0.299015448327532	24	44	0.140650180605724
CGN	TGFBR2	R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.0239664114781493	0.0418100171042166	0.573252226691326	10	19	-0.0245623784384551
CGN	TGFBR2	R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.0300542885249615	0.0482849214258961	0.573252226691326	12	23	-0.0607390941928314
CGN	TGFBR2	R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	0.0128296995780601	0.0303093726440498	0.573252226691326	2	5	-0.0806890803000834
CGN	TGFBR2	R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.0128296995780601	0.0303093726440498	0.573252226691326	2	5	-0.0806890803000834
CGN	TGFBR2	R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.018464050414008	0.0362091553977585	0.573252226691326	2	4	-0.0806890803000834
CGN	TGFBR2	R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.018464050414008	0.0362091553977585	0.573252226691326	2	4	-0.0806890803000834
CGN	TGFBR2	R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.018464050414008	0.0362091553977585	0.573252226691326	2	4	-0.0806890803000834
CGN	TGFBR2	R-HSA-5663202	Diseases of signal transduction by growth factor receptors and second messengers	4.78974558288897e-05	0.000880576303315742	0.573252226691326	93	170	0.142761878299528
CGN	TGFBR2	R-HSA-5688426	Deubiquitination	4.13769877845821e-05	0.00079112800644121	0.573252226691326	42	77	0.191275354265074
CGN	TGFBR2	R-HSA-9006936	Signaling by TGF-beta family members	0.0300686435378837	0.0482849214258961	0.573252226691326	21	39	-0.0245623784384551
COL18A1	GPC1	R-HSA-1630316	Glycosaminoglycan metabolism	0.0104550585791974	0.0267246951917452	0.690229094663647	28	52	0.00861350375104196
COL18A1	GPC1	R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.012008523395641	0.0292363710515267	0.690229094663647	9	18	-0.0767991108641289
COL18A1	GPC1	R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.0131337705805643	0.0306793338704579	0.690229094663647	6	12	-0.123867741039178
COL18A1	GPC1	R-HSA-196854	Metabolism of vitamins and cofactors	0.011024689869969	0.0275905851196083	0.690229094663647	3	7	-0.181545309957933
COL18A1	GPC1	R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.0155553500042705	0.0332930923971998	0.690229094663647	4	9	-0.278949565010362
COL18A1	GPC1	R-HSA-2022928	HS-GAG biosynthesis	0.012793010105417	0.0303093726440498	0.690229094663647	3	6	-0.181545309957933
COL18A1	GPC1	R-HSA-2187338	Visual phototransduction	0.0146608569968829	0.0323610702092959	0.690229094663647	5	10	-0.181545309957933
COL18A1	GPC1	R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.0125253620369349	0.0301875644120128	0.690229094663647	6	11	-0.0767991108641289
COL18A1	GPC1	R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.012793010105417	0.0303093726440498	0.690229094663647	3	6	-0.181545309957933
COL18A1	GPC1	R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.012793010105417	0.0303093726440498	0.690229094663647	3	6	-0.181545309957933
COL18A1	GPC1	R-HSA-3656237	Defective EXT2 causes exostoses 2	0.012793010105417	0.0303093726440498	0.690229094663647	3	6	-0.181545309957933
COL18A1	GPC1	R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.012793010105417	0.0303093726440498	0.690229094663647	3	6	-0.181545309957933
COL18A1	GPC1	R-HSA-3781865	Diseases of glycosylation	0.0141855657999327	0.0318921916874461	0.690229094663647	33	61	-0.0227285357043623
COL18A1	GPC1	R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.012793010105417	0.0303093726440498	0.690229094663647	3	6	-0.181545309957933
COL18A1	GPC1	R-HSA-5668914	Diseases of metabolism	0.0136431462168241	0.0312029851274732	0.690229094663647	46	84	-0.00211169769380383
COL18A1	GPC1	R-HSA-6806667	Metabolism of fat-soluble vitamins	0.011024689869969	0.0275905851196083	0.690229094663647	3	7	-0.181545309957933
COL18A1	GPC1	R-HSA-71387	Metabolism of carbohydrates	0.0135473508553547	0.0310830418025259	0.690229094663647	75	137	0.00861350375104196
COL18A1	GPC1	R-HSA-975634	Retinoid metabolism and transport	0.011024689869969	0.0275905851196083	0.690229094663647	3	7	-0.181545309957933
COL4A3	ITGA2	R-HSA-216083	Integrin cell surface interactions	0.00383172049984423	0.0157587229041109	0.486857460405668	3	7	0.137149208113365
COL4A3	ITGA2	R-HSA-3000157	Laminin interactions	0.0203132502593002	0.038277530712006	0.486857460405668	2	4	0.0111141983884412
COL4A3	ITGA2	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0200042152882748	0.0379947612230279	0.486857460405668	3	7	-0.0328980272297861
COL4A3	ITGA2	R-HSA-3000178	ECM proteoglycans	0.0173469882004861	0.0358363226239516	0.486857460405668	4	8	0.0487357599333148
COL4A3	ITGA2	R-HSA-8874081	MET activates PTK2 signaling	0.0255323241122369	0.0438991832259878	0.486857460405668	2	4	-0.0328980272297861
COL4A4	ITGA2	R-HSA-216083	Integrin cell surface interactions	0.00497793594346287	0.0184931609920356	0.440566824117811	3	7	0.137149208113365
COL4A4	ITGA2	R-HSA-3000157	Laminin interactions	0.0263897271730644	0.0445734614442572	0.440566824117811	2	4	0.0111141983884412
COL4A4	ITGA2	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0259882479184797	0.0443656518036903	0.440566824117811	3	7	-0.0328980272297861
COL4A4	ITGA2	R-HSA-3000178	ECM proteoglycans	0.022536141682969	0.0400953190736694	0.440566824117811	4	8	0.0487357599333148
COL4A4	ITGB1	R-HSA-195258	RHO GTPase Effectors	0.00253644709521467	0.0126480077785052	0.355043067518755	98	179	0.108641289247013
COL4A4	ITGB1	R-HSA-202733	Cell surface interactions at the vascular wall	0.00227567433599507	0.0118236123109309	0.355043067518755	28	51	0.167657682689636
COL4A4	ITGB1	R-HSA-210991	Basigin interactions	0.0198158163959274	0.0377368933755111	0.355043067518755	4	9	0.0583495415393165
COL4A4	ITGB1	R-HSA-373760	L1CAM interactions	0.000906476403054517	0.00670044928855762	0.355043067518755	14	26	0.233009169213671
COL4A4	ITGB1	R-HSA-445144	Signal transduction by L1	0.0263877196713234	0.0445734614442572	0.355043067518755	5	10	0.077354820783551
COL5A2	ITGB1	R-HSA-195258	RHO GTPase Effectors	0.00327248209592092	0.0148706764724382	0.299527646568491	98	179	0.108641289247013
COL5A2	ITGB1	R-HSA-202733	Cell surface interactions at the vascular wall	0.00293603739448795	0.0139621398022879	0.299527646568491	28	51	0.167657682689636
COL5A2	ITGB1	R-HSA-210991	Basigin interactions	0.0255660386112805	0.0438991832259878	0.299527646568491	4	9	0.0583495415393165
COL5A2	ITGB1	R-HSA-373760	L1CAM interactions	0.00116952086442774	0.00790153480569567	0.299527646568491	14	26	0.233009169213671
COL7A1	ITGA2	R-HSA-216083	Integrin cell surface interactions	0.00127326462089495	0.00826846703367296	0.65371844572085	3	7	0.137149208113365
COL7A1	ITGA2	R-HSA-3000157	Laminin interactions	0.00675000770322458	0.0206827159111625	0.65371844572085	2	4	0.0111141983884412
COL7A1	ITGA2	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.00664731668094308	0.0205632563244388	0.65371844572085	3	7	-0.0328980272297861
COL7A1	ITGA2	R-HSA-3000178	ECM proteoglycans	0.00576433128555671	0.0194350080188209	0.65371844572085	4	8	0.0487357599333148
COL7A1	ITGA2	R-HSA-373760	L1CAM interactions	0.0202609522283058	0.038277530712006	0.65371844572085	12	23	-0.107752153375938
COL7A1	ITGA2	R-HSA-6806834	Signaling by MET	0.018864853824514	0.036606495783969	0.65371844572085	15	29	-0.0755765490414004
COL7A1	ITGA2	R-HSA-8874081	MET activates PTK2 signaling	0.00848428401357974	0.0239969689851545	0.65371844572085	2	4	-0.0328980272297861
COL7A1	ITGA2	R-HSA-8875878	MET promotes cell motility	0.0196788742833684	0.0376436290707653	0.65371844572085	5	10	-0.188774659627674
COL9A2	ITGB1	R-HSA-195258	RHO GTPase Effectors	0.00170921896241446	0.00966589506281853	0.432509030286191	98	179	0.108641289247013
COL9A2	ITGB1	R-HSA-202733	Cell surface interactions at the vascular wall	0.00153349373409009	0.00916262506118831	0.432509030286191	28	51	0.167657682689636
COL9A2	ITGB1	R-HSA-210991	Basigin interactions	0.0133531541830861	0.0310037649263371	0.432509030286191	4	9	0.0583495415393165
COL9A2	ITGB1	R-HSA-216083	Integrin cell surface interactions	0.0217134016224966	0.0390137918935565	0.432509030286191	10	19	0.0734092803556544
COL9A2	ITGB1	R-HSA-3000157	Laminin interactions	0.0306590229143456	0.0487958255928653	0.432509030286191	4	9	-0.0320088913587108
COL9A2	ITGB1	R-HSA-373760	L1CAM interactions	0.000610841306331644	0.00515262607811516	0.432509030286191	14	26	0.233009169213671
COL9A2	ITGB1	R-HSA-445144	Signal transduction by L1	0.017781719524998	0.0359647190392765	0.432509030286191	5	10	0.077354820783551
CXCL10	SDC4	R-HSA-1630316	Glycosaminoglycan metabolism	0.0112794288383631	0.0280781679654802	0.671624971812543	28	52	0.0148673059653859
CXCL10	SDC4	R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.0103713756961205	0.0265581299075657	0.671624971812543	9	18	-0.0296512438599378
CXCL10	SDC4	R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.00957218371444559	0.0253724795684195	0.671624971812543	6	12	-0.0296512438599378
CXCL10	SDC4	R-HSA-196854	Metabolism of vitamins and cofactors	0.00382921277812409	0.0157587229041109	0.671624971812543	3	7	0.0196316785330497
CXCL10	SDC4	R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.00644113558218168	0.0202556763702819	0.671624971812543	4	9	-0.0296512438599378
CXCL10	SDC4	R-HSA-2022928	HS-GAG biosynthesis	0.00607572620560392	0.0195788570310922	0.671624971812543	3	6	0.0196316785330497
CXCL10	SDC4	R-HSA-202733	Cell surface interactions at the vascular wall	0.00275200860935294	0.0133775604942783	0.671624971812543	24	45	0.0910935120645512
CXCL10	SDC4	R-HSA-2187338	Visual phototransduction	0.00257260406241342	0.0127651011263005	0.671624971812543	5	10	0.112574684982763
CXCL10	SDC4	R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.00265300972856603	0.0130288217491907	0.671624971812543	6	11	0.146727804667734
CXCL10	SDC4	R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.00607572620560392	0.0195788570310922	0.671624971812543	3	6	0.0196316785330497
CXCL10	SDC4	R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.00607572620560392	0.0195788570310922	0.671624971812543	3	6	0.0196316785330497
CXCL10	SDC4	R-HSA-3656237	Defective EXT2 causes exostoses 2	0.00607572620560392	0.0195788570310922	0.671624971812543	3	6	0.0196316785330497
CXCL10	SDC4	R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.00607572620560392	0.0195788570310922	0.671624971812543	3	6	0.0196316785330497
CXCL10	SDC4	R-HSA-3781865	Diseases of glycosylation	0.00441530974133302	0.0171586833850178	0.671624971812543	33	60	0.0803668202839177
CXCL10	SDC4	R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.00607572620560392	0.0195788570310922	0.671624971812543	3	6	0.0196316785330497
CXCL10	SDC4	R-HSA-5668914	Diseases of metabolism	0.010617013719484	0.0269943221165604	0.671624971812543	45	83	0.0273447272335322
CXCL10	SDC4	R-HSA-6806667	Metabolism of fat-soluble vitamins	0.00382921277812409	0.0157587229041109	0.671624971812543	3	7	0.0196316785330497
CXCL10	SDC4	R-HSA-71387	Metabolism of carbohydrates	0.000415774333565657	0.00394847943266988	0.671624971812543	75	137	0.115853829102231
CXCL10	SDC4	R-HSA-975634	Retinoid metabolism and transport	0.00382921277812409	0.0157587229041109	0.671624971812543	3	7	0.0196316785330497
DLL1	NOTCH1	R-HSA-157118	Signaling by NOTCH	0.0179238009444588	0.036150113297263	0.590415260720363	31	57	0.0303417616004446
DLL1	NOTCH1	R-HSA-186712	Regulation of beta-cell development	2.76400444007718e-05	0.000614385657385304	0.590415260720363	4	9	0.361267018616282
DLL1	NOTCH1	R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.0117541293604031	0.0288126863296035	0.590415260720363	2	4	-0.00839121978327313
DLL1	NOTCH1	R-HSA-1912408	Pre-NOTCH Transcription and Translation	6.5657941424766e-07	3.2466720001074e-05	0.590415260720363	14	26	0.378660739094193
DLL1	NOTCH1	R-HSA-1912422	Pre-NOTCH Expression and Processing	2.25987353990521e-07	1.54317078867813e-05	0.590415260720363	15	29	0.361267018616282
DLL1	NOTCH1	R-HSA-1980143	Signaling by NOTCH1	0.029879044940662	0.0481963447074345	0.590415260720363	15	29	-0.0782439566546263
DLL1	NOTCH1	R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	0.000120495152537421	0.00166490587489175	0.590415260720363	4	8	0.361267018616282
DLL1	NOTCH1	R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.026212157520788	0.0443780801473554	0.590415260720363	11	21	-0.0587385384829119
DLL1	NOTCH1	R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.0290763253713965	0.0472790600391603	0.590415260720363	6	12	-0.145540427896638
DLL1	NOTCH1	R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.026212157520788	0.0443780801473554	0.590415260720363	11	21	-0.0587385384829119
DLL1	NOTCH1	R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.026212157520788	0.0443780801473554	0.590415260720363	11	21	-0.0587385384829119
DLL1	NOTCH1	R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.026212157520788	0.0443780801473554	0.590415260720363	11	21	-0.0587385384829119
DLL1	NOTCH1	R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.026212157520788	0.0443780801473554	0.590415260720363	11	21	-0.0587385384829119
DLL1	NOTCH1	R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.026212157520788	0.0443780801473554	0.590415260720363	11	21	-0.0587385384829119
DLL1	NOTCH1	R-HSA-350054	Notch-HLH transcription pathway	0.0173989412911359	0.0358363226239516	0.590415260720363	4	9	-0.091358710752987
DLL1	NOTCH1	R-HSA-3781865	Diseases of glycosylation	0.0266546769548469	0.0448680749491244	0.590415260720363	33	61	-0.00839121978327313
DLL1	NOTCH1	R-HSA-3906995	Diseases associated with O-glycosylation of proteins	0.0191277416300727	0.0369228602640703	0.590415260720363	11	21	-0.00839121978327313
DLL1	NOTCH1	R-HSA-5663202	Diseases of signal transduction by growth factor receptors and second messengers	3.3380270913472e-05	0.000693729108549549	0.590415260720363	97	178	0.141039177549319
DLL1	NOTCH1	R-HSA-8878159	Transcriptional regulation by RUNX3	0.000266664717284599	0.00285371048198593	0.590415260720363	19	36	0.192331203111976
DLL1	NOTCH1	R-HSA-8941856	RUNX3 regulates NOTCH signaling	2.76400444007718e-05	0.000614385657385304	0.590415260720363	4	9	0.361267018616282
DLL1	NOTCH1	R-HSA-9012852	Signaling by NOTCH3	0.0130030095202772	0.0305508653956215	0.590415260720363	8	16	0.010780772436788
DLL1	NOTCH1	R-HSA-9013508	NOTCH3 Intracellular Domain Regulates Transcription	0.00921407752306977	0.0248832150058042	0.590415260720363	6	11	0.0859175281975878
DLL1	NOTCH1	R-HSA-9013694	Signaling by NOTCH4	0.0156672644608886	0.0334328232692176	0.590415260720363	9	18	-0.00839121978327313
DLL1	NOTCH1	R-HSA-9013695	NOTCH4 Intracellular Domain Regulates Transcription	0.00621983536445363	0.0198205420280589	0.590415260720363	4	9	0.0399555432064462
DLL1	NOTCH2	R-HSA-157118	Signaling by NOTCH	0.0171172364808869	0.0355226007432588	0.52029230018541	29	53	0.0640213405456799
DLL1	NOTCH2	R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.013974047448557	0.0316831775490183	0.52029230018541	2	4	0.0410113920533482
DLL1	NOTCH2	R-HSA-1912408	Pre-NOTCH Transcription and Translation	5.50622030241338e-05	0.00096242051669587	0.52029230018541	13	25	0.274742984162267
DLL1	NOTCH2	R-HSA-1912422	Pre-NOTCH Expression and Processing	0.000224486145943042	0.00253474908096316	0.52029230018541	15	28	0.238510697415949
DLL1	NOTCH2	R-HSA-350054	Notch-HLH transcription pathway	0.00171209019941137	0.00966589506281853	0.52029230018541	5	10	0.215004167824396
DLL1	NOTCH2	R-HSA-3781865	Diseases of glycosylation	0.0209304185878298	0.0388785236463056	0.52029230018541	33	61	0.0468454753915307
DLL1	NOTCH2	R-HSA-3906995	Diseases associated with O-glycosylation of proteins	0.0175358535585761	0.0359448823047005	0.52029230018541	11	21	0.0468454753915307
DLL1	NOTCH2	R-HSA-5668914	Diseases of metabolism	0.0302496801907721	0.0484143397840753	0.52029230018541	48	88	0.0300393309557965
DLL1	NOTCH2	R-HSA-9013694	Signaling by NOTCH4	0.0295030777746958	0.047783290526958	0.52029230018541	9	18	-0.0308419005279244
DLL1	NOTCH2	R-HSA-9013695	NOTCH4 Intracellular Domain Regulates Transcription	0.00114975214023604	0.00781395530378428	0.52029230018541	5	10	0.238510697415949
EFNB1	EPHB6	R-HSA-3928662	EPHB-mediated forward signaling	0.0216184076433104	0.0390137918935565	0.572770213948319	12	22	0.0113364823562101
EFNB2	EPHB6	R-HSA-2682334	EPH-Ephrin signaling	0.0096942832277793	0.0256363798293751	0.755243678222642	26	48	-0.0803556543484301
EFNB2	EPHB6	R-HSA-3928662	EPHB-mediated forward signaling	0.00538626018443251	0.019287730632717	0.755243678222642	12	22	0.0113364823562101
EFNB2	EPHB6	R-HSA-3928664	Ephrin signaling	0.0101962567707203	0.0262032835290555	0.755243678222642	4	9	-0.568213392609058
EFNB2	EPHB6	R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.0101070554569465	0.0260655244707195	0.755243678222642	8	16	-0.290191719922201
EFNB2	PECAM1	R-HSA-418346	Platelet homeostasis	0.00605017793446387	0.0195788570310922	0.389797808305282	22	41	0.133981661572659
EFNB2	PECAM1	R-HSA-432142	Platelet sensitization by LDL	0.0212013347190756	0.0389778384450698	0.389797808305282	6	11	0.119811058627397
EFNB2	PECAM1	R-HSA-76002	Platelet activation, signaling and aggregation	0.00429130360416421	0.0168134682195942	0.389797808305282	45	82	0.125423728813559
FBN1	ITGA5	R-HSA-202733	Cell surface interactions at the vascular wall	0.0050408233551966	0.0186302595137936	0.660405668241178	24	44	0.0785773826062795
FBN1	ITGA5	R-HSA-216083	Integrin cell surface interactions	0.00230120560360372	0.0119113972727837	0.660405668241178	3	7	0.0813119504569147
FBN1	ITGA5	R-HSA-373760	L1CAM interactions	0.000149750610816857	0.00195641407931247	0.660405668241178	12	22	0.253125868296749
FBN1	ITGA5	R-HSA-445144	Signal transduction by L1	0.00105379155837492	0.00733790697965294	0.660405668241178	4	9	0.144206724090025
FBN1	ITGA5	R-HSA-8878166	Transcriptional regulation by RUNX2	0.00393999350009745	0.0158706479751116	0.660405668241178	16	30	0.0877465962767436
FBN1	ITGAV	R-HSA-194138	Signaling by VEGF	0.0211123285121755	0.0389139834016191	0.610002778549597	31	58	-0.00388996943595443
FBN1	ITGAV	R-HSA-202733	Cell surface interactions at the vascular wall	0.00914109904823306	0.024779463204473	0.610002778549597	25	46	0.0640186721188778
FBN1	ITGAV	R-HSA-210990	PECAM1 interactions	0.0245293258607014	0.0426364282233282	0.610002778549597	3	7	-0.251958877465963
FBN1	ITGAV	R-HSA-216083	Integrin cell surface interactions	0.0187708303970075	0.0365725146593868	0.610002778549597	6	11	-0.032342317310364
FBN1	ITGAV	R-HSA-3000157	Laminin interactions	0.0307966544163826	0.048816412045836	0.610002778549597	3	6	-0.40577938316199
FBN1	ITGAV	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0206583787554518	0.0386233574124093	0.610002778549597	4	9	-0.156256213891481
FBN1	ITGAV	R-HSA-3000178	ECM proteoglycans	0.0139558939908667	0.0316831775490183	0.610002778549597	4	8	-0.032342317310364
FBN1	ITGAV	R-HSA-373760	L1CAM interactions	0.00884631734385037	0.0245091622980174	0.610002778549597	12	23	0.0524034454015004
FBN1	ITGAV	R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.0226374931118347	0.040225731254487	0.610002778549597	31	57	-0.00388996943595443
FBN1	ITGAV	R-HSA-445144	Signal transduction by L1	0.00456045691770638	0.017436181314369	0.610002778549597	4	9	0.0566824117810503
FBN1	ITGB1	R-HSA-1566948	Elastic fibre formation	0.0276050058803929	0.0456502250101265	0.465962767435399	2	4	-0.0242848608645396
FBN1	ITGB1	R-HSA-195258	RHO GTPase Effectors	0.0014203122019609	0.0087039645197091	0.465962767435399	98	179	0.108641289247013
FBN1	ITGB1	R-HSA-202733	Cell surface interactions at the vascular wall	0.00127428954981989	0.00826846703367296	0.465962767435399	28	51	0.167657682689636
FBN1	ITGB1	R-HSA-210991	Basigin interactions	0.0110960902248074	0.0277099925818273	0.465962767435399	4	9	0.0583495415393165
FBN1	ITGB1	R-HSA-216083	Integrin cell surface interactions	0.0180432173692626	0.0361873758147169	0.465962767435399	10	19	0.0734092803556544
FBN1	ITGB1	R-HSA-3000157	Laminin interactions	0.0254767734871905	0.0438991832259878	0.465962767435399	4	9	-0.0320088913587108
FBN1	ITGB1	R-HSA-3000170	Syndecan interactions	0.0308081261516608	0.048816412045836	0.465962767435399	3	6	-0.0242848608645396
FBN1	ITGB1	R-HSA-373760	L1CAM interactions	0.000507591701193749	0.00452103415845861	0.465962767435399	14	26	0.233009169213671
FBN1	ITGB1	R-HSA-445144	Signal transduction by L1	0.0147761016982427	0.0324983586430676	0.465962767435399	5	10	0.077354820783551
FGF11	FGFR1	R-HSA-5655302	Signaling by FGFR1 in disease	0.0299511933895802	0.0482584396861325	0.379549874965268	12	22	0.0850236176715755
FGF11	FGFR1	R-HSA-5663202	Diseases of signal transduction by growth factor receptors and second messengers	0.00100923211157394	0.00716454875246052	0.379549874965268	94	172	0.119699916643512
FGF2	FGFR1	R-HSA-1226099	Signaling by FGFR in disease	0.00295026108219814	0.0139626217553536	0.801667129758266	13	24	0.0286190608502362
FGF2	FGFR1	R-HSA-1839124	FGFR1 mutant receptor activation	0.00197814146581036	0.0107449047801972	0.801667129758266	8	16	0.0286190608502362
FGF2	FGFR1	R-HSA-5655302	Signaling by FGFR1 in disease	0.00158654550424987	0.00940126550865419	0.801667129758266	12	22	0.0850236176715755
FGF2	FGFR1	R-HSA-5663202	Diseases of signal transduction by growth factor receptors and second messengers	5.34600624601248e-05	0.000958271619597737	0.801667129758266	94	172	0.119699916643512
FGF2	SDC3	R-HSA-1630316	Glycosaminoglycan metabolism	0.00753905820278885	0.0221991980755631	0.424951375382051	28	52	0.112574684982763
FGF2	SDC3	R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.00901457910919369	0.0245758677615661	0.424951375382051	9	18	0.112574684982763
FGF2	SDC3	R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.013017139997716	0.0305508653956215	0.424951375382051	4	9	0.0643512086690747
FGF2	SDC3	R-HSA-2022928	HS-GAG biosynthesis	0.021506021349664	0.0389982143732682	0.424951375382051	3	6	0.0643512086690747
FGF2	SDC3	R-HSA-2187338	Visual phototransduction	0.012525523587969	0.0301875644120128	0.424951375382051	5	10	0.112574684982763
FGF2	SDC3	R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.0304088311857122	0.0484514043559015	0.424951375382051	6	11	0.0643512086690747
FGF2	SDC3	R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.021506021349664	0.0389982143732682	0.424951375382051	3	6	0.0643512086690747
FGF2	SDC3	R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.021506021349664	0.0389982143732682	0.424951375382051	3	6	0.0643512086690747
FGF2	SDC3	R-HSA-3656237	Defective EXT2 causes exostoses 2	0.021506021349664	0.0389982143732682	0.424951375382051	3	6	0.0643512086690747
FGF2	SDC3	R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.021506021349664	0.0389982143732682	0.424951375382051	3	6	0.0643512086690747
FGF2	SDC3	R-HSA-3781865	Diseases of glycosylation	0.0107230971924643	0.027215790042467	0.424951375382051	33	61	0.0981035834872354
FGF2	SDC3	R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.021506021349664	0.0389982143732682	0.424951375382051	3	6	0.0643512086690747
FGF2	SDC3	R-HSA-5668914	Diseases of metabolism	0.005679579369601	0.0194350080188209	0.424951375382051	46	84	0.112574684982763
FGF2	SDC3	R-HSA-71387	Metabolism of carbohydrates	0.000117678895927366	0.00166490587489175	0.424951375382051	75	137	0.154265073631564
FGF2	SDC4	R-HSA-202733	Cell surface interactions at the vascular wall	0.0301624539360905	0.0483813858437962	0.251438101635162	24	45	0.0910935120645512
FGF2	SDC4	R-HSA-2187338	Visual phototransduction	0.0281961514453943	0.0461567136674605	0.251438101635162	5	10	0.112574684982763
FGF2	SDC4	R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.0290774103896019	0.0472790600391603	0.251438101635162	6	11	0.146727804667734
FGF2	SDC4	R-HSA-71387	Metabolism of carbohydrates	0.00455695310740017	0.017436181314369	0.251438101635162	75	137	0.115853829102231
FN1	C5AR1	R-HSA-166658	Complement cascade	0.00636448154359432	0.0200586077659654	0.517067478064322	17	31	0.125479299805502
FN1	C5AR1	R-HSA-977606	Regulation of Complement cascade	0.00636448154359432	0.0200586077659654	0.517067478064322	17	31	0.125479299805502
FN1	ITGA2	R-HSA-216083	Integrin cell surface interactions	0.00986993137644119	0.0258275211565998	0.301532391421034	3	7	0.137149208113365
FN1	ITGA4	R-HSA-202733	Cell surface interactions at the vascular wall	0.00686887822038139	0.0208132636843253	0.334046514212676	23	43	0.135011600618762
FN1	ITGA4	R-HSA-216083	Integrin cell surface interactions	0.00979394688723032	0.0257225638027258	0.334046514212676	2	5	0.121315888619013
FN1	ITGA6	R-HSA-1500931	Cell-Cell communication	0.00477537445928529	0.0179734566262864	0.51785952880573	7	14	0.130471092324861
FN1	ITGA6	R-HSA-202733	Cell surface interactions at the vascular wall	0.00500420110476062	0.0185426986672525	0.51785952880573	24	45	0.108781524547071
FN1	ITGA6	R-HSA-210991	Basigin interactions	0.031511579970412	0.0494312952116963	0.51785952880573	3	7	-0.144763961347661
FN1	ITGA6	R-HSA-216083	Integrin cell surface interactions	0.0203813698392988	0.0383554912723812	0.51785952880573	2	5	-0.100550611646781
FN1	ITGA6	R-HSA-3000157	Laminin interactions	0.02333865802333	0.0410599186332474	0.51785952880573	2	5	-0.126967392914602
FN1	ITGA6	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0229949099674382	0.040609237553333	0.51785952880573	4	8	-0.0154607688262196
FN1	ITGA6	R-HSA-446728	Cell junction organization	0.0177688245006559	0.0359647190392765	0.51785952880573	2	4	0.00172404256695255
GDF11	ACVR2B	R-HSA-1181150	Signaling by NODAL	0.000103717021851209	0.0015266905631359	0.828619060850236	2	4	0.323534315087524
GDF11	ACVR2B	R-HSA-1502540	Signaling by Activin	0.000103717021851209	0.0015266905631359	0.828619060850236	2	4	0.323534315087524
GDF11	ACVR2B	R-HSA-201451	Signaling by BMP	3.39587232649447e-05	0.000695668702313295	0.828619060850236	4	8	0.323534315087524
GDF11	ACVR2B	R-HSA-9006936	Signaling by TGF-beta family members	1.69979701762715e-07	1.45329154683725e-05	0.828619060850236	15	29	0.328924701305918
GDF11	BMPR1A	R-HSA-201451	Signaling by BMP	0.00707233786211968	0.021217013586359	0.707974437343707	5	10	-0.0332314531814393
GDF11	BMPR1A	R-HSA-9006936	Signaling by TGF-beta family members	0.000215550527194606	0.00248236625611569	0.707974437343707	17	31	0.203111975548764
GDF9	TGFBR1	R-HSA-5688426	Deubiquitination	0.00592008979030395	0.0195788570310922	0.365768268963601	42	77	0.120033342595165
GDF9	TGFBR1	R-HSA-5689880	Ub-specific processing proteases	0.0131360606669882	0.0306793338704579	0.365768268963601	26	49	0.0986940816893582
GNAI2	TBXA2R	R-HSA-392518	Signal amplification	0.000876038096772631	0.00650900844959561	0.673464851347597	7	14	0.167991108641289
GNAI2	TBXA2R	R-HSA-416476	G alpha (q) signalling events	0.000341012679369817	0.00344374776208674	0.673464851347597	23	42	0.176549041400389
GNAI2	TBXA2R	R-HSA-416482	G alpha (12/13) signalling events	0.00146818216912953	0.00888343135245464	0.673464851347597	10	19	0.145651569880522
GNAI2	TBXA2R	R-HSA-428930	Thromboxane signalling through TP receptor	0.00164666145979541	0.00952142150542994	0.673464851347597	7	13	0.167991108641289
GNAI2	TBXA2R	R-HSA-76002	Platelet activation, signaling and aggregation	2.10627239145602e-05	0.000497755551234346	0.673464851347597	47	86	0.183828841344818
GPI	AMFR	R-HSA-446203	Asparagine N-linked glycosylation	1.18786637779098e-10	5.67800128584089e-08	0.338927479855516	91	167	0.246957488191164
GPI	AMFR	R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	0.000742710649241539	0.00585190698358444	0.338927479855516	7	13	0.314920811336482
GPI	AMFR	R-HSA-901032	ER Quality Control Compartment (ERQC)	0.000150325989651465	0.00195641407931247	0.338927479855516	3	7	0.378883023061962
GPI	AMFR	R-HSA-901042	Calnexin/calreticulin cycle	0.000150325989651465	0.00195641407931247	0.338927479855516	3	7	0.378883023061962
HLA-B	CANX	R-HSA-2132295	MHC class II antigen presentation	9.8886223269983e-06	0.00027804479248854	0.428674631842178	23	43	0.273242567379828
HLA-B	CANX	R-HSA-446203	Asparagine N-linked glycosylation	2.31410521108334e-11	1.65921343634675e-08	0.428674631842178	86	157	0.263017504862462
HLA-B	CANX	R-HSA-447115	Interleukin-12 family signaling	1.92545718685879e-06	6.57406096656073e-05	0.428674631842178	24	44	0.307641011392053
HLA-B	CANX	R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	0.000816409320801723	0.00622729237249825	0.428674631842178	3	6	0.346207279799944
HLA-B	CANX	R-HSA-901042	Calnexin/calreticulin cycle	0.000198432923483	0.00235167613450101	0.428674631842178	2	4	0.495137538205057
HLA-B	CANX	R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.000297852986490687	0.00309508103353366	0.428674631842178	11	21	0.264128924701306
HSPG2	ITGB1	R-HSA-1566948	Elastic fibre formation	0.0315087870947442	0.0494312952116963	0.442233953876077	2	4	-0.0242848608645396
HSPG2	ITGB1	R-HSA-195258	RHO GTPase Effectors	0.00162116664541048	0.00949162940395101	0.442233953876077	98	179	0.108641289247013
HSPG2	ITGB1	R-HSA-202733	Cell surface interactions at the vascular wall	0.0014544940977843	0.00887550866477737	0.442233953876077	28	51	0.167657682689636
HSPG2	ITGB1	R-HSA-210991	Basigin interactions	0.0126652515848894	0.0303093726440498	0.442233953876077	4	9	0.0583495415393165
HSPG2	ITGB1	R-HSA-216083	Integrin cell surface interactions	0.0205948115735085	0.0386047595068514	0.442233953876077	10	19	0.0734092803556544
HSPG2	ITGB1	R-HSA-3000157	Laminin interactions	0.0290795892291069	0.0472790600391603	0.442233953876077	4	9	-0.0320088913587108
HSPG2	ITGB1	R-HSA-373760	L1CAM interactions	0.000579373136643041	0.0049453635592031	0.442233953876077	14	26	0.233009169213671
HSPG2	ITGB1	R-HSA-445144	Signal transduction by L1	0.0168656744547519	0.0352251344778575	0.442233953876077	5	10	0.077354820783551
ICAM1	CAV1	R-HSA-163560	Triglyceride catabolism	0.00573686550416097	0.0194350080188209	0.81561544873576	2	5	-0.765091747171154
ICAM1	CAV1	R-HSA-194138	Signaling by VEGF	7.94797713714486e-07	3.79913307155524e-05	0.81561544873576	33	60	0.247013059183106
ICAM1	CAV1	R-HSA-201681	TCF dependent signaling in response to WNT	0.00157542216647624	0.00937408874160554	0.81561544873576	29	53	0.0685746040566824
ICAM1	CAV1	R-HSA-202131	Metabolism of nitric oxide: eNOS activation and regulation	0.00557951103673909	0.0194350080188209	0.81561544873576	3	6	-0.412781328146707
ICAM1	CAV1	R-HSA-202733	Cell surface interactions at the vascular wall	8.72596176934877e-08	1.34711955559551e-05	0.81561544873576	24	45	0.29747151986663
ICAM1	CAV1	R-HSA-203615	eNOS activation	0.00529239714144676	0.0191960667561573	0.81561544873576	2	4	-0.412781328146707
ICAM1	CAV1	R-HSA-210991	Basigin interactions	1.9243403674747e-06	6.57406096656073e-05	0.81561544873576	3	6	0.521978327313143
ICAM1	CAV1	R-HSA-4420097	VEGFA-VEGFR2 Pathway	1.08021857748821e-05	0.000297891046176557	0.81561544873576	32	59	0.197943873298138
ICAM1	CAV1	R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.00103013094034799	0.00727688555891138	0.81561544873576	12	22	0.105140316754654
ICAM1	CAV1	R-HSA-5218920	VEGFR2 mediated vascular permeability	0.00574839486587695	0.0194350080188209	0.81561544873576	10	19	-0.412781328146707
ICAM1	CAV1	R-HSA-8939211	ESR-mediated signaling	0.00489751006471254	0.0182416348903838	0.81561544873576	39	72	-0.0262850791886635
ICAM1	CAV1	R-HSA-8979227	Triglyceride metabolism	0.00311923736844495	0.0145226830725651	0.81561544873576	5	10	-0.0606279522089469
ICAM1	CAV1	R-HSA-9006931	Signaling by Nuclear Receptors	0.00130847039740615	0.00832952504304956	0.81561544873576	49	90	0.0680744651292026
ICAM1	CAV1	R-HSA-9009391	Extra-nuclear estrogen signaling	0.0052589190112673	0.0191833579172205	0.81561544873576	17	32	-0.0964156710197277
ICAM1	CAV1	R-HSA-9614085	FOXO-mediated transcription	0.00570195602919677	0.0194350080188209	0.81561544873576	15	29	-0.20150041678244
ICAM1	CAV1	R-HSA-9617828	FOXO-mediated transcription of cell cycle genes	0.00570590002541964	0.0194350080188209	0.81561544873576	6	12	-0.351602550777899
ICAM1	IL2RG	R-HSA-5683057	MAPK family signaling cascades	0.014573327306048	0.032250233575421	0.254959711030842	59	108	0.100305640455682
ICAM1	IL2RG	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.00935659195297925	0.0250841129920326	0.254959711030842	34	62	0.132177440655166
ICAM1	IL2RG	R-HSA-9020558	Interleukin-2 signaling	0.0272937797962822	0.045510790962638	0.254959711030842	4	9	0.0694081689358155
ICAM1	ITGAL	R-HSA-202733	Cell surface interactions at the vascular wall	1.62306981663663e-05	0.000431015206862393	0.655959988885802	24	45	0.231289681735043
ICAM1	ITGAL	R-HSA-8878159	Transcriptional regulation by RUNX3	0.0189450301104988	0.0367123961871018	0.655959988885802	15	29	-0.0810225062517366
ICAM1	ITGAL	R-HSA-8949275	RUNX3 Regulates Immune Response and Cell Migration	0.017670249224321	0.0359647190392765	0.655959988885802	2	4	-0.268463462072798
ICAM1	ITGAM	R-HSA-202733	Cell surface interactions at the vascular wall	2.04602531627101e-06	6.82325651984332e-05	0.501472631286469	24	45	0.285801611558766
ICAM1	ITGAM	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.00206779500098445	0.0111076117389324	0.501472631286469	35	64	0.136723636167661
ICAM1	ITGAX	R-HSA-202733	Cell surface interactions at the vascular wall	5.34572535200066e-07	2.8391741313959e-05	0.674631842178383	24	45	0.288489211527323
ICAM1	ITGAX	R-HSA-216083	Integrin cell surface interactions	0.000276509468194269	0.00289426698825243	0.674631842178383	2	4	0.356520651891198
ICAM1	ITGAX	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.000475264610778845	0.00434095192265518	0.674631842178383	35	65	0.135593220338983
ICAM1	ITGB2	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.00567540549741632	0.0194350080188209	0.295137538205057	47	86	0.125145873853848
ICAM1	ITGB2	R-HSA-168898	Toll-like Receptor Cascades	0.0026953741255312	0.0131916945256373	0.295137538205057	50	91	0.140316754654071
ICAM1	ITGB2	R-HSA-202733	Cell surface interactions at the vascular wall	2.79089467378442e-06	9.09577945956105e-05	0.295137538205057	25	47	0.290691858849681
ICAM1	ITGB2	R-HSA-216083	Integrin cell surface interactions	0.00118347296971296	0.00793037494658122	0.295137538205057	2	5	0.302639622117255
ICAM1	ITGB2	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.000220418713899604	0.00250857488676216	0.295137538205057	35	65	0.194943039733259
ICAM2	ITGAL	R-HSA-202733	Cell surface interactions at the vascular wall	2.78487222664189e-05	0.000614385657385304	0.579438732981384	24	45	0.231289681735043
ICAM2	ITGAL	R-HSA-8949275	RUNX3 Regulates Immune Response and Cell Migration	0.0303187119853077	0.0484216656349601	0.579438732981384	2	4	-0.268463462072798
ICAM2	ITGB2	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.000350353102092214	0.00350063233426965	0.74231731036399	47	86	0.125145873853848
ICAM2	ITGB2	R-HSA-168898	Toll-like Receptor Cascades	0.000166390346312496	0.00205692893631137	0.74231731036399	50	91	0.140316754654071
ICAM2	ITGB2	R-HSA-202733	Cell surface interactions at the vascular wall	1.72287003460483e-07	1.45329154683725e-05	0.74231731036399	25	47	0.290691858849681
ICAM2	ITGB2	R-HSA-216083	Integrin cell surface interactions	7.30579385684384e-05	0.00123253039890754	0.74231731036399	2	5	0.302639622117255
ICAM2	ITGB2	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	1.36068480409123e-05	0.000368155096050345	0.74231731036399	35	65	0.194943039733259
ICAM3	ITGAL	R-HSA-202733	Cell surface interactions at the vascular wall	6.11160454077676e-06	0.000190522628510302	0.774159488746874	24	45	0.231289681735043
ICAM3	ITGAL	R-HSA-8878159	Transcriptional regulation by RUNX3	0.00713367538855533	0.0212675478319924	0.774159488746874	15	29	-0.0810225062517366
ICAM3	ITGAL	R-HSA-8949275	RUNX3 Regulates Immune Response and Cell Migration	0.00665366173956737	0.0205632563244388	0.774159488746874	2	4	-0.268463462072798
ICAM3	ITGB2	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.000243160209589915	0.00264160409509044	0.782828563489858	47	86	0.125145873853848
ICAM3	ITGB2	R-HSA-168898	Toll-like Receptor Cascades	0.00011548209860701	0.00165601329402453	0.782828563489858	50	91	0.140316754654071
ICAM3	ITGB2	R-HSA-202733	Cell surface interactions at the vascular wall	1.1957463376489e-07	1.45329154683725e-05	0.782828563489858	25	47	0.290691858849681
ICAM3	ITGB2	R-HSA-216083	Integrin cell surface interactions	5.07053699494087e-05	0.000920398740600658	0.782828563489858	2	5	0.302639622117255
ICAM3	ITGB2	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	9.44374119061041e-06	0.000270846497346707	0.782828563489858	35	65	0.194943039733259
ICAM4	ITGA4	R-HSA-202733	Cell surface interactions at the vascular wall	0.000753634965491536	0.00587343772018947	0.693941749883595	23	43	0.135011600618762
ICAM4	ITGA4	R-HSA-216083	Integrin cell surface interactions	0.0010745656841728	0.00740947330341938	0.693941749883595	2	5	0.121315888619013
ICAM4	ITGA4	R-HSA-8878159	Transcriptional regulation by RUNX3	0.0165709333772724	0.0347543970143755	0.693941749883595	15	29	-0.160130037943183
ICAM4	ITGA4	R-HSA-8949275	RUNX3 Regulates Immune Response and Cell Migration	0.0146911134632159	0.0323610702092959	0.693941749883595	2	4	-0.341849706197289
ICAM4	ITGAL	R-HSA-202733	Cell surface interactions at the vascular wall	1.76669821899516e-05	0.000453124196803426	0.644501175662367	24	45	0.231289681735043
ICAM4	ITGAL	R-HSA-8878159	Transcriptional regulation by RUNX3	0.0206215103084018	0.0386047595068514	0.644501175662367	15	29	-0.0810225062517366
ICAM4	ITGAL	R-HSA-8949275	RUNX3 Regulates Immune Response and Cell Migration	0.0192339217412714	0.0370718330335795	0.644501175662367	2	4	-0.268463462072798
ICAM4	ITGAM	R-HSA-202733	Cell surface interactions at the vascular wall	6.44257417899198e-06	0.000196567050482436	0.274914185510891	24	45	0.285801611558766
ICAM4	ITGAM	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.00651112309063264	0.0203419401132183	0.274914185510891	35	64	0.136723636167661
ICAM4	ITGAV	R-HSA-194138	Signaling by VEGF	0.0315753601212788	0.0494312952116963	0.549716662697722	31	58	-0.00388996943595443
ICAM4	ITGAV	R-HSA-202733	Cell surface interactions at the vascular wall	0.0136713245147631	0.0312176422837107	0.549716662697722	25	46	0.0640186721188778
ICAM4	ITGAV	R-HSA-216083	Integrin cell surface interactions	0.0280734419805541	0.0461137638031096	0.549716662697722	6	11	-0.032342317310364
ICAM4	ITGAV	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0308964379911476	0.0489003125095758	0.549716662697722	4	9	-0.156256213891481
ICAM4	ITGAV	R-HSA-3000178	ECM proteoglycans	0.0208722774620466	0.0388208117776587	0.549716662697722	4	8	-0.032342317310364
ICAM4	ITGAV	R-HSA-373760	L1CAM interactions	0.013230452326379	0.0308495424976057	0.549716662697722	12	23	0.0524034454015004
ICAM4	ITGAV	R-HSA-445144	Signal transduction by L1	0.00682056786920079	0.0208132636843253	0.549716662697722	4	9	0.0566824117810503
ICAM4	ITGB1	R-HSA-1500931	Cell-Cell communication	0.0156585320205563	0.0334328232692176	0.675835360561109	6	12	-0.144763961347661
ICAM4	ITGB1	R-HSA-1566948	Elastic fibre formation	0.00687969803791507	0.0208132636843253	0.675835360561109	2	4	-0.0242848608645396
ICAM4	ITGB1	R-HSA-195258	RHO GTPase Effectors	0.000353969099350836	0.00350063233426965	0.675835360561109	98	179	0.108641289247013
ICAM4	ITGB1	R-HSA-202733	Cell surface interactions at the vascular wall	0.000317577447859134	0.00327630259158272	0.675835360561109	28	51	0.167657682689636
ICAM4	ITGB1	R-HSA-210991	Basigin interactions	0.00276535895260781	0.0133970430339176	0.675835360561109	4	9	0.0583495415393165
ICAM4	ITGB1	R-HSA-216083	Integrin cell surface interactions	0.00449671656187397	0.0173808397566773	0.675835360561109	10	19	0.0734092803556544
ICAM4	ITGB1	R-HSA-3000157	Laminin interactions	0.00634930162057028	0.0200586077659654	0.675835360561109	4	9	-0.0320088913587108
ICAM4	ITGB1	R-HSA-3000170	Syndecan interactions	0.00767797717398653	0.0225619247284768	0.675835360561109	3	6	-0.0242848608645396
ICAM4	ITGB1	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0115709215595316	0.0285097964198768	0.675835360561109	6	11	-0.0320088913587108
ICAM4	ITGB1	R-HSA-3000178	ECM proteoglycans	0.0089388367377009	0.0245091622980174	0.675835360561109	6	12	-0.0242848608645396
ICAM4	ITGB1	R-HSA-373760	L1CAM interactions	0.000126501607929196	0.0017276505311473	0.675835360561109	14	26	0.233009169213671
ICAM4	ITGB1	R-HSA-445144	Signal transduction by L1	0.00368248854218274	0.0156696990192583	0.675835360561109	5	10	0.077354820783551
ICAM4	ITGB1	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.0164139229636981	0.034512559428069	0.675835360561109	36	66	-0.0221172547929981
ICAM4	ITGB1	R-HSA-6806834	Signaling by MET	0.0165774111281959	0.0347543970143755	0.675835360561109	17	32	-0.0679633231453182
ICAM4	ITGB1	R-HSA-8874081	MET activates PTK2 signaling	0.00837090868852041	0.0237700654640362	0.675835360561109	3	6	-0.0403445401500417
ICAM4	ITGB1	R-HSA-8875878	MET promotes cell motility	0.0117138410029984	0.0287630958874994	0.675835360561109	7	13	-0.0320088913587108
ICAM4	ITGB2	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.000505446993629699	0.00452103415845861	0.698177025373047	47	86	0.125145873853848
ICAM4	ITGB2	R-HSA-168898	Toll-like Receptor Cascades	0.000240047825494977	0.00264160409509044	0.698177025373047	50	91	0.140316754654071
ICAM4	ITGB2	R-HSA-202733	Cell surface interactions at the vascular wall	2.48554807765483e-07	1.62012542879865e-05	0.698177025373047	25	47	0.290691858849681
ICAM4	ITGB2	R-HSA-216083	Integrin cell surface interactions	0.000105399139295993	0.0015266905631359	0.698177025373047	2	5	0.302639622117255
ICAM4	ITGB2	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	1.96303112316817e-05	0.000485342522521234	0.698177025373047	35	65	0.194943039733259
IL10	IL10RA	R-HSA-6783783	Interleukin-10 signaling	0.0139043161784719	0.0316488720633788	0.567370135654077	13	25	0.0375659905529314
IL15	IL15RA	R-HSA-451927	Interleukin-2 family signaling	0.0015063832588788	0.00903829955327282	0.635398721867185	12	22	0.168435676576827
IL15	IL15RA	R-HSA-8983432	Interleukin-15 signaling	0.0157384581939922	0.033534842570854	0.635398721867185	6	12	-0.068463462072798
IL15	IL2RA	R-HSA-451927	Interleukin-2 family signaling	0.00263519584409883	0.0129858104482396	0.849902750764101	14	26	-0.0222839677688247
IL15	IL2RA	R-HSA-512988	Interleukin-3, Interleukin-5 and GM-CSF signaling	0.0029343995776381	0.0139621398022879	0.849902750764101	18	34	-0.0383995554320645
IL15	IL2RA	R-HSA-5673001	RAF/MAP kinase cascade	0.00357941739266723	0.0154604956056771	0.849902750764101	45	82	-0.0282300639066407
IL15	IL2RA	R-HSA-5683057	MAPK family signaling cascades	0.00348051509581456	0.0153370510384127	0.849902750764101	59	108	-0.0151153098082801
IL15	IL2RA	R-HSA-5684996	MAPK1/MAPK3 signaling	0.00349694765647231	0.0153370510384127	0.849902750764101	46	85	-0.0282300639066407
IL15	IL2RA	R-HSA-8877330	RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)	0.00371545655917935	0.0157534654560702	0.849902750764101	3	6	-0.347818838566268
IL15	IL2RA	R-HSA-8878171	Transcriptional regulation by RUNX1	0.00389962007027783	0.0158467320427842	0.849902750764101	23	43	-0.127090858571826
IL15	IL2RA	R-HSA-9020558	Interleukin-2 signaling	0.00224631117029424	0.0117134917025525	0.849902750764101	4	9	-0.124312308974715
IL15	IL2RA	R-HSA-912526	Interleukin receptor SHC signaling	0.00219897895032879	0.0115506806401886	0.849902750764101	9	18	-0.0411225340372326
IL15	IL2RA	R-HSA-9607240	FLT3 Signaling	0.00360286443512232	0.015515037837734	0.849902750764101	51	94	-0.0305084745762712
IL15	IL2RB	R-HSA-451927	Interleukin-2 family signaling	0.000226270736459785	0.00253493934440103	0.354542928591275	15	28	0.263073075854404
IL15	IL2RB	R-HSA-512988	Interleukin-3, Interleukin-5 and GM-CSF signaling	0.00113998994880861	0.00778450279329307	0.354542928591275	18	34	0.195554320644624
IL15	IL2RB	R-HSA-8983432	Interleukin-15 signaling	0.00123726415548539	0.00816773800659695	0.354542928591275	6	12	0.263073075854404
IL15	IL2RB	R-HSA-9020558	Interleukin-2 signaling	0.00365721868080571	0.0156084868698672	0.354542928591275	4	9	0.184328980272298
IL15	IL2RB	R-HSA-912526	Interleukin receptor SHC signaling	0.00351287697512474	0.0153370931507481	0.354542928591275	9	18	0.178271742150597
IL16	CD4	R-HSA-162594	Early Phase of HIV Life Cycle	0.0209866220315644	0.0389139834016191	0.279326664311248	2	5	0.0674718277320512
IL16	CD4	R-HSA-202403	TCR signaling	0.00425132252466713	0.0167082939277595	0.279326664311248	25	46	0.16097169497001
IL16	CD4	R-HSA-202424	Downstream TCR signaling	0.0113174205607026	0.0280781679654802	0.279326664311248	19	36	0.127906031048342
IL16	CD4	R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	0.00381927003059358	0.0157587229041109	0.279326664311248	6	11	0.272680019029697
IL16	CD4	R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.00294042274776216	0.0139621398022879	0.279326664311248	6	12	0.237547751112925
IL16	CD4	R-HSA-202433	Generation of second messenger molecules	0.0055934640476504	0.0194350080188209	0.279326664311248	11	20	0.210123357556272
IL16	CD4	R-HSA-388841	Costimulation by the CD28 family	0.00317410063944263	0.014635563720131	0.279326664311248	24	45	0.16097169497001
IL16	CD4	R-HSA-389948	PD-1 signaling	0.00213749710188519	0.0113105935206766	0.279326664311248	7	14	0.237547751112925
IL16	KCND1	R-HSA-397014	Muscle contraction	0.0259271502362799	0.0443656518036903	0.505473742706307	46	85	0.0400111141983884
IL18	IL18BP	R-HSA-9008059	Interleukin-37 signaling	0.0205096817958155	0.0384959210670149	0.361494627501747	6	12	0.0929146985273687
INSL3	VIPR1	R-HSA-9662851	Anti-inflammatory response favouring Leishmania parasite infection	0.0141891340980409	0.0318921916874461	0.250972546791919	31	58	0.110760717188192
INSL3	VIPR1	R-HSA-9664433	Leishmania parasite growth and survival	0.0141891340980409	0.0318921916874461	0.250972546791919	31	58	0.110760717188192
LAMB1	ITGA2	R-HSA-216083	Integrin cell surface interactions	0.00405293654333412	0.0161441972309476	0.477188107807724	3	7	0.137149208113365
LAMB1	ITGA2	R-HSA-3000157	Laminin interactions	0.0214859915521386	0.0389982143732682	0.477188107807724	2	4	0.0111141983884412
LAMB1	ITGA2	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0211591151196618	0.0389501554320861	0.477188107807724	3	7	-0.0328980272297861
LAMB1	ITGA2	R-HSA-3000178	ECM proteoglycans	0.0183484788092958	0.0362091553977585	0.477188107807724	4	8	0.0487357599333148
LAMB1	ITGA2	R-HSA-8874081	MET activates PTK2 signaling	0.0270063772748933	0.0451617352514063	0.477188107807724	2	4	-0.0328980272297861
LAMB1	ITGA7	R-HSA-216083	Integrin cell surface interactions	0.0150918609278494	0.0329042986428705	0.342873020283412	2	4	0.163656571269797
LAMB1	ITGA7	R-HSA-3000178	ECM proteoglycans	0.00664139869896516	0.0205632563244388	0.342873020283412	2	5	0.153764934704085
LAMC1	ITGAV	R-HSA-194138	Signaling by VEGF	0.00686496810442281	0.0208132636843253	0.753709363712142	31	58	-0.00388996943595443
LAMC1	ITGAV	R-HSA-202733	Cell surface interactions at the vascular wall	0.00297235586161421	0.0140209154787986	0.753709363712142	25	46	0.0640186721188778
LAMC1	ITGAV	R-HSA-210990	PECAM1 interactions	0.00797605245482972	0.0230665197501802	0.753709363712142	3	7	-0.251958877465963
LAMC1	ITGAV	R-HSA-216083	Integrin cell surface interactions	0.00610359733151519	0.0196245707923605	0.753709363712142	6	11	-0.032342317310364
LAMC1	ITGAV	R-HSA-3000157	Laminin interactions	0.0100139617555436	0.0259728597088795	0.753709363712142	3	6	-0.40577938316199
LAMC1	ITGAV	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.00671736000903337	0.0206710177102014	0.753709363712142	4	9	-0.156256213891481
LAMC1	ITGAV	R-HSA-3000178	ECM proteoglycans	0.0045379535971484	0.017436181314369	0.753709363712142	4	8	-0.032342317310364
LAMC1	ITGAV	R-HSA-373760	L1CAM interactions	0.00287650347862446	0.0138419664038506	0.753709363712142	12	23	0.0524034454015004
LAMC1	ITGAV	R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.00736089664800422	0.0217191888749754	0.753709363712142	31	57	-0.00388996943595443
LAMC1	ITGAV	R-HSA-445144	Signal transduction by L1	0.00148289617905451	0.00893476101161415	0.753709363712142	4	9	0.0566824117810503
LAMC1	ITGB1	R-HSA-1566948	Elastic fibre formation	0.0232820513976669	0.0410153092189857	0.495359822172826	2	4	-0.0242848608645396
LAMC1	ITGB1	R-HSA-195258	RHO GTPase Effectors	0.00119789076771305	0.00798965284139774	0.495359822172826	98	179	0.108641289247013
LAMC1	ITGB1	R-HSA-202733	Cell surface interactions at the vascular wall	0.00107473531876655	0.00740947330341938	0.495359822172826	28	51	0.167657682689636
LAMC1	ITGB1	R-HSA-210991	Basigin interactions	0.00935843825016557	0.0250841129920326	0.495359822172826	4	9	0.0583495415393165
LAMC1	ITGB1	R-HSA-216083	Integrin cell surface interactions	0.0152176426257827	0.0329963359544387	0.495359822172826	10	19	0.0734092803556544
LAMC1	ITGB1	R-HSA-3000157	Laminin interactions	0.0214871010115157	0.0389982143732682	0.495359822172826	4	9	-0.0320088913587108
LAMC1	ITGB1	R-HSA-3000170	Syndecan interactions	0.0259835618089194	0.0443656518036903	0.495359822172826	3	6	-0.0242848608645396
LAMC1	ITGB1	R-HSA-3000178	ECM proteoglycans	0.0302505219292409	0.0484143397840753	0.495359822172826	6	12	-0.0242848608645396
LAMC1	ITGB1	R-HSA-373760	L1CAM interactions	0.000428102646578891	0.00403881049469822	0.495359822172826	14	26	0.233009169213671
LAMC1	ITGB1	R-HSA-445144	Signal transduction by L1	0.0124621585188644	0.0301361472446064	0.495359822172826	5	10	0.077354820783551
LAMC1	ITGB1	R-HSA-8874081	MET activates PTK2 signaling	0.0283285582095652	0.0463205843472253	0.495359822172826	3	6	-0.0403445401500417
LAMC1	ITGB4	R-HSA-1500931	Cell-Cell communication	0.00349736101085142	0.0153370510384127	0.554598499583218	7	13	0.173381494859683
LAMC1	ITGB4	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.00970749947513994	0.0256363798293751	0.554598499583218	2	5	-0.0181786773374944
LGALS9	HAVCR2	R-HSA-451927	Interleukin-2 family signaling	0.0079467067788894	0.0230665197501802	0.499638788552376	11	21	0.110530702973048
LHB	ADRB2	R-HSA-5688426	Deubiquitination	0.0219853321736778	0.039325285328905	0.660618789182146	40	73	-0.108030008335649
LHB	ADRB2	R-HSA-5689880	Ub-specific processing proteases	0.0220213863275913	0.0393258630059351	0.660618789182146	26	48	-0.164267852181161
LHB	ADRB2	R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.0202489664641597	0.038277530712006	0.660618789182146	28	51	-0.0543484301194776
LHB	ADRB2	R-HSA-8856828	Clathrin-mediated endocytosis	0.0193648516245689	0.0372241249726968	0.660618789182146	53	98	-0.0229508196721312
LHB	ADRB2	R-HSA-9660821	ADORA2B mediated anti-inflammatory cytokines production	0.0146821022389301	0.0323610702092959	0.660618789182146	9	18	-0.0715198666296194
LHB	ADRB2	R-HSA-9662851	Anti-inflammatory response favouring Leishmania parasite infection	0.0211097243569467	0.0389139834016191	0.660618789182146	31	57	-0.0726312864684635
LHB	ADRB2	R-HSA-9664433	Leishmania parasite growth and survival	0.0211097243569467	0.0389139834016191	0.660618789182146	31	57	-0.0726312864684635
LIN7C	ABCA1	R-HSA-1989781	PPARA activates gene expression	0.00580068579641237	0.0194350080188209	0.310752986940817	24	45	0.139983328702417
LIN7C	ABCA1	R-HSA-400206	Regulation of lipid metabolism by PPARalpha	0.00580068579641237	0.0194350080188209	0.310752986940817	24	45	0.139983328702417
LIN7C	ABCA1	R-HSA-9006931	Signaling by Nuclear Receptors	0.00194277511564202	0.0105929259157059	0.310752986940817	52	96	0.135370936371214
LPL	VLDLR	R-HSA-174824	Plasma lipoprotein assembly, remodeling, and clearance	0.00618500139799239	0.0197534343089557	0.790573531269506	6	12	-0.165320750676901
LPL	VLDLR	R-HSA-8866427	VLDLR internalisation and degradation	4.7252686066186e-05	0.000880004569076762	0.790573531269506	3	7	0.281437242282319
LPL	VLDLR	R-HSA-8964043	Plasma lipoprotein clearance	0.00332905367199007	0.0150595046234504	0.790573531269506	5	10	-0.0288974790415201
LTA	LTBR	R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.0275108888057757	0.0456502250101265	0.599666574048347	13	25	-0.0787440955821062
LTA	LTBR	R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.00141931858652136	0.0087039645197091	0.599666574048347	3	6	0.231508752431231
LTA	TNFRSF1B	R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.0272447229465891	0.0454818774218961	0.539372047791053	13	25	-0.0102806335093081
LTA	TNFRSF1B	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.00975667448023423	0.0257188808909116	0.539372047791053	34	62	0.0835787718810781
LTB	LTBR	R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.00178071221174042	0.0100138874966109	0.565823839955543	3	6	0.231508752431231
LY86	CD180	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.00245330463316187	0.0123874607181483	0.636621283689914	47	86	0.0984162267296471
LY86	CD180	R-HSA-168898	Toll-like Receptor Cascades	0.000638418567871382	0.00532262922283466	0.636621283689914	50	91	0.130425118088358
MDK	SDC1	R-HSA-196854	Metabolism of vitamins and cofactors	0.0177780145421354	0.0359647190392765	0.340857379650429	3	7	0.0692685145940546
MDK	SDC1	R-HSA-2022928	HS-GAG biosynthesis	0.0315529757466353	0.0494312952116963	0.340857379650429	3	6	0.0692685145940546
MDK	SDC1	R-HSA-202733	Cell surface interactions at the vascular wall	0.00183245020126475	0.0101456895313269	0.340857379650429	25	46	0.176069000514475
MDK	SDC1	R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.0315529757466353	0.0494312952116963	0.340857379650429	3	6	0.0692685145940546
MDK	SDC1	R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.0315529757466353	0.0494312952116963	0.340857379650429	3	6	0.0692685145940546
MDK	SDC1	R-HSA-3656237	Defective EXT2 causes exostoses 2	0.0315529757466353	0.0494312952116963	0.340857379650429	3	6	0.0692685145940546
MDK	SDC1	R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.0315529757466353	0.0494312952116963	0.340857379650429	3	6	0.0692685145940546
MDK	SDC1	R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.0315529757466353	0.0494312952116963	0.340857379650429	3	6	0.0692685145940546
MDK	SDC1	R-HSA-6806667	Metabolism of fat-soluble vitamins	0.0177780145421354	0.0359647190392765	0.340857379650429	3	7	0.0692685145940546
MDK	SDC1	R-HSA-975634	Retinoid metabolism and transport	0.0177780145421354	0.0359647190392765	0.340857379650429	3	7	0.0692685145940546
MFGE8	PDGFRB	R-HSA-1257604	PIP3 activates AKT signaling	0.00682996763415614	0.0208132636843253	0.543526369133138	55	100	0.0872464573492637
MFGE8	PDGFRB	R-HSA-186763	Downstream signal transduction	3.58476476776759e-05	0.000713965649580378	0.543526369133138	12	22	0.3219227563212
MFGE8	PDGFRB	R-HSA-186797	Signaling by PDGF	3.58476476776759e-05	0.000713965649580378	0.543526369133138	12	22	0.3219227563212
MFGE8	PDGFRB	R-HSA-199418	Negative regulation of the PI3K/AKT network	0.00570791094787625	0.0194350080188209	0.543526369133138	29	54	0.0958043901083634
MFGE8	PDGFRB	R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.00778204966132406	0.0227744065598749	0.543526369133138	23	43	0.0872464573492637
MFGE8	PDGFRB	R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.0149235600084757	0.0326858993302064	0.543526369133138	11	20	0.0716310086135038
MFGE8	PDGFRB	R-HSA-5663202	Diseases of signal transduction by growth factor receptors and second messengers	0.00206815365013594	0.0111076117389324	0.543526369133138	95	173	0.0986940816893582
MFGE8	PDGFRB	R-HSA-5673001	RAF/MAP kinase cascade	0.00408929289385633	0.0162438947639612	0.543526369133138	45	83	0.0986940816893582
MFGE8	PDGFRB	R-HSA-5683057	MAPK family signaling cascades	0.00324449444947735	0.014817213504938	0.543526369133138	59	109	0.0958043901083634
MFGE8	PDGFRB	R-HSA-5684996	MAPK1/MAPK3 signaling	0.00456462083592072	0.017436181314369	0.543526369133138	47	86	0.0986940816893582
MFGE8	PDGFRB	R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	0.0047742797067196	0.0179734566262864	0.543526369133138	28	51	0.114754098360656
MFGE8	PDGFRB	R-HSA-9006925	Intracellular signaling by second messengers	0.00345941495218689	0.0153111143254197	0.543526369133138	67	122	0.0985273687135316
MFGE8	PDGFRB	R-HSA-9607240	FLT3 Signaling	0.000833176269397079	0.00628828826481796	0.543526369133138	52	95	0.13375937760489
MMP9	LRP1	R-HSA-196854	Metabolism of vitamins and cofactors	0.000814615186634392	0.00622729237249825	0.776379054319534	3	7	0.0882712652214322
MMP9	LRP1	R-HSA-2187338	Visual phototransduction	0.000271078781252792	0.00287945905419632	0.776379054319534	5	10	0.210558488469019
MMP9	LRP1	R-HSA-6806667	Metabolism of fat-soluble vitamins	0.000814615186634392	0.00622729237249825	0.776379054319534	3	7	0.0882712652214322
MMP9	LRP1	R-HSA-975634	Retinoid metabolism and transport	0.000814615186634392	0.00622729237249825	0.776379054319534	3	7	0.0882712652214322
NTN1	ADORA2B	R-HSA-9662851	Anti-inflammatory response favouring Leishmania parasite infection	1.69717833641002e-07	1.45329154683725e-05	0.418325966630898	31	58	0.296252199803862
NTN1	ADORA2B	R-HSA-9664433	Leishmania parasite growth and survival	1.69717833641002e-07	1.45329154683725e-05	0.418325966630898	31	58	0.296252199803862
PLAT	ITGAM	R-HSA-202733	Cell surface interactions at the vascular wall	5.94429145177333e-06	0.000189424754263177	0.293748263406502	24	45	0.285801611558766
PLAT	ITGAM	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.00600753864119997	0.0195788570310922	0.293748263406502	35	64	0.136723636167661
PLAT	ITGB2	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.00307992460708978	0.0144333721783227	0.421783828841345	47	86	0.125145873853848
PLAT	ITGB2	R-HSA-168898	Toll-like Receptor Cascades	0.00146272351787301	0.00888343135245464	0.421783828841345	50	91	0.140316754654071
PLAT	ITGB2	R-HSA-202733	Cell surface interactions at the vascular wall	1.51456053413234e-06	6.03299946096048e-05	0.421783828841345	25	47	0.290691858849681
PLAT	ITGB2	R-HSA-216083	Integrin cell surface interactions	0.000642246183625808	0.00532358975329138	0.421783828841345	2	5	0.302639622117255
PLAT	ITGB2	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.000119616654900082	0.00166490587489175	0.421783828841345	35	65	0.194943039733259
PLAU	ITGB2	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.00211876715097034	0.0112530077573758	0.48876187804584	47	86	0.125145873853848
PLAU	ITGB2	R-HSA-168898	Toll-like Receptor Cascades	0.00100624883267825	0.00716454875246052	0.48876187804584	50	91	0.140316754654071
PLAU	ITGB2	R-HSA-202733	Cell surface interactions at the vascular wall	1.04190898065777e-06	4.5275681159492e-05	0.48876187804584	25	47	0.290691858849681
PLAU	ITGB2	R-HSA-216083	Integrin cell surface interactions	0.000441819294397669	0.00411408355952115	0.48876187804584	2	5	0.302639622117255
PLAU	ITGB2	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	8.22876763047531e-05	0.00133413322377151	0.48876187804584	35	65	0.194943039733259
PLAU	ITGB5	R-HSA-216083	Integrin cell surface interactions	0.00801439489358128	0.023124028727154	0.376809605457797	3	6	0.195517832222394
PLAU	ITGB5	R-HSA-397014	Muscle contraction	0.00244723766969822	0.0123874607181483	0.376809605457797	46	85	0.130359863772154
PLAU	ITGB5	R-HSA-445355	Smooth Muscle Contraction	0.00202245779397939	0.0109441678360998	0.376809605457797	12	23	0.19704138111977
PLAU	LRP1	R-HSA-196854	Metabolism of vitamins and cofactors	0.000729079681571081	0.00577624454902172	0.788166778069026	3	7	0.0882712652214322
PLAU	LRP1	R-HSA-2187338	Visual phototransduction	0.000242615206246044	0.00264160409509044	0.788166778069026	5	10	0.210558488469019
PLAU	LRP1	R-HSA-6806667	Metabolism of fat-soluble vitamins	0.000729079681571081	0.00577624454902172	0.788166778069026	3	7	0.0882712652214322
PLAU	LRP1	R-HSA-975634	Retinoid metabolism and transport	0.000729079681571081	0.00577624454902172	0.788166778069026	3	7	0.0882712652214322
PLTP	ABCA1	R-HSA-1989781	PPARA activates gene expression	0.00187725869915929	0.0103141340022775	0.523978883023062	24	45	0.139983328702417
PLTP	ABCA1	R-HSA-400206	Regulation of lipid metabolism by PPARalpha	0.00187725869915929	0.0103141340022775	0.523978883023062	24	45	0.139983328702417
PLTP	ABCA1	R-HSA-9006931	Signaling by Nuclear Receptors	0.000628734534907036	0.00527254574886953	0.523978883023062	52	96	0.135370936371214
PSAP	LRP1	R-HSA-196854	Metabolism of vitamins and cofactors	0.0184510010039966	0.0362091553977585	0.288135593220339	3	7	0.0882712652214322
PSAP	LRP1	R-HSA-2187338	Visual phototransduction	0.00613992342288881	0.0196972040009453	0.288135593220339	5	10	0.210558488469019
PSAP	LRP1	R-HSA-6806667	Metabolism of fat-soluble vitamins	0.0184510010039966	0.0362091553977585	0.288135593220339	3	7	0.0882712652214322
PSAP	LRP1	R-HSA-975634	Retinoid metabolism and transport	0.0184510010039966	0.0362091553977585	0.288135593220339	3	7	0.0882712652214322
PSEN1	NCSTN	R-HSA-1236394	Signaling by ERBB4	0.000156648016831037	0.00195641407931247	0.611725479299806	2	4	0.434787440955821
PSEN1	NCSTN	R-HSA-1251985	Nuclear signaling by ERBB4	0.000156648016831037	0.00195641407931247	0.611725479299806	2	4	0.434787440955821
PSEN1	NCSTN	R-HSA-157118	Signaling by NOTCH	0.0129925906069427	0.0305508653956215	0.611725479299806	23	43	0.0335093081411503
PSEN1	NCSTN	R-HSA-193692	Regulated proteolysis of p75NTR	0.00895814997280331	0.0245152424828243	0.611725479299806	3	7	-0.0322867463184218
PSEN1	NCSTN	R-HSA-193704	p75 NTR receptor-mediated signalling	0.014852734910298	0.032616878807607	0.611725479299806	14	27	0.00372325646012781
PSEN1	NCSTN	R-HSA-1980143	Signaling by NOTCH1	0.000746815048692472	0.00585209169303282	0.611725479299806	11	20	0.217560433453737
PSEN1	NCSTN	R-HSA-1980145	Signaling by NOTCH2	8.28018528003236e-05	0.00133413322377151	0.611725479299806	6	12	0.315809947207558
PSEN1	NCSTN	R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.014008534893103	0.0316849196162614	0.611725479299806	11	20	0.0335093081411503
PSEN1	NCSTN	R-HSA-205043	NRIF signals cell death from the nucleus	0.00104377145657979	0.00733709935654618	0.611725479299806	6	11	0.24156710197277
PSEN1	NCSTN	R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.000523405409996844	0.00463310714774984	0.611725479299806	7	14	0.217560433453737
PSEN1	NCSTN	R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.00892440943911549	0.0245091622980174	0.611725479299806	8	16	0.0335093081411503
PSEN1	NCSTN	R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.00892440943911549	0.0245091622980174	0.611725479299806	8	16	0.0335093081411503
PSEN1	NCSTN	R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.00892440943911549	0.0245091622980174	0.611725479299806	8	16	0.0335093081411503
PSEN1	NCSTN	R-HSA-2682334	EPH-Ephrin signaling	1.88213315961445e-07	1.49943275049284e-05	0.611725479299806	26	49	0.297582661850514
PSEN1	NCSTN	R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.00892440943911549	0.0245091622980174	0.611725479299806	8	16	0.0335093081411503
PSEN1	NCSTN	R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.00892440943911549	0.0245091622980174	0.611725479299806	8	16	0.0335093081411503
PSEN1	NCSTN	R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.000263490851945135	0.0028409464788671	0.611725479299806	6	11	0.315809947207558
PSEN1	NCSTN	R-HSA-3928665	EPH-ephrin mediated repulsion of cells	5.60916500262696e-07	2.87269379063109e-05	0.611725479299806	11	20	0.434787440955821
PSEN1	NCSTN	R-HSA-5663202	Diseases of signal transduction by growth factor receptors and second messengers	0.00687662022809345	0.0208132636843253	0.611725479299806	96	175	0.0653514865240345
PSEN1	NCSTN	R-HSA-73887	Death Receptor Signalling	0.0210713950276235	0.0389139834016191	0.611725479299806	30	55	0.00372325646012781
PSEN1	NCSTN	R-HSA-9012852	Signaling by NOTCH3	0.000690732836618632	0.00559610671023231	0.611725479299806	7	14	0.204125819935609
PSEN1	NCSTN	R-HSA-9013507	NOTCH3 Activation and Transmission of Signal to the Nucleus	0.000156648016831037	0.00195641407931247	0.611725479299806	2	4	0.434787440955821
PSEN1	NCSTN	R-HSA-9013694	Signaling by NOTCH4	0.0118593487300469	0.0289715606113923	0.611725479299806	8	15	0.0335093081411503
PSEN1	NCSTN	R-HSA-9013700	NOTCH4 Activation and Transmission of Signal to the Nucleus	3.14733547580261e-05	0.000663717510632491	0.611725479299806	2	5	0.414337315921089
PSEN1	NCSTN	R-HSA-9017802	Noncanonical activation of NOTCH3	0.000156648016831037	0.00195641407931247	0.611725479299806	2	4	0.434787440955821
PSEN1	NCSTN	R-HSA-977225	Amyloid fiber formation	0.000832721284757709	0.00628828826481796	0.611725479299806	4	8	0.24156710197277
PSEN1	NOTCH4	R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.0303563998645949	0.0484216656349601	0.434176160044457	2	4	-0.00839121978327313
PSEN1	NOTCH4	R-HSA-9604323	Negative regulation of NOTCH4 signaling	0.0153113158021983	0.0330505564684341	0.434176160044457	4	9	0.0446235065295916
RPS27A	SMAD3	R-HSA-5663202	Diseases of signal transduction by growth factor receptors and second messengers	0.026996400305607	0.0451617352514063	0.339816615726591	93	170	0.0692970269519311
RPS27A	TLR4	R-HSA-109581	Apoptosis	0.0207678396231224	0.0387270247328447	0.422784106696305	40	73	0.0774659627674354
RPS27A	TLR4	R-HSA-1236975	Antigen processing-Cross presentation	0.027632074831792	0.0456502250101265	0.422784106696305	12	22	0.0742428452347875
RPS27A	TLR4	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.0118527457608252	0.0289715606113923	0.422784106696305	46	84	0.0931925534870798
RPS27A	TLR4	R-HSA-166058	MyD88:MAL(TIRAP) cascade initiated on plasma membrane	0.0162982224497705	0.0343196049823362	0.422784106696305	34	63	0.0817449291469853
RPS27A	TLR4	R-HSA-166166	MyD88-independent TLR4 cascade	0.0100341452431794	0.0259728597088795	0.422784106696305	40	73	0.101972770213948
RPS27A	TLR4	R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.017077086933314	0.03549064153967	0.422784106696305	36	66	0.0843011947763268
RPS27A	TLR4	R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.0162982224497705	0.0343196049823362	0.422784106696305	34	63	0.0817449291469853
RPS27A	TLR4	R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.0108980957731103	0.027513854469437	0.422784106696305	35	64	0.101972770213948
RPS27A	TLR4	R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.0162982224497705	0.0343196049823362	0.422784106696305	34	63	0.0817449291469853
RPS27A	TLR4	R-HSA-168898	Toll-like Receptor Cascades	0.0138036089522425	0.031469594972203	0.422784106696305	49	90	0.0843011947763268
RPS27A	TLR4	R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.0162982224497705	0.0343196049823362	0.422784106696305	34	63	0.0817449291469853
RPS27A	TLR4	R-HSA-2562578	TRIF-mediated programmed cell death	0.0202597091851919	0.038277530712006	0.422784106696305	3	7	0.0112809113642679
RPS27A	TLR4	R-HSA-5357801	Programmed Cell Death	0.0214157675336132	0.0389982143732682	0.422784106696305	41	75	0.0747429841622673
RPS27A	TLR4	R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.0207067173729342	0.0386633238447756	0.422784106696305	2	5	-0.0159488746874132
RPS27A	TLR4	R-HSA-937041	IKK complex recruitment mediated by RIP1	0.0180405654760019	0.0361873758147169	0.422784106696305	7	14	0.0742428452347875
RPS27A	TLR4	R-HSA-937061	TRIF(TICAM1)-mediated TLR4 signaling	0.0100341452431794	0.0259728597088795	0.422784106696305	40	73	0.101972770213948
RPS27A	TLR4	R-HSA-937072	TRAF6-mediated induction of TAK1 complex within TLR4 complex	0.0281910646301264	0.0461567136674605	0.422784106696305	6	11	0.0742428452347875
RPS27A	TLR4	R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.0152110943492507	0.0329963359544387	0.422784106696305	34	63	0.0843011947763268
RPS27A	TLR4	R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.0108980957731103	0.027513854469437	0.422784106696305	35	64	0.101972770213948
RPS27A	TLR4	R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.0281910646301264	0.0461567136674605	0.422784106696305	6	11	0.0742428452347875
RTN4	RTN4R	R-HSA-193704	p75 NTR receptor-mediated signalling	0.0019216547886699	0.0105177594158498	0.66901917199222	13	24	0.136760211169769
RTN4	RTN4R	R-HSA-73887	Death Receptor Signalling	0.016875639739392	0.0352251344778575	0.66901917199222	28	52	-0.0321200333425952
S100A9	TLR4	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.0254424739419711	0.0438991832259878	0.260284248248712	46	84	0.0931925534870798
S100A9	TLR4	R-HSA-166166	MyD88-independent TLR4 cascade	0.0215387627500896	0.0389982143732682	0.260284248248712	40	73	0.101972770213948
S100A9	TLR4	R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.0233932730288446	0.0410599186332474	0.260284248248712	35	64	0.101972770213948
S100A9	TLR4	R-HSA-168898	Toll-like Receptor Cascades	0.0296300931581052	0.0478485963836969	0.260284248248712	49	90	0.0843011947763268
S100A9	TLR4	R-HSA-937061	TRIF(TICAM1)-mediated TLR4 signaling	0.0215387627500896	0.0389982143732682	0.260284248248712	40	73	0.101972770213948
S100A9	TLR4	R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.0233932730288446	0.0410599186332474	0.260284248248712	35	64	0.101972770213948
SELPLG	ITGAM	R-HSA-202733	Cell surface interactions at the vascular wall	1.64219127639414e-06	6.19711129039264e-05	0.537371492081134	24	45	0.285801611558766
SELPLG	ITGAM	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.00165966417178892	0.00955806595319401	0.537371492081134	35	64	0.136723636167661
SELPLG	ITGB2	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.000455621870076518	0.00421523717219178	0.711030841900528	47	86	0.125145873853848
SELPLG	ITGB2	R-HSA-168898	Toll-like Receptor Cascades	0.000216384785226263	0.00248236625611569	0.711030841900528	50	91	0.140316754654071
SELPLG	ITGB2	R-HSA-202733	Cell surface interactions at the vascular wall	2.24053180171026e-07	1.54317078867813e-05	0.711030841900528	25	47	0.290691858849681
SELPLG	ITGB2	R-HSA-216083	Integrin cell surface interactions	9.50092760580899e-05	0.00148090545507936	0.711030841900528	2	5	0.302639622117255
SELPLG	ITGB2	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	1.76952266534114e-05	0.000453124196803426	0.711030841900528	35	65	0.194943039733259
SEMA4D	ERBB2	R-HSA-1227986	Signaling by ERBB2	0.0180039730970917	0.0361873758147169	0.674687413170325	17	31	-0.0800777993887191
SEMA4D	ERBB2	R-HSA-1227990	Signaling by ERBB2 in Cancer	0.0143793460230293	0.0320186058960001	0.674687413170325	6	11	-0.0816337871631009
SEMA4D	ERBB2	R-HSA-1250196	SHC1 events in ERBB2 signaling	0.015893258879289	0.0336645985714924	0.674687413170325	3	7	-0.270075020839122
SEMA4D	ERBB2	R-HSA-1257604	PIP3 activates AKT signaling	0.0197173553088327	0.0376493841715926	0.674687413170325	55	100	-0.0767991108641289
SEMA4D	ERBB2	R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.0151600842343729	0.0329887113688782	0.674687413170325	4	9	-0.20668000476509
SEMA4D	ERBB2	R-HSA-199418	Negative regulation of the PI3K/AKT network	0.0188043134064367	0.0365880399251428	0.674687413170325	29	54	-0.0767991108641289
SEMA4D	ERBB2	R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.0187300906958969	0.0365427891944437	0.674687413170325	22	40	-0.0816337871631009
SEMA4D	ERBB2	R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.00629093626705231	0.0199584128472412	0.674687413170325	9	17	0.0488469019171992
SEMA4D	ERBB2	R-HSA-373755	Semaphorin interactions	0.00097187391247109	0.00703872318426032	0.674687413170325	17	32	0.142428452347874
SEMA4D	ERBB2	R-HSA-400685	Sema4D in semaphorin signaling	0.000932372440480467	0.00678691410989335	0.674687413170325	9	17	0.177938316198944
SEMA4D	ERBB2	R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.00123531105220889	0.00816773800659695	0.674687413170325	8	15	0.173325923867741
SEMA4D	ERBB2	R-HSA-5663202	Diseases of signal transduction by growth factor receptors and second messengers	0.0194376378488354	0.0372641345925534	0.674687413170325	95	173	-0.0312864684634621
SEMA4D	ERBB2	R-HSA-5673001	RAF/MAP kinase cascade	0.0158696147889581	0.0336642420227306	0.674687413170325	44	81	-0.011058627396499
SEMA4D	ERBB2	R-HSA-5683057	MAPK family signaling cascades	0.0143640103811871	0.0320186058960001	0.674687413170325	58	107	0.00544595721033621
SEMA4D	ERBB2	R-HSA-5684996	MAPK1/MAPK3 signaling	0.0145507048598532	0.0322499393648061	0.674687413170325	46	84	0.00455682133926091
SEMA4D	ERBB2	R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	0.0190269200666049	0.0368213270924581	0.674687413170325	28	51	-0.0767991108641289
SEMA4D	ERBB2	R-HSA-8848021	Signaling by PTK6	0.0115253450093402	0.0284954219713687	0.674687413170325	14	27	-0.0198388441233676
SEMA4D	ERBB2	R-HSA-8863795	Downregulation of ERBB2 signaling	0.018633489504387	0.0364038473423582	0.674687413170325	7	13	-0.192775771047513
SEMA4D	ERBB2	R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	0.0175684995073167	0.0359448823047005	0.674687413170325	6	11	-0.162378438455126
SEMA4D	ERBB2	R-HSA-9006925	Intracellular signaling by second messengers	0.0197501347483398	0.0376618261025522	0.674687413170325	67	122	-0.0711864406779661
SEMA4D	ERBB2	R-HSA-9006927	Signaling by Non-Receptor Tyrosine Kinases	0.0115253450093402	0.0284954219713687	0.674687413170325	14	27	-0.0198388441233676
SEMA4D	ERBB2	R-HSA-9607240	FLT3 Signaling	0.0149917341962548	0.0327715653009594	0.674687413170325	50	91	0.00455682133926091
SEMA4D	ERBB2	R-HSA-9634285	Constitutive Signaling by Overexpressed ERBB2	0.0179866222408297	0.0361873758147169	0.674687413170325	3	7	-0.35187552097805
SEMA4D	ERBB2	R-HSA-9664565	Signaling by ERBB2 KD Mutants	0.0143793460230293	0.0320186058960001	0.674687413170325	6	11	-0.0816337871631009
SEMA4D	ERBB2	R-HSA-9665348	Signaling by ERBB2 ECD mutants	0.0143793460230293	0.0320186058960001	0.674687413170325	6	11	-0.0816337871631009
SEMA4D	ERBB2	R-HSA-9665686	Signaling by ERBB2 TMD/JMD mutants	0.0181381160711934	0.0361979456523672	0.674687413170325	4	8	-0.270075020839122
SPON2	ITGAM	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.0257090801946042	0.0440463811219384	0.635843289802723	47	87	-0.0622950819672131
SPON2	ITGAM	R-HSA-168898	Toll-like Receptor Cascades	0.025529400003904	0.0438991832259878	0.635843289802723	50	92	-0.0522367324256738
SPON2	ITGAM	R-HSA-202733	Cell surface interactions at the vascular wall	8.45092039021801e-07	3.90923220631375e-05	0.635843289802723	24	45	0.285801611558766
SPON2	ITGAM	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.00085408380813484	0.00641233602547309	0.635843289802723	35	64	0.136723636167661
SPON2	ITGB2	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.000579045148301479	0.0049453635592031	0.680911364267852	47	86	0.125145873853848
SPON2	ITGB2	R-HSA-168898	Toll-like Receptor Cascades	0.000275001197880345	0.00289426698825243	0.680911364267852	50	91	0.140316754654071
SPON2	ITGB2	R-HSA-202733	Cell surface interactions at the vascular wall	2.84746882141021e-07	1.77533490865315e-05	0.680911364267852	25	47	0.290691858849681
SPON2	ITGB2	R-HSA-216083	Integrin cell surface interactions	0.000120746311707631	0.00166490587489175	0.680911364267852	2	5	0.302639622117255
SPON2	ITGB2	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	2.24886815464588e-05	0.000520141440929387	0.680911364267852	35	65	0.194943039733259
SPP1	S1PR1	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	9.18652664199104e-06	0.000268846514379901	0.382219021306195	34	63	0.24156710197277
TCTN1	TMEM67	R-HSA-1852241	Organelle biogenesis and maintenance	2.24631829851937e-10	8.05305110019195e-08	0.516976938038344	79	144	0.256348985829397
TCTN1	TMEM67	R-HSA-5617833	Cilium Assembly	4.37694179391711e-13	6.27653453247714e-10	0.516976938038344	61	111	0.329035843289803
TCTN1	TMEM67	R-HSA-5620912	Anchoring of the basal body to the plasma membrane	8.07772551396626e-10	2.31669167740552e-07	0.516976938038344	48	89	0.294303973325924
TF	TFR2	R-HSA-917937	Iron uptake and transport	0.0216164239101957	0.0390137918935565	0.276413954096613	5	10	0.125979438732981
TGFB1	ITGAV	R-HSA-445144	Signal transduction by L1	0.0221881571142132	0.0395252388842008	0.334926368435677	4	9	0.0566824117810503
TGFB1	ITGB1	R-HSA-195258	RHO GTPase Effectors	0.00373513127968191	0.0157534654560702	0.268574604056682	98	179	0.108641289247013
TGFB1	ITGB1	R-HSA-202733	Cell surface interactions at the vascular wall	0.0033511215001412	0.0150642891260266	0.268574604056682	28	51	0.167657682689636
TGFB1	ITGB1	R-HSA-210991	Basigin interactions	0.0291804531592637	0.0473893203062108	0.268574604056682	4	9	0.0583495415393165
TGFB1	ITGB1	R-HSA-373760	L1CAM interactions	0.00133486260120711	0.00835892126694759	0.268574604056682	14	26	0.233009169213671
TGFB1	ITGB5	R-HSA-216083	Integrin cell surface interactions	0.0016437523431446	0.00952142150542994	0.638563121088683	3	6	0.195517832222394
TGFB1	ITGB5	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0111110500240939	0.0277099925818273	0.638563121088683	2	4	-0.067569287884304
TGFB1	ITGB5	R-HSA-397014	Muscle contraction	0.000501928430931189	0.00452103415845861	0.638563121088683	46	85	0.130359863772154
TGFB1	ITGB5	R-HSA-445355	Smooth Muscle Contraction	0.000414806081046395	0.00394847943266988	0.638563121088683	12	23	0.19704138111977
TGFB2	TGFBR2	R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.0235580694008844	0.0412683281497713	0.575846666255575	10	19	-0.0245623784384551
TGFB2	TGFBR2	R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.0295422205994738	0.047783290526958	0.575846666255575	12	23	-0.0607390941928314
TGFB2	TGFBR2	R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	0.0126111058940968	0.0302920031024035	0.575846666255575	2	5	-0.0806890803000834
TGFB2	TGFBR2	R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.0126111058940968	0.0302920031024035	0.575846666255575	2	5	-0.0806890803000834
TGFB2	TGFBR2	R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.0181494581060335	0.0361979456523672	0.575846666255575	2	4	-0.0806890803000834
TGFB2	TGFBR2	R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.0181494581060335	0.0361979456523672	0.575846666255575	2	4	-0.0806890803000834
TGFB2	TGFBR2	R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.0181494581060335	0.0361979456523672	0.575846666255575	2	4	-0.0806890803000834
TGFB2	TGFBR2	R-HSA-5663202	Diseases of signal transduction by growth factor receptors and second messengers	4.70813742629573e-05	0.000880004569076762	0.575846666255575	93	170	0.142761878299528
TGFB2	TGFBR2	R-HSA-5688426	Deubiquitination	4.06720025948585e-05	0.000788157455689555	0.575846666255575	42	77	0.191275354265074
TGFB2	TGFBR2	R-HSA-9006936	Signaling by TGF-beta family members	0.0295563310302732	0.047783290526958	0.575846666255575	21	39	-0.0245623784384551
TGM2	SDC4	R-HSA-196854	Metabolism of vitamins and cofactors	0.0255925503325842	0.0438991832259878	0.362782931554272	3	7	0.0196316785330497
TGM2	SDC4	R-HSA-202733	Cell surface interactions at the vascular wall	0.0183930543773736	0.0362091553977585	0.362782931554272	24	45	0.0910935120645512
TGM2	SDC4	R-HSA-2187338	Visual phototransduction	0.0171940037725928	0.0356303488582342	0.362782931554272	5	10	0.112574684982763
TGM2	SDC4	R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.0177313951836399	0.0359647190392765	0.362782931554272	6	11	0.146727804667734
TGM2	SDC4	R-HSA-3781865	Diseases of glycosylation	0.0295097304162796	0.047783290526958	0.362782931554272	33	60	0.0803668202839177
TGM2	SDC4	R-HSA-6806667	Metabolism of fat-soluble vitamins	0.0255925503325842	0.0438991832259878	0.362782931554272	3	7	0.0196316785330497
TGM2	SDC4	R-HSA-71387	Metabolism of carbohydrates	0.00277882848912579	0.0134169698767892	0.362782931554272	75	137	0.115853829102231
TGM2	SDC4	R-HSA-975634	Retinoid metabolism and transport	0.0255925503325842	0.0438991832259878	0.362782931554272	3	7	0.0196316785330497
TGM2	TBXA2R	R-HSA-392518	Signal amplification	0.00652556209185724	0.0203427305211376	0.343051307914701	7	14	0.167991108641289
TGM2	TBXA2R	R-HSA-416476	G alpha (q) signalling events	0.00254018566262867	0.0126480077785052	0.343051307914701	23	42	0.176549041400389
TGM2	TBXA2R	R-HSA-416482	G alpha (12/13) signalling events	0.0109364124027348	0.0275244470289418	0.343051307914701	10	19	0.145651569880522
TGM2	TBXA2R	R-HSA-428930	Thromboxane signalling through TP receptor	0.0122658953300659	0.0297936899303215	0.343051307914701	7	13	0.167991108641289
TGM2	TBXA2R	R-HSA-76002	Platelet activation, signaling and aggregation	0.000156895131883496	0.00195641407931247	0.343051307914701	47	86	0.183828841344818
THBS1	CD47	R-HSA-1500931	Cell-Cell communication	0.0307896333597785	0.048816412045836	0.426895185287993	6	11	0.0616838010558489
THBS1	CD47	R-HSA-391160	Signal regulatory protein family interactions	0.00884190747079878	0.0245091622980174	0.426895185287993	3	6	0.162322867463184
THBS1	ITGA4	R-HSA-202733	Cell surface interactions at the vascular wall	0.00947179129714197	0.0252838121279093	0.260500889537243	23	43	0.135011600618762
THBS1	ITGA4	R-HSA-216083	Integrin cell surface interactions	0.0135052941564581	0.0310654752932157	0.260500889537243	2	5	0.121315888619013
THBS1	ITGA6	R-HSA-1500931	Cell-Cell communication	0.00871614665010094	0.0244597931433361	0.411643568764958	7	14	0.130471092324861
THBS1	ITGA6	R-HSA-202733	Cell surface interactions at the vascular wall	0.00913380742548484	0.024779463204473	0.411643568764958	24	45	0.108781524547071
THBS1	LRP1	R-HSA-196854	Metabolism of vitamins and cofactors	0.00489309566409215	0.0182416348903838	0.540014623390621	3	7	0.0882712652214322
THBS1	LRP1	R-HSA-2187338	Visual phototransduction	0.00162827115297904	0.00949162940395101	0.540014623390621	5	10	0.210558488469019
THBS1	LRP1	R-HSA-6806667	Metabolism of fat-soluble vitamins	0.00489309566409215	0.0182416348903838	0.540014623390621	3	7	0.0882712652214322
THBS1	LRP1	R-HSA-975634	Retinoid metabolism and transport	0.00489309566409215	0.0182416348903838	0.540014623390621	3	7	0.0882712652214322
THBS1	SDC4	R-HSA-196854	Metabolism of vitamins and cofactors	0.0276124953704569	0.0456502250101265	0.346942251915077	3	7	0.0196316785330497
THBS1	SDC4	R-HSA-202733	Cell surface interactions at the vascular wall	0.0198447642866277	0.0377418991870347	0.346942251915077	24	45	0.0910935120645512
THBS1	SDC4	R-HSA-2187338	Visual phototransduction	0.018551076129598	0.0362922826328014	0.346942251915077	5	10	0.112574684982763
THBS1	SDC4	R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.0191308822707143	0.0369228602640703	0.346942251915077	6	11	0.146727804667734
THBS1	SDC4	R-HSA-3781865	Diseases of glycosylation	0.0318388470048452	0.049789429231132	0.346942251915077	33	60	0.0803668202839177
THBS1	SDC4	R-HSA-6806667	Metabolism of fat-soluble vitamins	0.0276124953704569	0.0456502250101265	0.346942251915077	3	7	0.0196316785330497
THBS1	SDC4	R-HSA-71387	Metabolism of carbohydrates	0.00299815328266004	0.0140962354338836	0.346942251915077	75	137	0.115853829102231
THBS1	SDC4	R-HSA-975634	Retinoid metabolism and transport	0.0276124953704569	0.0456502250101265	0.346942251915077	3	7	0.0196316785330497
TIMP2	ITGB1	R-HSA-1500931	Cell-Cell communication	0.0166167359407165	0.034785984436478	0.668074465129203	6	12	-0.144763961347661
TIMP2	ITGB1	R-HSA-1566948	Elastic fibre formation	0.00730069239554672	0.0215859647324	0.668074465129203	2	4	-0.0242848608645396
TIMP2	ITGB1	R-HSA-195258	RHO GTPase Effectors	0.000375629787477175	0.00363954807596127	0.668074465129203	98	179	0.108641289247013
TIMP2	ITGB1	R-HSA-202733	Cell surface interactions at the vascular wall	0.000337011195230447	0.00342747556000327	0.668074465129203	28	51	0.167657682689636
TIMP2	ITGB1	R-HSA-210991	Basigin interactions	0.00293458157102187	0.0139621398022879	0.668074465129203	4	9	0.0583495415393165
TIMP2	ITGB1	R-HSA-216083	Integrin cell surface interactions	0.00477188740367322	0.0179734566262864	0.668074465129203	10	19	0.0734092803556544
TIMP2	ITGB1	R-HSA-3000157	Laminin interactions	0.00673783904509534	0.0206827159111625	0.668074465129203	4	9	-0.0320088913587108
TIMP2	ITGB1	R-HSA-3000170	Syndecan interactions	0.00814782120645115	0.0234617984137569	0.668074465129203	3	6	-0.0242848608645396
TIMP2	ITGB1	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0122789893645885	0.0297936899303215	0.668074465129203	6	11	-0.0320088913587108
TIMP2	ITGB1	R-HSA-3000178	ECM proteoglycans	0.00948583746500361	0.0252838121279093	0.668074465129203	6	12	-0.0242848608645396
TIMP2	ITGB1	R-HSA-373760	L1CAM interactions	0.000134242712680599	0.00181607594324508	0.668074465129203	14	26	0.233009169213671
TIMP2	ITGB1	R-HSA-445144	Signal transduction by L1	0.00390783373753262	0.0158467320427842	0.668074465129203	5	10	0.077354820783551
TIMP2	ITGB1	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.0174183520703586	0.0358363226239516	0.668074465129203	36	66	-0.0221172547929981
TIMP2	ITGB1	R-HSA-6806834	Signaling by MET	0.0175918446848212	0.0359448823047005	0.668074465129203	17	32	-0.0679633231453182
TIMP2	ITGB1	R-HSA-8874081	MET activates PTK2 signaling	0.00888315578231653	0.0245091622980174	0.668074465129203	3	6	-0.0403445401500417
TIMP2	ITGB1	R-HSA-8875878	MET promotes cell motility	0.0124306545813384	0.0301107409960122	0.668074465129203	7	13	-0.0320088913587108
TNFSF13	TNFRSF14	R-HSA-388841	Costimulation by the CD28 family	0.00253069282925067	0.0126480077785052	0.583995554320645	26	48	0.122978605168102
TNFSF13	TNFRSF14	R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.0118819232177065	0.0289773433574678	0.583995554320645	15	28	0.0548485690469575
TNFSF13	TNFRSF1A	R-HSA-5357905	Regulation of TNFR1 signaling	0.0300276656262392	0.0482849214258961	0.589997221450403	12	22	-0.0697415948874688
TNFSF13	TNFRSF1A	R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.0184833345545043	0.0362091553977585	0.589997221450403	15	28	0.0123367602111698
TNFSF13	TNFRSF1A	R-HSA-6783783	Interleukin-10 signaling	0.0117044435823939	0.0287630958874994	0.589997221450403	13	25	0.0392886913031398
TNFSF13	TNFRSF1A	R-HSA-73887	Death Receptor Signalling	0.00353827249183209	0.0153414674530782	0.589997221450403	31	57	0.106474020561267
TNFSF13	TNFRSF1A	R-HSA-75893	TNF signaling	0.0136428756678182	0.0312029851274732	0.589997221450403	18	33	0.049847872300897
TNFSF4	TNFRSF4	R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.00019543569655448	0.00233545657382603	0.705696026674076	15	28	0.202834120589053
TNFSF4	TRAF2	R-HSA-140534	Caspase activation via Death Receptors in the presence of ligand	0.0154189834570309	0.0330505564684341	0.447735482078355	3	6	0.0904140038899695
TNFSF4	TRAF2	R-HSA-3371378	Regulation by c-FLIP	0.0154189834570309	0.0330505564684341	0.447735482078355	3	6	0.0904140038899695
TNFSF4	TRAF2	R-HSA-5218900	CASP8 activity is inhibited	0.0154189834570309	0.0330505564684341	0.447735482078355	3	6	0.0904140038899695
TNFSF4	TRAF2	R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	0.0154189834570309	0.0330505564684341	0.447735482078355	3	6	0.0904140038899695
TNFSF4	TRAF2	R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.0078897179153841	0.0229956412411805	0.447735482078355	17	31	0.134092803556544
TNFSF4	TRAF2	R-HSA-69416	Dimerization of procaspase-8	0.0154189834570309	0.0330505564684341	0.447735482078355	3	6	0.0904140038899695
TNFSF9	TNFRSF9	R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.00994177659625941	0.0259681377760218	0.383195098607397	15	28	0.131621723015245
TNF	TNFRSF1B	R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.00885901629281792	0.0245091622980174	0.697916087802167	13	25	-0.0102806335093081
TNF	TNFRSF1B	R-HSA-6783783	Interleukin-10 signaling	0.012709361323398	0.0303093726440498	0.697916087802167	13	24	-0.0505848241349717
TNF	TNFRSF1B	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.00317252402799482	0.014635563720131	0.697916087802167	34	62	0.0835787718810781
TNF	TNFRSF21	R-HSA-1989781	PPARA activates gene expression	0.0057221957978014	0.0194350080188209	0.753363008530271	20	38	0.000166759317168953
TNF	TNFRSF21	R-HSA-400206	Regulation of lipid metabolism by PPARalpha	0.0057221957978014	0.0194350080188209	0.753363008530271	20	38	0.000166759317168953
TNF	TRAF2	R-HSA-109581	Apoptosis	0.00548376462478209	0.0193211756067261	0.789052514587386	41	75	0.00138927479855515
TNF	TRAF2	R-HSA-140534	Caspase activation via Death Receptors in the presence of ligand	0.00132072688697037	0.00832952504304956	0.789052514587386	3	6	0.0904140038899695
TNF	TRAF2	R-HSA-168928	DDX58/IFIH1-mediated induction of interferon-alpha/beta	0.00316956804896944	0.014635563720131	0.789052514587386	20	37	0.0360100027785496
TNF	TRAF2	R-HSA-3371378	Regulation by c-FLIP	0.00132072688697037	0.00832952504304956	0.789052514587386	3	6	0.0904140038899695
TNF	TRAF2	R-HSA-5213460	RIPK1-mediated regulated necrosis	0.00648698543832692	0.0203107797348489	0.789052514587386	5	10	-0.201389274798555
TNF	TRAF2	R-HSA-5218859	Regulated Necrosis	0.00648698543832692	0.0203107797348489	0.789052514587386	5	10	-0.201389274798555
TNF	TRAF2	R-HSA-5218900	CASP8 activity is inhibited	0.00132072688697037	0.00832952504304956	0.789052514587386	3	6	0.0904140038899695
TNF	TRAF2	R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	0.00132072688697037	0.00832952504304956	0.789052514587386	3	6	0.0904140038899695
TNF	TRAF2	R-HSA-5357786	TNFR1-induced proapoptotic signaling	0.00576551447069012	0.0194350080188209	0.789052514587386	4	8	-0.171436510141706
TNF	TRAF2	R-HSA-5357801	Programmed Cell Death	0.00671313084448129	0.0206710177102014	0.789052514587386	42	77	-0.0321200333425952
TNF	TRAF2	R-HSA-5357905	Regulation of TNFR1 signaling	0.00659988798179981	0.0205298033967482	0.789052514587386	11	21	-0.117477076965824
TNF	TRAF2	R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.0071073725889622	0.0212675478319924	0.789052514587386	11	20	-0.143873298138372
TNF	TRAF2	R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.000675800879513111	0.00553770549269601	0.789052514587386	17	31	0.134092803556544
TNF	TRAF2	R-HSA-5675482	Regulation of necroptotic cell death	0.00563680646088411	0.0194350080188209	0.789052514587386	4	9	-0.201389274798555
TNF	TRAF2	R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.00546082192251264	0.019287730632717	0.789052514587386	7	13	-0.0772992497916088
TNF	TRAF2	R-HSA-5688426	Deubiquitination	0.00323542403318991	0.014817213504938	0.789052514587386	41	76	0.0360100027785496
TNF	TRAF2	R-HSA-5689880	Ub-specific processing proteases	0.00689974611906956	0.0208299703889384	0.789052514587386	28	51	-0.0563489858293971
TNF	TRAF2	R-HSA-69416	Dimerization of procaspase-8	0.00132072688697037	0.00832952504304956	0.789052514587386	3	6	0.0904140038899695
TNF	TRAF2	R-HSA-73887	Death Receptor Signalling	0.00527074129664218	0.0191833579172205	0.789052514587386	29	54	-0.0101694915254237
TNF	TRAF2	R-HSA-75893	TNF signaling	0.00457182996806328	0.017436181314369	0.789052514587386	15	28	-0.0101694915254237
TNF	TRAF2	R-HSA-933541	TRAF6 mediated IRF7 activation	0.00380401411662523	0.0157587229041109	0.789052514587386	5	10	-0.048791330925257
TNF	TRAF2	R-HSA-933542	TRAF6 mediated NF-kB activation	0.00616198298839017	0.0197238473333739	0.789052514587386	7	14	-0.143873298138372
UBA52	TLR4	R-HSA-109581	Apoptosis	0.0105114133543357	0.0267732979575798	0.540094470686302	40	73	0.0774659627674354
UBA52	TLR4	R-HSA-1236974	ER-Phagosome pathway	0.0184220716704589	0.0362091553977585	0.540094470686302	8	15	0.037454848569047
UBA52	TLR4	R-HSA-1236975	Antigen processing-Cross presentation	0.0139856704243575	0.0316831775490183	0.540094470686302	12	22	0.0742428452347875
UBA52	TLR4	R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.00599913675841226	0.0195788570310922	0.540094470686302	46	84	0.0931925534870798
UBA52	TLR4	R-HSA-166058	MyD88:MAL(TIRAP) cascade initiated on plasma membrane	0.00824916583618602	0.0234719186919437	0.540094470686302	34	63	0.0817449291469853
UBA52	TLR4	R-HSA-166166	MyD88-independent TLR4 cascade	0.00507867213068559	0.0186738867574439	0.540094470686302	40	73	0.101972770213948
UBA52	TLR4	R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.00864337951859629	0.0243031494699354	0.540094470686302	36	66	0.0843011947763268
UBA52	TLR4	R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.00824916583618602	0.0234719186919437	0.540094470686302	34	63	0.0817449291469853
UBA52	TLR4	R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.00551595117860787	0.0193395452081264	0.540094470686302	35	64	0.101972770213948
UBA52	TLR4	R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.00824916583618602	0.0234719186919437	0.540094470686302	34	63	0.0817449291469853
UBA52	TLR4	R-HSA-168898	Toll-like Receptor Cascades	0.00698654468214804	0.0210476997357149	0.540094470686302	49	90	0.0843011947763268
UBA52	TLR4	R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.00824916583618602	0.0234719186919437	0.540094470686302	34	63	0.0817449291469853
UBA52	TLR4	R-HSA-2562578	TRIF-mediated programmed cell death	0.0102542287281091	0.0263051234277431	0.540094470686302	3	7	0.0112809113642679
UBA52	TLR4	R-HSA-5357801	Programmed Cell Death	0.0108393549320142	0.0274622526016048	0.540094470686302	41	75	0.0747429841622673
UBA52	TLR4	R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.0104804770004089	0.0267420000330719	0.540094470686302	2	5	-0.0159488746874132
UBA52	TLR4	R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.0188591412195097	0.036606495783969	0.540094470686302	3	6	-0.0159488746874132
UBA52	TLR4	R-HSA-5686938	Regulation of TLR by endogenous ligand	0.0169845750173374	0.0354009892076481	0.540094470686302	2	4	-0.0159488746874132
UBA52	TLR4	R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.0308046413828728	0.048816412045836	0.540094470686302	4	9	-0.140427896637955
UBA52	TLR4	R-HSA-937041	IKK complex recruitment mediated by RIP1	0.00913103357429062	0.024779463204473	0.540094470686302	7	14	0.0742428452347875
UBA52	TLR4	R-HSA-937061	TRIF(TICAM1)-mediated TLR4 signaling	0.00507867213068559	0.0186738867574439	0.540094470686302	40	73	0.101972770213948
UBA52	TLR4	R-HSA-937072	TRAF6-mediated induction of TAK1 complex within TLR4 complex	0.0142685969558493	0.0319705750541999	0.540094470686302	6	11	0.0742428452347875
UBA52	TLR4	R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.00769892791827783	0.0225772242020663	0.540094470686302	34	63	0.0843011947763268
UBA52	TLR4	R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.00551595117860787	0.0193395452081264	0.540094470686302	35	64	0.101972770213948
UBA52	TLR4	R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.0142685969558493	0.0319705750541999	0.540094470686302	6	11	0.0742428452347875
WNT11	FZD7	R-HSA-373080	Class B/2 (Secretin family receptors)	0.00933896005403296	0.0250841129920326	0.519548569692604	4	9	0.0448457904973604
WNT11	FZD7	R-HSA-4086400	PCP/CE pathway	0.030929277159125	0.0489003125095758	0.519548569692604	13	25	-0.0107252014448458
WNT11	FZD7	R-HSA-4608870	Asymmetric localization of PCP proteins	0.0275623830295377	0.0456502250101265	0.519548569692604	4	8	-0.0482911919977772
WNT3	RYK	R-HSA-201681	TCF dependent signaling in response to WNT	0.00436276783783104	0.0170468912246586	0.609002500694638	29	53	0.0992497916087802
WNT7B	FZD1	R-HSA-201681	TCF dependent signaling in response to WNT	0.0248792263581813	0.0431922646460435	0.469417817508969	29	54	0.0508474576271187
WNT7B	FZD1	R-HSA-373080	Class B/2 (Secretin family receptors)	0.0279903928034538	0.0460793893625722	0.469417817508969	4	8	-0.00172270075020839
WNT7B	FZD1	R-HSA-3858494	Beta-catenin independent WNT signaling	2.12303588260644e-07	1.54317078867813e-05	0.469417817508969	30	55	0.307196443456516
WNT7B	FZD1	R-HSA-4086400	PCP/CE pathway	0.021323536978952	0.0389982143732682	0.469417817508969	14	26	0.0669074742984162
WNT7B	FZD1	R-HSA-4608870	Asymmetric localization of PCP proteins	0.0175964486596233	0.0359448823047005	0.469417817508969	4	8	0.0589608224506808
WNT7B	FZD1	R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.00983150369689004	0.0257739968945893	0.469417817508969	11	21	0.108363434287302
WNT7B	LRP5	R-HSA-4791275	Signaling by WNT in cancer	0.0130929853413463	0.0306786617311939	0.322189804416232	9	18	0.120255626562934
WNT7B	LRP5	R-HSA-5663202	Diseases of signal transduction by growth factor receptors and second messengers	0.00162469340523697	0.00949162940395101	0.322189804416232	94	171	0.120255626562934
LGALS1	ITGB1	R-HSA-1500931	Cell-Cell communication	0.00953279639221084	0.0253148704193155	0.737038066129481	6	12	-0.144763961347661
LGALS1	ITGB1	R-HSA-1566948	Elastic fibre formation	0.00418830836436268	0.0165455487451683	0.737038066129481	2	4	-0.0242848608645396
LGALS1	ITGB1	R-HSA-195258	RHO GTPase Effectors	0.000215493722452145	0.00248236625611569	0.737038066129481	98	179	0.108641289247013
LGALS1	ITGB1	R-HSA-202733	Cell surface interactions at the vascular wall	0.00019333875903723	0.00232981328117133	0.737038066129481	28	51	0.167657682689636
LGALS1	ITGB1	R-HSA-210991	Basigin interactions	0.0016835297084031	0.00965672640740016	0.737038066129481	4	9	0.0583495415393165
LGALS1	ITGB1	R-HSA-216083	Integrin cell surface interactions	0.00273756718455808	0.0133526236144772	0.737038066129481	10	19	0.0734092803556544
LGALS1	ITGB1	R-HSA-3000157	Laminin interactions	0.00386540701913643	0.015792004744848	0.737038066129481	4	9	-0.0320088913587108
LGALS1	ITGB1	R-HSA-3000170	Syndecan interactions	0.00467429469170991	0.017732641766963	0.737038066129481	3	6	-0.0242848608645396
LGALS1	ITGB1	R-HSA-3000171	Non-integrin membrane-ECM interactions	0.00704428992145962	0.0211771734745767	0.737038066129481	6	11	-0.0320088913587108
LGALS1	ITGB1	R-HSA-3000178	ECM proteoglycans	0.00544189650037766	0.019287730632717	0.737038066129481	6	12	-0.0242848608645396
LGALS1	ITGB1	R-HSA-373760	L1CAM interactions	7.70132264054639e-05	0.00128415077517948	0.737038066129481	14	26	0.233009169213671
LGALS1	ITGB1	R-HSA-445144	Signal transduction by L1	0.00224187129695126	0.0117134917025525	0.737038066129481	5	10	0.077354820783551
LGALS1	ITGB1	R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	0.00999267271063184	0.0259728597088795	0.737038066129481	36	66	-0.0221172547929981
LGALS1	ITGB1	R-HSA-6806834	Signaling by MET	0.0100922030741837	0.0260655244707195	0.737038066129481	17	32	-0.0679633231453182
LGALS1	ITGB1	R-HSA-8874081	MET activates PTK2 signaling	0.00509614618028663	0.0186902138683658	0.737038066129481	3	6	-0.0403445401500417
LGALS1	ITGB1	R-HSA-8875878	MET promotes cell motility	0.00713129820252124	0.0212675478319924	0.737038066129481	7	13	-0.0320088913587108
ICAM1	SPN	R-HSA-202733	Cell surface interactions at the vascular wall	5.4673355232529e-05	0.00096242051669587	0.721644901361489	24	45	0.194998610725201
ICAM1	SPN	R-HSA-210991	Basigin interactions	0.00100310436924574	0.00716454875246052	0.721644901361489	3	6	0.181772714642956
CD1D	LILRB2	R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	4.05131323504202e-05	0.000788157455689555	0.302806335093081	14	27	0.299527646568491
CD274	CD80	R-HSA-1257604	PIP3 activates AKT signaling	5.74219874979604e-08	1.0465639948457e-05	0.683877177568522	55	100	0.242600588414216
CD274	CD80	R-HSA-199418	Negative regulation of the PI3K/AKT network	1.59986173338722e-06	6.19711129039264e-05	0.683877177568522	29	54	0.252726332501221
CD274	CD80	R-HSA-2219528	PI3K/AKT Signaling in Cancer	2.10926136806618e-05	0.000497755551234346	0.683877177568522	23	42	0.241515687262037
CD274	CD80	R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.0133285824327542	0.0310037649263371	0.683877177568522	10	19	-0.0621731814133439
CD274	CD80	R-HSA-388841	Costimulation by the CD28 family	0.0034401215323424	0.015272861539873	0.683877177568522	24	45	0.0771392537177641
CD274	CD80	R-HSA-389356	CD28 co-stimulation	0.0135180310899349	0.0310654752932157	0.683877177568522	11	21	-0.062312271304649
CD274	CD80	R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.00446882325308061	0.0173197095808584	0.683877177568522	8	15	0.0776956132829842
CD274	CD80	R-HSA-389359	CD28 dependent Vav1 pathway	0.0178848182994262	0.0361222949878552	0.683877177568522	4	8	-0.347530002414723
CD274	CD80	R-HSA-389513	CTLA4 inhibitory signaling	0.00842412703691715	0.0238739094287336	0.683877177568522	9	18	-0.0152720700652912
CD274	CD80	R-HSA-5663202	Diseases of signal transduction by growth factor receptors and second messengers	3.6540854500563e-07	2.16451757873361e-05	0.683877177568522	95	173	0.180594314870438
CD274	CD80	R-HSA-6783783	Interleukin-10 signaling	0.00181375240640274	0.0101456895313269	0.683877177568522	13	25	0.112851056206487
CD274	CD80	R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	1.21974309944674e-06	5.14444589590183e-05	0.683877177568522	28	51	0.274424355544804
CD274	CD80	R-HSA-9006925	Intracellular signaling by second messengers	6.50679027086177e-09	1.55512287473596e-06	0.683877177568522	67	122	0.241515687262037
ANXA1	FPR3	GO:0007204	positive regulation of cytosolic calcium ion concentration	0.000918511252353197	0.00675459044038197	0.830529653281478	3	6	0.0836088537073582
B2M	CD247	GO:0002250	adaptive immune response	0.0149297517861124	0.0326858993302064	0.371637961371049	18	34	0.102910406808122
B2M	CD247	GO:0038096	Fc-gamma receptor signaling pathway involved in phagocytosis	0.0170417091480091	0.0354685209263354	0.371637961371049	41	75	0.0918354728144041
B2M	CD247	GO:0050776	regulation of immune response	0.00411877200186701	0.016315798482534	0.371637961371049	18	33	0.169555286684674
B2M	CD247	GO:0050852	T cell receptor signaling pathway	0.00628066549672355	0.0199584128472412	0.371637961371049	27	50	0.130025862329264
CCL2	CCR4	GO:0007204	positive regulation of cytosolic calcium ion concentration	0.0153268186891104	0.0330505564684341	0.608640659128083	3	6	-0.0631871643330413
CCL5	CCR4	GO:0007204	positive regulation of cytosolic calcium ion concentration	0.00334217361126775	0.0150642891260266	0.79583024220251	3	6	-0.0631871643330413
CD40LG	CD40	GO:0033209	tumor necrosis factor-mediated signaling pathway	0.00977886866421061	0.0257225638027258	0.40655737704918	12	23	0.122311753264796
CD40LG	CD40	GO:0051092	positive regulation of NF-kappaB transcription factor activity	0.0013501968403285	0.00838174142437695	0.40655737704918	23	42	0.185273687135315
COL5A2	DDR1	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	9.29192383574734e-05	0.00146424382202876	0.557877188107808	8	15	0.326590719644346
COL5A2	DDR1	GO:0038083	peptidyl-tyrosine autophosphorylation	0.0266580194258396	0.0448680749491244	0.557877188107808	4	9	-0.133301995228297
CXCL10	CXCR3	GO:0007204	positive regulation of cytosolic calcium ion concentration	0.0237226936868589	0.0414857838377508	0.434884545371258	3	6	0.0439566546262851
GNAI2	CXCR3	GO:0007204	positive regulation of cytosolic calcium ion concentration	0.00530100588245347	0.0191960667561573	0.667574326201723	3	6	0.0439566546262851
LTB	CD40	GO:0033209	tumor necrosis factor-mediated signaling pathway	0.00920422519733059	0.0248832150058042	0.418116143373159	12	23	0.122311753264796
LTB	CD40	GO:0051092	positive regulation of NF-kappaB transcription factor activity	0.00127085414538707	0.00826846703367296	0.418116143373159	23	42	0.185273687135315
SEMA4A	PLXNB2	GO:0008360	regulation of cell shape	0.00108347373236882	0.00743397766610949	0.582328424562379	17	32	0.162545151430953
SEMA4A	PLXNB2	GO:0030334	regulation of cell migration	0.00169452401981545	0.00966589506281853	0.582328424562379	7	13	0.206724090025007
SEMA4D	PLXNB2	GO:0008360	regulation of cell shape	0.000374191720152844	0.00363954807596127	0.724701305918311	17	32	0.162545151430953
SEMA4D	PLXNB2	GO:0030334	regulation of cell migration	0.000585225870154472	0.00496576270888469	0.724701305918311	7	13	0.206724090025007
TGFB1	ENG	GO:0051897	positive regulation of protein kinase B signaling	0.000149638220205662	0.00195641407931247	0.74131703250903	15	28	0.201833842734093
TIMP1	CD63	GO:0016477	cell migration	6.84548992542224e-05	0.0011686229229828	0.840344540150042	21	39	0.175545367819332
